WO2012158630A1 - Sorghum maturity gene and uses thereof in modulating photoperiod sensitivity - Google Patents

Abstract

Compositions relating to the sorghum maturity gene 1 (Ma1) and expression control sequences and methods of use thereof are provided. The compositions can be used to modulate flowering and photoperiod sensitivity in a plant. For example, methods are provided for developing genetically modified plant varieties in which flowering is accelerated, delayed or prevented. Methods are provided for treating a plant in order to delay flowermg in the plant. Methods of placing a polynucleotide of interest, such a gene, under photoperiod sensitive control or photoperiod insensitive control are also provided. Screening methods are for identifying chemical agents that can modify photoperiod sensitivity are also disclosed.

Description

SORGHUM MATURITY GENE AND USES THEREOF IN MODULATING PHOTOPERIOD SENSITIVITY

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

This invention was made with Government Support under Agreement 00-35300-9215 awarded by the US Department of Agriculture. The

Government has certain rights in the invention.

FIELD OF THE INVENTION

The invention is generally related to the field of plant genetics and molecular biology, more particularly to genes involved in plant photoperiod sensitivity, and methods for modifying photoperiod sensitivity in plants.

BACKGROUND OF THE INVENTION

Biomass yield is one of the most important attributes of a biomass or bioenergy crop designed for ligno-cellulosic conversion to biofuels or bioenergy. To maximize yield, it is essential to tailor the plants' life cycle to the agro-environments in which they are grown. The transition from vegetative to reproductive growth is a critical developmental switch and a key adaptive trait that ensures that plants set their flowers at an optimum time for pollination, seed development, and dispersal. For example, temperate environments with a long growing season allow cereal crops to exploit an extended vegetative period for resource storage. Conversely, early flowering has evolved as an adaptation to short growing seasons.

For example, once grain sorghum initiates flowering, growth of the vegetative plant (stem, leaves) decreases so that carbon and nitrogen compounds can be used for grain production. As a consequence, biomass accumulation overall decreases to some extent during the reproductive phase and largely ceases once grain filling has been completed.

In contrast, a late or non-flowering bioenergy sorghum crop grown for biomass production will continue to accumulate biomass by building larger vegetative plants until frost or adverse environmental conditions inhibit photosynthesis. It is estimated that late/non-flowering biomass sorghum will generate more than two times the biomass accumulated by grain sorghum per acre assuming reasonable growth conditions throughout the growing season.

Flowering is generally controlled by environmental factors, such as daylength. Daylength regulates flowering by a phenomenon known as photoperiod sensitivity, which allows plants to coordinate their reproduction with the environment or with other members of their species. Photoperiod sensitivity refers to the fact that some plants will not flower until they are exposed to day lengths that are less than a critical photoperiod (short day plants) or greater than a critical photoperiod (long day plants). Long day (LD) and short day (SD) plant designations refer to the day length required to induce flowering. Facultative LD or SD plants are those that show accelerated flowering in LD or SD but will eventually flower regardless of photoperiod.

Therefore, it is an object of the invention to provide a gene in sorghum responsible for genetic control of photoperiod sensitivity.

It is another object of the invention to provide late or non-flowering recombinant sorghum plants.

It is yet another object of the invention to provide methods for modifying photoperiod sensitivity in plants.

It is a further object of the invention to provide methods for imposing photoperiod sensitivity on a plant process.

SUMMARY OF THE INVENTION

Compositions including the nucleic acid sequence of the sorghum Maturity gene 1 (Mai), and expression control sequences thereof are disclosed. The expression control sequence can be photoperiod sensitive or photoperiod insensitive. The compositions and methods can be used to modulating flowering in plants, particularly sorghum.

Methods of using the compositions for modulating photoperiod sensitivity for flowering and other plant processes in a plant are provided. For example, methods are provided for developing genetically modified plant varieties in which flowering is accelerated, or delayed or prevented. Methods are also provided for treating a plant in order to accelerate or delay flowering in the plant. Methods and compositions for placing a polynucleotide of interest under photoperiod sensitive or photoperiod insensitive control are also disclosed. The compositions and methods and can be used, for example, to make photoperiod sensitive a gene that is normally or naturally photoperiod insensitive. In other embodiments, compositions and methods and can be used to make photoperiod insensitive a gene that is normally or naturally photoperiod sensitive.

Screening methods are also provided for identifying plants for photoperiod sensitivity and chemical agents that can modify photoperiod sensitivity.

BRIEF DESCRIPTION OF THE DRAWINGS

Figure 1 is a bar graph showing frequency distribution of F₂ population of S. bicolor x S. propinquum as a function of flowering time. Also shown is a boxed line indicating average day length (hrs) over the time period. Also shown are two lines indicating the high (solid line) and low (dashed) temperature during the time period. S. propinquum and most F₂s flowered when photoperiod was less than 12.5 hours. Segregation of the S, bicolor and S. propinquum alleles at the Mai locus imparts dichotomous phenotype when grown in a temperate environment

Figure 2 A is a diagram mapping the 1.1 centiMorgan (cM) interval delineated by progeny testing of recombinants. Figure 2B is a diagram showing the % of conversion at the DNA marker loci plotted along the sorghum genome sequence (on base pair, bp, scale). The diagram also maps the relative locations of the FT gene (Sb06g012260) and SbPRR37

(Sb06g012570). The dark line at the top of the diagram indicates the span of converted regions with approximate locations of genes in the sequence shown as cross-hatches along the axis. While the terminal regions that these data exclude from consideration are physically small, they contain the majority of genes.

Figure 3 A is a diagram illustrating two major S. bicolor haplotypes

(each with two rare variants) for the gene Sb06g012260 identified from analysis of re-sequencing data. One of the haplotypes (haplotype 1) closely resembled the allele found in the short-day flowering accession of Sorghum propinquum. Figure 3B is a physical map showing the positions of four insertion-deletion events relative to the coding region of Sb06g012260. Figure 3C is a diagram comparing the PRR37 alleles in S, bicolor (top) and S. propinquum (bottom). The S. propinquum allele has an "AT" insertion between 97 and 98 nucleotides after the translation starting site. This insertion causes frameshift shortly before the beginning of the PRR domain (arrowhead), leading to numerous nonsense mutations (arrows) and resulting in premature protein termination near the end of the PRR domain. Coding regions are shown as boxes, introns as solid horizontal lines, vertical bars indicate nucleotide substitutions between the two alleles.

Figure 4 is a series of pie graphs showing haplotype frequencies for the gene Sb06g012260 in sub-populations from West Africa, South Africa, Central/ East Africa, and Asia/ India.

Figure 5A-5C are bar graphs showing flowering (days) for individuals having haplotype 1 of Figure 3 A (empty bars) or haplotype 2 of Figure 3 A (shaded bars) for the gene Sb06g012260 in West Africa (Fig. 5 A, 2008 p=0.005; R²=0.13) and South Africa (Fig. 5B (2008), p-3.84 E-08; R² >.33) and Fig. 5C (2007), p=0.0346; R²=O.08). These data show a statistically-significant association of the haplotypes with flowering in subpopulations in which the two haplotypes each occur at similar frequencies.

Figure 6 is a line graph of log p value versus Mai region (Mbp) showing the association analysis of Mai region markers and photoperiod sensitive in Sorghum bicolor based on routine application of the software TASSEL (Bradbury, et al, Bioinformatics, 23:2633-2635 (2007)), as detailed below. (♦) single marker analysis; (e)analysis considering population structure.

Figure 7 is a diagram showing homologs identified by BLAST of a candidate Mai gene (Sb06g012260) in sorghum, rice, and Arabidopsis genomes; and maize and sugarcane ESTs. DETAILED DESCRIPTION OF THE INVENTION I. Definitions

Before describing the various embodiments, it is to be understood that the invention is not limited in its application to the details of

construction and the arrangement of the components set forth in the following description. Other embodiments can be practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

Unless otherwise indicated, the disclosure encompasses conventional techniques of plant breeding, microbiology, cell biology and recombinant DNA, which are within the skill of the art. See, e.g., Sambrook and Russell, Molecular Cloning: A Laboratory Manual, 3rd edition (2001); Current Protocols In Molecular Biology [(F. M. Ausubel, et al. eds., (1987)]; Plant Breeding: Principles and Prospects (Plant Breeding, Vol 1) M. D. Hayward, N. O. Bosemark, I. Romagosa; Chapman & Hall, (1993); Coligan, Dunn, Ploegh, Speicher and Wingfeld, eds. (1995) Current Protocols in Protein Science (John Wiley & Sons, Inc.); the series Methods in Enzymology (Academic Press, Inc.): PCR 2: A Practical Approach (M. J. MacPherson, B. D. Hames and G. R. Taylor eds. (1995)].

Unless otherwise noted, technical terms are used according to conventional usage. Definitions of common terms in molecular biology may be found in Lewin, Genes VII, published by Oxford University Press, 2000; Kendrew et al. (eds.), The Encyclopedia of Molecular Biology, published by Wiley-Interscience., 1999; and Robert A. Meyers (ed.)_? Molecular Biology and Biotechnology, a Comprehensive Desk Reference, published by VCH Publishers, Inc., 1995; Sambrook and Russell. (2001) Molecular Cloning: A Laboratory Manual 3rd. edition, Cold Spring Harbor Laboratory Press.

To facilitate understanding of the disclosure, the following definitions are provided:

The term "plant" is used in it broadest sense. It includes, but is not limited to, any species of woody, ornamental or decorative crop or cereal, and fruit or vegetable plant. It also refers to a plurality of plant cells that are largely differentiated into a structure that is present at any stage of a plant's development. Such structures include, but are not limited to, a fruit, shoot, stem, leaf, flower petal, etc.

The term "photoperiod" refers to the period of a plant's exposure to daylight every 24 hours.

The term "photoperiod sensitivity" refers to the photoperiod that is required to induce a specific response, such as flowering. Some plants will not flower until they are exposed to day lengths that are less than a critical photoperiod (short day plants) or greater than a critical photoperiod (long day plants). In some plant species, photoperiodic control enforces long-day flowering. Therefore, a photoperiod sensitive plant can have either short-day or long-day flowering, but in both cases, the flowering is controlled by day length.

A plant is "photoperiod insensitive" or "day neutral" if the day length does not impact when flowering occurs. In order to modulate flowering based on day length, photoperiod sensitivity can be increased.

A "non-flowering" plant does not flower under the agronomic conditions, regardless of the photoperiod.

"Delayed flowering" refers to a plant that flowers on average at least 1 day later, including at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 days later, than a wild-type plant of the same species.

The term "non-naturally occurring plant" refers to a plant that does not occur in nature without human intervention. Non-naturally occurring plants include transgenic plants and plants produced by non-transgenic means such as plant breeding.

The term "plant tissue" includes differentiated and undifferentiated tissues of plants including those present in roots, shoots, leaves, pollen, seeds and tumors, as well as cells in culture (e.g., single cells, protoplasts, embryos, callus, etc.). Plant tissue may be in planta, in organ culture, tissue culture, or cell culture. The term "plant part" as used herein refers to a plant structure, a plant organ, or a plant tissue. The term "plant material" refers to leaves, stems, roots, flowers or flower parts, fruits, pollen, egg cells, zygotes, seeds, cuttings, cell or tissue cultures, or any other part or product of a plant.

The term "plant organ^*' refers to a distinct and visibly structured and differentiated part of a plant such as a root, stem, leaf, flower bud, or embryo.

The term "plant cell" refers to a structural and physiological unit of a plant, comprising a protoplast and a cell wall. The plant cell may be in form of an isolated single cell or a cultured cell, or as a part of higher organized unit such as, for example, a plant tissue, a plant organ, or a whole plant.

The term "plant cell culture" refers to cultures of plant units such as, for example, protoplasts, cell culture cells, cells in plant tissues, pollen, pollen tubes, ovules, embryo sacs, zygotes and embryos at various stages of development.

The term "transgenic plant" refers to a plant or tree that contains recombinant genetic material not normally found in plants or trees of this type and which has been introduced into the plant in question (or into progenitors of the plant) by human manipulation. Thus, a plant that is grown from a plant cell into which recombinant DNA is introduced by

transformation is a transgenic plant, as are all offspring of that plant that contain the introduced transgene (whether produced sexually or asexually). It is understood that the term transgenic plant encompasses the entire plant or tree and parts of the plant or tree, for instance grains, seeds, flowers, leaves, roots, fruit, pollen, stems etc.

The term "construct" refers to a recombinant genetic molecule having one or more isolated polynucleotide sequences. Genetic constructs used for transgene expression in a host organism include in the 5' -3' direction, a promoter sequence; a sequence encoding a gene of interest; and a termination sequence. The construct may also include selectable marker gene(s) and other regulatory elements for expression.

The term "gene" refers to a DNA sequence that encodes through its template or messenger R A a sequence of amino acids characteristic of a specific peptide, polypeptide, or protein. The term "gene" also refers to a DNA sequence that encodes an RNA product. The term gene as used herein with reference to genomic DNA includes intervening, non-coding regions as well as regulatory regions and can include 5' and 3' ends.

The term "orthologous genes" or "orthologs" refer to genes that have a similar nucleic acid sequence because they were separated by a speciation event.

As used herein, "polypeptide" refers generally to peptides and proteins having more than about ten amino acids. The polypeptides can be "exogenous," meaning that they are "heterologous," i.e., foreign to the host cell being utilized, such as human polypeptide produced by a bacterial cell.

The term "isolated" is meant to describe a compound of interest (e.g., nucleic acids) that is in an environment different from that in which the compound naturally occurs, e.g., separated from its natural milieu such as by concentrating a peptide to a concentration at which it is not found in nature. "Isolated" is meant to include compounds that are within samples that are substantially enriched for the compound of interest and/or in which the compound of interest is partially or substantially purified. Isolated nucleic acids are at least 60% free, preferably 75% free, and most preferably 90% free from other associated components. An "isolated" nucleic acid molecule or polynucleotide is a nucleic acid molecule that is identified and separated from at least one contaminant nucleic acid molecule with which it is ordinarily associated in the natural source. The isolated nucleic can be, for example, free of association with all components with which it is naturally associated. An isolated nucleic acid molecule is other than in the form or setting in which it is found in nature.

As used herein, the term "linkage disequilibrium" or "LD" refers to the situation in which the alleles for two or more loci do not occur together in individuals sampled from a population at frequencies predicted by the product of their individual allele frequencies. Markers that are in LD do not follow Mendel's second law of independent random segregation. LD can be caused by any of several demographic or population artifacts as well as by the presence of genetic linkage between markers. However, when these artifacts are controlled and eliminated as sources of LD, then LD results directly from the fact that the loci involved are located close to each other on the same chromosome so that specific combinations of alleles for different markers (haplotypes) are inherited together. Markers that are in high LD can be assumed to be located near each other and a marker or haplotype that is in high LD with a genetic trait can be assumed to be located near the gene that affects that trait.

As used herein, the term "locus" refers to a specific position along a chromosome or DNA sequence. Depending upon context, a locus could be a gene, a marker, a chromosomal band or a specific sequence of one or more nucleotides.

The term "vector" refers to a replicon, such as a plasmid, phage, or cosmid, into which another DNA segment may be inserted so as to bring about the replication of the inserted segment. The vectors can be expression vectors.

The term "expression vector" refers to a vector that includes one or more expression control sequences

The term "expression control sequence" refers to a DNA sequence that controls and regulates the transcription and/or translation of another DNA sequence. Control sequences that are suitable for prokaryotes, for example, include a promoter, optionally an operator sequence, a ribosome binding site, and the like. Eukaryotic cells are known to utilize promoters, polyadenylation signals, and enhancers.

The term "promoter" refers to a regulatory nucleic acid sequence, typically located upstream (5') of a gene or protein coding sequence that, in conjunction with various elements, is responsible for regulating the expression of the gene or protein coding sequence. The promoters suitable for use in the constructs of this disclosure are functional in plants and in host organisms used for expressing the disclosed polynucleotides. Many plant promoters are publicly known. These include constitutive promoters, inducible promoters, tissue- and cell-specific promoters and

developmentally-regulated promoters. Exemplary promoters and fusion promoters are described, e.g., in U.S. Pat. No. 6,717,034, which is herein incorporated by reference in its entirety. A nucleic acid sequence or polynucleotide is "operably linked" when it is placed into a functional relationship with another nucleic acid sequence. For example, DNA for a presequence or secretory leader is operably linked to DNA for a polypeptide if it is expressed as a preprotein that participates in the secretion of the polypeptide; a promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; or a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation. Generally, "operably linked" means that the DNA sequences being linked are contiguous and, in the case of a secretory leader, contiguous and in reading frame. Linking can be accomplished by ligation at convenient restriction sites. If such sites do not exist, synthetic oligonucleotide adaptors or linkers are used in accordance with conventional practice.

"Transformed," "transgenic," "transfected" and "recombinant" refer to a host organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule can be stably integrated into the genome of the host or the nucleic acid molecule can also be present as an extrachromosomal molecule. Such an

extrachromosomal molecule can be auto-replicating. Transformed cells, tissues, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof. A "non- transformed," "non-transgenic," or "non-recombinant" host refers to a wild- type organism, e.g., a bacterium or plant, which does not contain the heterologous nucleic acid molecule.

The term "endogenous" with regard to a nucleic acid refers to nucleic acids normally present in the host.

The term "heterologous" refers to elements occurring where they are not normally found. For example, a promoter may be linked to a

heterologous nucleic acid sequence, e.g., a sequence that is not normally found operably linked to the promoter. When used herein to describe a promoter element, heterologous means a promoter element that differs from that normally found in the native promoter, either in sequence, species, or number. For example, a heterologous control element in a promoter sequence may be a control/ regulatory element of a different promoter added to enhance promoter control, or an additional control element of the same promoter. The term "heterologous" thus can also encompasses "exogenous" and "non-native" elements.

The term "percent (%) sequence identity" is defined as the percentage of nucleotides or amino acids in a candidate sequence that are identical with the nucleotides or amino acids in a reference nucleic acid sequence, after aligning the sequences and introducing gaps, if necessary, to achieve the maximum percent sequence identity. Alignment for purposes of determining percent sequence identity can be achieved in various ways that are within the skill in the art, for instance, using publicly available computer software such as BLAST, BLAST-2, ALIGN, ALIGN-2 or Megalign (DNASTAR) software. Appropriate parameters for measuring alignment, including any algorithms needed to achieve maximal alignment over the full-length of the sequences being compared can be determined by known methods.

For purposes herein, the % sequence identity of a given nucleotides or amino acids sequence C to, with, or against a given nucleic acid sequence D (which can alternatively be phrased as a given sequence C that has or comprises a certain % sequence identity to, with, or against a given sequence D) is calculated as follows:

100 times the fraction W/Z,

where W is the number of nucleotides or amino acids scored as identical matches by the sequence alignment program in that program's alignment of C and D, and where Z is the total number of nucleotides or amino acids in D. It will be appreciated that where the length of sequence C is not equal to the length of sequence D, the % sequence identity of C to D will not equal the % sequence identity of D to C.

As used herein, "polypeptide" refers generally to peptides and proteins having more than about ten amino acids. The polypeptides can be "exogenous " meaning that they are "heterologous," i.e., foreign to the host cell being utilized, such as human polypeptide produced by a bacterial cell.

The term "stringent hybridization conditions" as used herein mean that hybridization will generally occur if there is at least 95% and preferably at least 97% sequence identity between the probe and the target sequence. Examples of stringent hybridization conditions are overnight incubation in a solution comprising 50% formamide, 5X SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5X Denhardt's solution, 10% dextran sulfate, and 20 μg/ml denatured, sheared carrier DNA such as salmon sperm D A, followed by washing the hybridization support in 0.1X SSC at approximately 65°C. Other hybridization and wash conditions are well known and are exemplified in Sambrook et al, Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring Harbor, N.Y. (2000).

II. Compositions

Photoperiod sensitivity refers to the fact that some plants will not flower until they are exposed to day lengths that are less than a critical photoperiod (short day plants) or greater than a critical photoperiod (long day plants). Long day (LD) and short day (SD) plant designations refer to the day length required to induce flowering. Facultative LD or SD plants are those that show accelerated flowering in LD or SD but will eventually flower regardless of photoperiod. Most plants including sorghum must pass tlirough a juvenile stage (lasting about 14-21 days for sorghum) before they become sensitive to photoperiod.

In general, Sorghum is a facultative SD plant where long days inhibit flowering and short days accelerate flowering. The degree of flowering photoperiod sensitivity in sorghum refers to the length of the short days that are required to induce flowering. Different sorghum genotypes vary in their degree of photoperiod sensitivity. For example, Sorghum inbreds have been identified with photoperiod sensitivity ranging from -10.5 to -14 hours and still others that are nearly completely insensitive to photoperiod.

Flowering depends on when seeds are planted and on the latitude in which they are planted. Therefore, in some embodiments, a photoperiod insensitive sorghum planted in Georgia in April can flower in approximately 48-55 days; whereas a highly photoperiod sensitive sorghum planted in Georgia in April can flower in -175-180 days, or may even fail to flower at all. The maturity gene (Mai) contains one or more mutation or deletions in some S. bicolor genotypes such that sorghum plants containing this mutant gene are photoperiod insensitive (day-neutral). Identification of this gene allows for identification of orthologous genes in related plants. Moreover, based on this identification, methods of modulating photoperiod sensitivity in plants by modulating the expression control sequences of maturity gene in that plant are disclosed. Methods are also disclosed for modulating photoperiod sensitivity involving modulating the activity of the protein encoded by the Maturity (Mai) gene in the plant.

A. Mai

Compositions and methods for modifying photoperiod sensitivity in plants are provided. The methods can involve modulating the activity of the endogenous gene or gene(s) responsible for photoperiod sensitivity in the plant.

For example, the methods can involve promoting the expression of one or more endogenous gene orthologous to sorghum grain maturity gene 1 (Mai ). Thus, the methods can involve introducing to the plant a composition that promotes maturity gene 1 (Mai) activity in a Sorghum plant.

The term "Maturity gene" refers to the Mai gene found in Sorghum as well as orthologous genes serving the same function in related plants.

Sorghum

Sorghum has been an excellent biomass source with its high yield potential, high water use efficiency, and established production systems and is a representative plant that can be used with the disclosed methods and compositions. Sorghum is a genus of numerous species of grasses, some of which are raised for grain and some of which are used as fodder plants either cultivated or as part of pasture. The plants are cultivated in warmer climates worldwide. Sorghum is in the subfamily Panicoideae and the tribe

Andropogoneae.

Sorghum is well adapted to growth in hot, arid or semi-arid areas.

The many subspecies are divided into four groups— grain sorghums (such as milo), grass sorghums (for pasture and hay), sweet sorghums (used to produce sorghum syrups), and broom corn (for brooms and brushes). Sorghum species include, but are not limited to Sorghum almum, Sorghum amplum, Sorghum angustwn, Sorghum arundinaceum, Sorghum bicolor, Sorghum brachypodum, Sorghum bulbosum, Sorghum burmahicum, Sorghum controversum, Sorghum drummondii, Sorghum ecarinatum, Sorghum exstans, Sorghum grande, Sorghum halepense, Sorghum

inter jectum, Sorghum intrans, Sorghum laxiflorum, Sorghum leiocladum, Sorghum macrospermum, Sorghum matarankense, Sorghum miliaceum, Sorghum nigrum, Sorghum nitidum, Sorghum plumosum, Sorghum propinquum, Sorghum purpureosericeum, Sorghum stipoideum, Sorghum timorense, Sorghum trichocladum, Sorghum versicolor, Sorghum virgatum, and Sorghum vulgar e.

Sorghum Maturity Gene 1

There are six classic maturity genes in sorghum that control flowering time temied Mal-Ma6. Therefore, in general, sorghum plants with recessive Mai -Ma6 genes (with low or no activity) flower earlier than plants with dominant or active Mal-Ma6 genes that repress flowering.

Nucleic acid sequences for Mai genes in Sorghum bicolor and Sorghum propinquum are provided. It is understood that the skilled artisan can identify orthologous sequences in other Sorghum species for use in the present compositions and methods. For example, Mai genes from Sorghum almum, Sorghum amplum, Sorghum angustum, Sorghum arundinaceum, Sorghum brachypodum, Sorghum bulbosum, Sorghum burmahicum, Sorghum controversum, Sorghum drummondii, Sorghum ecarinatum, Sorghum exstans, Sorghum grande, Sorghum halepense, Sorghum interjectum, Sorghum intrans, Sorghum laxiflorum, Sorghum leiocladum, Sorghum macrospermum, Sorghum matarankense, Sorghum miliaceum, Sorghum nigrum, Sorghum nitidum, Sorghum plumosum, Sorghum purpureosericeum, Sorghum stipoideum, Sorghum timorense, Sorghum trichocladum, Sorghum versicolor, Sorghum virgatum, and Sorghum vulgar e can be identified and used in the disclosed methods.

Within the species Sorghum bicolor, there are both day-neutral (photoperiod insensitive) and short-day flowering forms. The vast majority of wild members of the species are short-day, as are forms cultivated in the tropics. Forms cultivated in temperate latitudes (such as most of the USA) for seed/grain have been selected for day-neutral mutations. Therefore, the skilled artisan can use the guidance provided by the sequence comparisons to identify variants of Mai genes that can generate a photoperiod sensitive or insensitive phenotype.

Also disclosed is a transgenic plant having a nucleic acid molecule, or antisense constructs thereof, encoding a Ma 1 gene product, or variant, such as a codon optimized variant thereof, optionally operatively linked to an heterologous regulatory element. For example, disclosed is a transgenic plant characterized by high photoperiod sensitivity, low photoperiod sensitivity, or photoperiod insensitivity, wherein the cells of the plant express a nucleic acid molecule encoding an Mai gene product, or antisense construct thereof, that is operatively linked to an expression control sequence. In some embodiments, the construct encodes an inhibitory nucleic acid such as siRNA or RNAi that when express down regulates the expression of Mai .

Nucleic Acids

Mai gene

Disclosed are polynucleotides containing a maturity gene from a sorghum plant. It is understood that where coding sequences for a maturity gene are provided, also provided are the non-coding sequences that are known or can be identified to correspond to the coding sequences that are provided. For example, where a maturity gene is provided, also provided for use in the disclosed compositions and methods is the 5' untranslated region (UTR), which contains the endogenous promoter for the maturity gene. It is understood that the skilled artisan can identify these sequences with routine skill and experimentation based on the sequences that are provided.

1. Sequences for Short Day Flowering

The S. propinquum cultivar from which the sequences described below are derived is a short-day cultivar, that has a dominant (functional) Mai allele. Sequences for a dominant Mai gene are therefore provided. In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in short day 5. propinquum includes the nucleic acid sequence:

1 AAAAGAAAAG TGAGCACACC ACGACCTGTC ATCAGCTCAT GGTCAGCTCT ACAAACTTAT

61 AGATTGCATC GAGATCTAAG ACTCAGGTAC AAATCATGTC AACATCTAAT GGTTTAGAAA

121 ATGAAAAGTT TTGAGTTTCA AAATATGATA CGTGATATTA ACATTTGAAC TTTTAGCAAG

181 ATCTGAAATA AAAAATTCAA CTAGATCATG TTAACATTGA TATAATCGCT TCCAATCGCC

241 TCCCATCACT TCCGCTAGAA AACTTTTTTT CTCGATTTAA TTAATGAAAG GGTAATAACA

301 TCATTGTACA AGATTCTTTC AAACCTCAAC CCCTATCATC GACGGTGACG GCTCCCTATA

361 ACACGCACTA GTGGACGCCG GGCGGGTGGA ACCCTAAGAA GATTTAAAAA AACTTAAGAA

421 GAAGATTTTT ATCTAACTAA CTATAGTACT TATATCATAC ACTATACTAT TCAAAATATT

481 ATTTTCACAA TATGAATTT ACCCTTTTAC TCTTCATTAA AAAAATACGA AAAAAGAATC

541 ACCACGTCTC TATTTAGGGT CCTAGTCCCC ATAATTTAAG AGGCGGTGAG AGACGATGTG

601 ACGTCTATGG ACCACCGACC AAAGACACAC CTATCGTCTC CCATCGCCTT GCTTCCATCG

661 CCTCTCATCG CTTTTCATAT TCTAGATCCA GCGGCCATAG ACACACCAAT CGTTTCTCAT

721 CGCCTCTCCA ACCATTGTAA AAATATTTAT AATTTTGATA TAAAATTTGT CTTCACTTGA

781 GTTCATGCCA AAAAAATTAT ACATATTATT TTCGTGTGAG AATTTACAGA AGTGGACTCT

841 TAAGATGTCC AAATGTAAAT GACCCTATTT ATTATGAGGC GCGGATCTAT AGGCCTGACT

901 CTGAAAATGG ATTATGGATT TGAGATAATA AATTTAAGGG CCTATCTTCG CACATAACAT

961 CTATAGTTCC TAAATTTTTT TTTATTGTAG TAGTAGAACT TTTCTCCCTG TAAACCAAGT

1021 TGACGCTGGG CTTTATTTTG CGACACAGAA CACCAAATTG GTGGCTATGA ACTCTTCCAC

1081 CTGGGCAGGG AAAACGGTTT ATTATGTTTC TCTTTAATTT ATCTATCGTG GCACTATAAC

1141 ACAACATGGC TTTGCCGACA CTTCCAACTA TCGGCAAAGG GTACCTTTAC CGACACTTAA

1201 CGTCTCACGA AAGGTTTTGC CGACAATTTT CAAACAGTCG CGGTAGAAGC AGTTGGCGAA

1261 ACTTTTGCCG ACAGTTAAAG GCATCGCCGA CACATTTTCT GTAGTCAAAT GGCATACCTA

1321 CGCCGACAGT TGAACTTTCA CCGACAGTGA ACCCTTTGCC GACAGTTTGG ACCTACGCCG

1381 ACAGTTTGGA CCTTTTCCGA CAGTTGGTAT GTTAGCGAAA CCGTTTCTAG GGTGTTTCAT

1441 AAACCATGCC TTGTCCAACA GTAGAAGTGT CGGCAAAACT ATATTGCTAG GATGTAGATA

1501 CAATTTAAAT ΑΤΤΤΤΑΑΤΑΛ ATACACATCA CATTGATTGA GCAAAATCAC ATGGTCTGTT

1561 TTCACTAAAA CTGTCAGAGG TACACTCCAG TACTACCAGT ACGTCGCCCG CACAGTGGCC

1621 AAGGATTTTA CTGCTACTGT TGATTAACAT AAGCACTTGC GACTTTCCCT AAAATCTTTT

1681 ATAAAACAAC GGCCGCAATA ATATTGAACT ATTTTTTTTC TAGTACCAAA ATTAGAATTT

1741 GATCCCTCAC CTCATTACAT CCATAGTAAC ATGACCAGAT ATATATGGAC AGGATGGGAT

1801 CACTCAGCGA GCAGATACAC TGAGCGATTC ATAATCAGAT TTTTTAATTT CTTCTAGTGA

1861 AGTGGGGTTT TCCTAGTCTT TTAACATTCA AAATTTAGTA CAAACTTTCC CTAGTAAATG

1921 CCTTCTAGTA AAGATTTCCT AGTATTTTGA CTAGCGATAG TGTTTTATTA CTAATTAAAA

1981 ACATTAGAAG AACTCCATTT AGTGATTGGT TGTTTGGATT AGTCTTCTCA CGTTAGACCT

2041 ATATATGCAG GACAACTCAA GCCAGCATAA ATATATGAAA TATCTTGGTG TTTGTTTGTC

2101 TGACACAGGC AACCGCGTTT GGTATAAATG TGTTTTCTTG TTTACATTTT ACCATCTATA

2161 GTCATCTCAA TGTTATATAG TAGAGGCTTC ATGTTTGTAG TAGATAAGGT AGAGAATTGA

2221 GAATATTTTA TTTTTGTGCG ACCATCAATT TTATGTAATC TGCATTGTCT AATGCTTTAT

2281 TTGACATTTG AAACTACTTA ATTTGACAGT TATGCAGGTC CGCATGATCC TATGAAAGCA

2341 ATTAATTAGT ACGGGTAAAC TGCACTACAC AAGTTTGCTA GTACTATTCT AT ACCGAC

2401 CTGTCAATAT TACCTTAAGT TACTGATTTC AATTAGAATC TAACACATTC AGGAAAAGAA

2461 GTTTCACTAG TACAAAAATC ATTTTCGTTG GCACGTTGTT TTTTTTTTCA CAGGCAGTTC

2521 ACAATATCAT GGTGCTAGTA GAAAAATTTC AACGGGCCCA ACAAGAGAAC CGCCAGGCGG

2581 TCTTCTTAAT TCAACCGCCT GTGTAAACTT TCCATTTACA TAGGCGGCTT ACGATAAAAA

2641 CCGTGTGTAT AAATACCATT AACACAGGCA GTCGAGTTAC GACAACCGCC TGTGTAAATG

2701 TGTCTTTTTA CACAGGCGGl¹ TTGTATAGAG GGCCGCCTGT GCTAATATAT TTACACAGGC 2761 TATGAGCCGC CTGTGTTAAG TCTTCTATAA ATACCCTTCG TCCACCTCCA GACAAGAACA

2821 GTTACTCCCA TGAGCTCTGC ACACTGGCGG ACCAGACGAT TCCAGTTTCC AAGGGGGGAG

2881 GTTTTGATTT TCATTTCTTT GGTGAGAAAC TTCCAAAAGG TTAGTTAGTG CCATTGATGC

294 1 ΤΑΤΊ ΪΤΤΑΑ GCGATTCTTT GGTTCAATTC TTGTATTGGA GGTGCTCTAG ATCTAGAGTT

3001 CATCATGCAT TCTTGCTTAG GGTTAGAGTT CATAGGGCAA AAAGAGAGAG ATTTAGCTAA

3061 ATTTTTATGT AAATTCATAG TAAATTGTAA AAATTAAAAA AAATAAAAAA TAAATACTTT

3121 TTAGAATTCT TGTGAGTAGA TCTATACAAT AGAGTAATGA TGAGGATATT TTGAAGTTTA

3181 TAATTTTGAT TCAGTTTTAG CTTTTCTTTT TTCAGATGAA TTAGACTTTA TAAACTCAAA

3241 CATTAAAATG TTGAAAATCA TAAAATGGCA AATAAATACT TTTTCAAATC TTTGTGCATA

3301 AATACTTCAT AGAAATCCTT GAATTATTCC TAAATTTTAT ACAATTGTTT CTTATAATTA

3361 TGAAAATGAG TTTAAACAAT TATTTAAATT CCATAAATTG TAACTCCGTA AGGTGTAGGT

3421 TTTCATCTCT GTTTAATAGA AGGAGGTTAG TATCTTAGTT AAGTCTGTTT TCGGGGGTTA

3481 TATTAGTTTT GTTTTTAGAT TGACCTACAT TAATTGTTCT TAACTAATTA CAGCTAAATA

3541 TGGAGAGGTC ATTATGGATG TACAACTTAT CAAGATTGGA CCTATCATAT GTAGTGCAGG

3601 TCCAAAAATT TATTGATGTC GCAAAGATAC ATGCTCGCAG AACAAAGGCG AAGCACATAT

3661 GTTGTCCATG CGCAGACTGC AAAAATATTA TGGTATTTGA CAATGTAGAA GCAATTACTT

3721 CCCATCTGGT TTGAAGAGGA TTTATGGAGG ACTACTTGAT TTGGACAAAA CATGGTGAGG

3781 GTAGTTTTGC ACCTTATATG CGGACAACTG ACAACACTGC AACTAACATC AATGTGGAGG

3841 GTCCAATGCC ACCTCTCAAT GAATTTCATG CTATGCCAGA TGTTAATGAA ACTCATACGT

3901 CTGATGTCAA TGAAACTCAG CATGCTAACA CAGATGTTGT TGAAGATGCA GATTTCTTAG

3961 AGGCAATAAT GAACCGTTGT GCGGATCCAT CAATATTCTT CATGAAGGGA ATGAAAGCAT

4021 TGAAGAAGGC AGCAGAGGAC ACTTTGTACG ACGAGTCAAA AGGTTGTACC AAACAATGGT

4081 CGACATTATG TGTTGTTCTT CAGTTTTTGA CGATGAAGGC TAGACATGGT TGGTCCGATG

4141 CTAGCTTCAA TGATTTCTTG CGTGTACTTG GAGACCTTCT TCCTAAGGAG AACAAAGTGC

4201 CTGCTAACAC ATACTATGCA AAGAAGCTAG TCAGTCCACT TACGATAGGT GTTGAGAAGA

4261 TCCACGCATG TAGAAATCAT TGTATTCTAT ATCGAGGTGA TCAATATAAA GACTTAGACA

4321 GTTGTCCAAA CTGTGGTGCC AGTAGGTACA AGACAAACAA AGATTTTCGG GAGGAAGAGA

4381 ATCTAGCCTC TGTTTCTACA GGGAGGAAGC GAAAGAAGAC CCAAACAAAG ACTCAACAAG

4441 ACAAGCGCTC AAAGCCTAGT AGCAATGAAG AAGTGGACTA TTATGCATTG AGAAGAGTCT

4501 CCCTATGAGC CAAAAAAGGG GACAGCAGCA GGCACAACTC TCTTTCTGAA AGGACTTGGA

4561 AAGCAGCGGA CGGCACGGCT CATTGAGCTC GAACCGTCAC AGAAAAAGGA AGCCACCGCC

4621 CAGTCAATAG AAGCCATGCC CCCATCAAAG GAAGCCCCAA GTGGCGATGT ACATATTGAA

4681 CAGCCATCAA GTCAACCATT GACCCTAAAG GATATCAGAA AGCCAACGAT TGATGATTAT

4741 GTCAATGTCC CTAGTGACTA TGTGCCCGGA AGGCCTATGC TCCAATGGAC GCTGCTCGAT

4801 TAGATTCAAT GGCTGATAAA AAGGTTTCAT GACTGGTACA TGAGAGCAGT GCATGCTAGC

4861 CTCCATGGAA TCAGAGTTGA TATACCAACA GACATGTTTG CTACTGGTAA CAAAAAAAGC

4921 AAGACATTTG TTACCTTTGA GGACATGCAC TTGTTATTGA ACTATAGGCG GCTTGACGTC

4981 CAACTCATAA CAATCTGGTG CCTGTAAGTA TCACTCATGC ACACACAATT ATTATATATT

5041 AATATGTAGT GTGAAACTCT AATATGTAGA TGTTGTCTGT AGTTTGCAAG ATCACGAGCA

5101 GATGTCATTA TTATCTGCCG GATCGATGGT CGGTTATCTG AGCCCTATCA AGTTACAAGA

5161 AAATATGAAC AAATTCGTAT TATCAAAGGA AGATAGAGCA AAGATAGAGG AAGACAAAAC

5221 ACCAGGATAA TTATGCCATC TATCTTGGTA GATCAATGCT GAGGTATAAA TATAGGGATT

5281 TTATATTGGC ACCATACAAC ATTAGGTAAG CTTGACTTCA TATACGTATT TCAAATTATC

5341 GTGTAAACAA TATACATGTG TCGCTCACTC ATTTATTCAT GCAGTGACCA TTGGATTGTT

5401 TTTTATATTT ATCCCTTCGA AGGGAAGGTG CTTGTCCTAG ACTCTTTACA TGTTCCTCCC

5461 GAGAAGTATC AACCATTCTT GGTTCAATTA GAAAGGTGAG CCAACATGAA ACCACATGCG

5521 TACTTATATA AATTAGAGTT TCAAAATAAC TTTAGTGATT TAGGTTCGAT ATCTACGGGG

5581 CATGGCGGTT TTATAAGAAA CAAAAGGGAC CTGTCGACGC TGCACGCTCA GATCCTAGGA

5641 TCCCATTGAT GATACAACAC CACTATCCGG TAAGTTTTCT GAACACATTT CATCATATAA

5701 ATAATACATA AAGCATGGCA AATTTAGAAT AATCCGTTGC TCATTATATA GTGCCACAAG 5761 CAACCACCTG GATCGGTCTA TTGTGGGTAC TATGTCTGTG AGTTTATAAG GCAGCGGGGA

5821 CGTTACGTCA AGGACAAAAA TATGGTAAAT AATATCTATG TATGAAAGTT TTCTCATTAA

5881 AGCTGCAAAA TTATATATTG AACATGTGTC AATCATGCTT TTAAACTTTA TTTTCAGCCG

5941 AAAAAGCAAG GAAAAGACGT GCCCTTTACA CCAAAGACTC TGGAAGATAT AGTAGCATAC

6001 TTGTGTGGTT TTATTATGAG AGAAATAATT TCAAGTGACA GTGCATATTT TGATCATGAG

6061 GGCGATTTAG CAAGTGATAA ATTTAGAGTG CTGACAGACA TAGCAGGTCT ARATCTGAAG

6121 CGAAACGACA TGTAAACATT GTATGGTTGT GCGGATAACA TGCATTGACG TGTATATATA

6181 TAATTTTATG GTTGATGTTT GATTTGTTTA CAATTCTATA ATATATATAT GTGGTGTATG

6241 TATGATGTTG TGTGTGTATA TATATATATA TATATATATA TATATATATA TATATATATA

6301 TATATATATA TATATAATGT TTAGCACTGT GTTTGGTGGG AAAAATTAAA ATTTGAAATA

6361 TATATAAAAA ATTATTTACA CAGACAGTGT ACGTGTCGAG CGTCGTCCTG TGCTATACAA

6421 ATACATTCTA ACAGGCGGCT CGCCTTGTCC ACCGGTCGGT TAAAAATACA TTTCCACACH

6481 GGCCTGGCTG GGAGAGCCGC CTGTGAAAAC ATAATTTTCA CAGGCGGCTC GCACAGCCCC

6541 GCCTGTACTG TGGTCCATTT TGTACTGACC CCTGGTACAG GCGGTGGGCT TGGCCGCCTG

6601 TGAAGATGCT TTTAGCACCG CCTGTAAAAA TGTTTTTTGT AGCAGTGTTT TTCTTATTAG

6661 TAGTATCTTT TATACTAATT AAGATTCAAT ¾¾¾¾¾TT0A.C CATGACATCC CCATTGCCAA

6721 GAGAATATTT CGCCGCCCCT CAAAGCAGCC AATAAGGCTT TACTAAAAAG ACTATCCACG

6781 CAGTAGAGAT TTAGTCAAAA TATTCCAATA GCAATTGTTT CCTGCCTGCT TGACCTTCGT

6841 CAGCCACTCA CTGTATAAAT ATCGCACCAC GCCCTTTGCA GGCTTACAGA GCTTGTATTA

6901 CGT&CTAACA AGGCACACAC AGTACCCTGT GTTCACCGGC CCTGCACAAA ACTCAAGCAG

6961 TTATTACTAA CATGGCGGCT AACGATTCCT TGGTTACTGC TCATGTGATA GGAGATGTCT

7021 TGGACCCCTT CTATACAACC GTTGACATGA TGATCCTATT CGATGGTACT CCTATTATCA

7081 GCGGCATGGA GTTGCGCGCT CCGGCGGTTT CTGACAGGCC AAGGGTTGAA ATTGGAGGAG

7141 ATGATTATCG AGTTGCATAT ACTCTGGTAA ACTCATGCCA TGTCAATTAA CTAGTAG TG

7201 AATTTAGATG CTGGTGGTAT CGTGGATACA TGTACTATAT GTTATGGTTG ATACATATTT

7261 GTTTAATTGA TCGCAACACC ATTTGCGGTA ACTTCAAATT ACATTCTTTC AATATATAGG

7321 TGATGGTCGA TCCTGATGCT CCTAACCCAA GCAACCCAAC CTTGAGGGAG TACTTGCACT

7381 GGTAAGAGAA ACCTATAGAC GACAATTATT GTTGTTGGCA TGTTTTGCCC ACATATACTT

7441 TGTGTGTGTA TATTTGTGCT TATGCTTCTC CATAAAATTT TGGTGTATGT CTCAAGAGAG

7501 ATAGGTATAG AGGTTAGCAG TCCTTTAAAA ATGGTTTAAT CCAGTAGTTT TTTTTCGGTC

7561 GGACTGCTCG AATTATTGTA TATATGGAGA TCACATGCTA GTAACTTTTT CAATAATTTC

7621 ATGTTTCGAG CAGGATGGTG ACTGACATCC CAGCATCAAC TGATAATACA TACGGTGAGT

7681 ACACCCCTAT TCCCATTTTG AAACAAGTAG AATGTCTATT TTTATGATTT AGTATGTTCG

7741 TGACAATAGG CTATAGCTAT TTTGAAACTT CGGGAGCATA AAATAGTACT CGATTTTGTA

7801 TAACCATAAA CACACAGCTA GCCAATCTCT ATTCATATTT ATTTTAGTTT TATTTGCCGA

7861 ACCATCCTCA ACATCATAGC CACTTGATCG ATCATCTCAA TCAGCGTTTG TATCCTTGCC

7921 CGCTTGATTA TCATCCATGG CAGTTCATAT TTTTTTTCAT TTCTTTCATG CTTGTTATAG

7981 TTTTATCTGA TGAATCCAAG ATGTTATTGA TCAATTAGTT CAGATGAGCA GTAATGCATG

8041 TTGGAGGTTT GGTAGTATAT ATACGTTCAA AATTTCACGA AATCGGTAAT TACGGTGGGA

8101 GCCAAAAAAA ATTCCAAAAT TTCGTATTAC ATTAATAATG CATGTGCTGT AGACTCATAT

8161 TTTCTATGAT TTCGATTCTG TCACCATCCT GCTCGAATAT TTAAATCATG CTAATATTTT

8221 GTTTACATCT AAATCTTTTA TAAAAATTAT AATTTATATT TGGGTTTAAC AATTTCGGGC

8281 GCGTTTAGTG AGATTGGGTA ATTTCGGAGC GAGGCCACCG GCCACACGAA AAATTNCTAT

8341 ACACGHACTA TATGTGTACA TGTACATGCA TGGCACCCTG ATAGGCTACC CCATGGGGAA

8401 AAAATTGGAA ACGGACCATT CATACGCAGT CGTGGTGCAG ACTGTGGGCC ACAATAGCAG

8461 TGTAAACATA ATTACGGTAA TCAAATACCC CATGGGACCA TATATATCAT CCACAGATCC

8521 GTACGGTGCT TCCGTGTGGA TGGTCTACAC CAGATCTTTT CCACACCATA AGGGCAGCAA

8581 TGCAGCATCA TATTCATATA TGCACTAGTG ATGTACCATT TGGCTTATAT CATATTCAAC

8641 CTAACTCCTT GGAAACATTA TGATATTCTA TTGGGTTGAA GATGTCACTA CTACAAAAAA

8701 AAATCTTATG AGAGGTGTTT TGAAAACTGC CGGAGGTGCT TAAAGGAGAC AGACGAGTTA 8761 GGACAACCGT CTCTATTAAT GTGTACTAAC TGAGGTAGTT ACCGTAACGT GCCTGACTTG

8821 ATTAACAGAT TCAACCGTCT CAGTAAAGGC CATGATTAAC CGAAACAGAT TCGAGAGTTT

8881 TCTTAAGTAG TTAAACTATT TTAATCTTCA CCGAACTTAT AGAAAATGAA AGAGCTAACA

8941 CCAAIATTTA TAAAAATAAA TTAGTATCAC TAAATACATC ACGAAATCTA TTTGGTGTTG

9001 TAGAAGTTAT CCTTTTCTAT AAAATTGATC AAATTTATGA TAACTTAGTT TTAGGAATTC

9061 ATTTATTTTA GGACAACTGA GGAAGTACAT ATTTTTTAAG TCATCCACAA AGTAGTGGAT

9121 CCAATTTATT ACATTACTCT ACTACTTCAA ACTGAACAAA AGCCTAATCC TGGTTATTTT

9181 TAGAGTGATT TTTTACAACA TCAGCAGTAG TCCAGAAAAT GGGAGGACAT TAATAAAAGT

9241 GAAAAGGAGC AGAAGAAAGA TTACGGTATT TTATTTGTGC TATTTGTTTA ACTATTGGCA

9301 GTTTGGGACC GAAATAAATA ACTGTTCGTA GCTCTATATT TGTCGATTCA AAAAGTGTAA

9361 CGATGATTTT TGTGTTTCAA AAGAAAAATA AAGAAGTGCA CCAATGATTG GATATCATAG

9421 GCTATATATG TTGGATTAAT TGCATCCAAC GTATATAGTG AAAATGCTTT TCAATCAAGT

9481 AATCTTCGAG CGGTTACCAG TTTTAATAGT TGCGAGTCGT CGTTTTTTAT GTACCCTAGG

9541 ACATATATAT CCGCATGTAG ACGATGATGA GACTAGCAAG TTTTTGAGCA

9601 AATACATAAT TATTGGATTT GCAGGCCGTG AGATGATGTG CTACGAGCCC CCTGCCCCGT

9661 CCACGGGCAT CCACCGTATG GTGCTGGTGC TATTCCAGCA GCTTGGCCGT GACACGGTGT

9721 TCGCGGCGCC GTCCAGGCGC CACAACTTCA ACACCCGTGC CTTCGCCCGC CGCTACAACC

9781 TCGGCGCGCC CGTCGCCGCC ATGTTCTTCA ACTGCCAGCG CCAGACCGGC TCCGGTGGCC

9841 CCAGGTTCAC CGGGCCCTAC ACCAGCCGAC GTCGTGCGGG CTGATGACGA CGATCGTCGT

9901 TACGTCACGT GTACCGTACA CATATATGTA TAGATATACA TGCATGCATG TTCCATGGTA

9961 TAGGATCGGT GACAAAACGT CTAATAATGT ATACACACAC ATGCATGGAA TGCATGTAAT

10021 AAGAGAATAT ATGTATAATA AGTAGGGGAG AGCATGCATA TATTGTGTAC ACGCGTCCGA

10081 TGCGTATAGC CCTTTACATT ATTGTAGTTG TAATCAGCTG TTTAAGCATT CTGCTGTGTC

10141 AGAACATGAT GCATATATAG TTTGGTGTGA GTATTGATCT AGTGGAACTC TTATCAGCCT

10201 TCAACTCTTA TCACAAGTGT AAGATATAGC TTTTATACCT TCAGGTGTCT TCCCAGTGTA

10261 CCTAGAAATG CTACAACGGT TGTATTTTAT CTATGCGCTT CACTACTGGA AACCTGAATA

10321 CTTCTGTGGA TGTCGAATTT TTCTGTGCGT TTTTTTCGAT ACACACGGAA AAATTATAAT

10381 TATTCTGTGG GTTTTAAAAT ATCCTCATAG AAAAATACAA ATACCCACAG AAAAATTATA

10441 TCATTTTTCT GTGCGTGACA ATACACTCAC AGAAAAATTA CAATTTTTGT GTGTGTTTAT

10501 ATAAAACGCA CAGAAAAAAT AATCACACAC AGAAAAATTA TAATTATTCT GTAGGTTTCT

10561 ATAAAACGCA CATAAAAAAT AAACACACAC TGAAAAATAG AACAAGCACC CTCATACTAA

10621 ATTCATATAA ACACCCATAT TTTTTTCTTT TTAATCTCTC TGTAAAACTT GTAACTAGTT

10681 TTTCCCTCTC GTACTAACTC CAAATTGGAT GATTT

(SEQ ID N0:1 Sb06g012260 - S. propinquum) or functional fragment, or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:l.

The coding sequence of the maturity Mai gene of SEQ ID NO:l, including introns, can be:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TAT CAACCG TTGACATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

121 TTGCGCGCTC CGGCGGTTTC TGACAGGCCA AGGGTTGAAA TTGGAGG G TGATTATCGA

181 GTTGCATATA CTCTGGTAAA CTCATGCCAT GTCAATTAAC TAGTAGTTGA ATTTAGATGC

2 1 TGGTGGTATC GTGGATACAT GTACTATATG TTATGGTTGA TACATATTTG TTTAATTGAT

301 CGCAACACCA TTTGCGGTAA CXTCAAATTA CATTCTTTCA ATATATAGGT GATGGTCGAT

361 CCTGATGCTC CTAACCCAAG CAACCCAACC TTGAGGGAGT ACTTGCACTG GTAAGAGAAA

421 CCTATAGACG ACAATTATTG TTGTTGGCAT GTTTTGCCCA CATATACTTT GTGTGTGTAT 481 ATTTGTGCTT ATGCTTCTCC ATAAAATTTT GGTGTATGTC TCAAGAGAGA TAGGTATAGA

541 GGTTAGCAGT CCTTTAAAAA TGGTTTAATC CAGTAGTTTT TTTTCGGTCG GACTGCTCGA

601 ATTATTGTAT ATATGGAGAT CACATGCTAG TAACTTTTTC AATAATTTCA TGTTTCGAGC

661 AGGATGGTGA CTGACATCCC AGCATCAACT GATAATACAT ACGGTGAGTA CACCCCTATT

721 CCCATTTTGA AACAAGTAGA ATGTCTATTT TTATGATTTA GTATGTTCGT GACAATAGGC

781 TATAGCTATT TTGAAACTTC GGGAGCATAA AATAGTACTC GATTTTGTAT AACCATAAAC

841 ACACAGCTAG CCAATCTCTA TTCATATTTA TTTTAGTTTT ATTTGCCGAA CCATCCTCAA

901 CATCATAGCC ACTTGATCGA TCATCTCAAT CAGCGTTTGT ATCCTTGCCC GCTTGATTAT

961 CATCCATGGC AGTTCATATT TTTTTTCATT TCTTTCATGC TTGTTATAGT TTTATCTGAT

1021 GAATCCAAGA TGTTATTGAT CAATTAGTTC AGATGAGCAG TAATGCATGT TGGAGGTTTG

1081 GTAGTATATA TACGTTCAAA ATTTCACGAA ATCGGTAATT ACGGTGGGAG

1141 TTCCAAAATT TCGTATTACA TTAATAATGC ATGTGCTGTA GACTCATATT TTCTATGATT

1201 TCGATTCTGT CACCATCCTG CTCGAATATT TAAATCATGC TAATATTTTG TTTACATCTA

1261 AATCTTTTAT AAAAATTATA ATTTATATTT GGGTTTAACA ATTTCGGGCG CGTTTAGTGA

1321 GATTGGGTAA TTTCGGAGCG AGGCCACCGG CCACACGAAA AATTNCTATA CACGHACTAT

1381 ATGTGTACAT GTACATGCAT GGCACCCTGA TAGGCTACCC CATGGGGAAA AAATTGGAAA

144 1 CGGACCATTC ATACGCAGTC GTGGTGCAGA CTGTGGGCCA CAATAGCAGT GTAAACATAA

1501 TTACGGTAAT CAAATACCCC ATGGGACCAT ATATATCATC CACAGATCCG TACGGTGCTT

1561 CCGTGTGGAT GGTCTACACC AGATCTTTTC CACACCATAA GGGCAGCAAT GCAGCATCAT

1621 ATTCATATAT GCACTAGTGA TGTACCATTT GGCTTATATC ATATTCAACC TAACTCCTTG

1681 GAAACATTAT GATATTCTAT TGGGTTGAAG ATGTCACTAC TACAAAAAAA AATCTTATGA

1741 GAGGTGTTTT GAAAACTGCC GGAGGTGCTT AAAGGAGACA GACGAGTTAG GACAACCGTC

1801 TCTATTAATG TGTACTAACT GAGGTAGTTA CCGTAACGTG CCTGACTTGA TTAACAGATT

1861 CAACCGTCTC AGTAAAGGCC ATGATTAACC GAAACAGATT CGAGAGTTTT CTTAAGTAGT

1921 TAAACTATTT TAATCTTCAC CGAACTTATA GAAAATGAAA GAGCTAACAC C ¾i¾ X i X" T T? \T

1981 AAAAATAAAT TAGTATCACT AAATACATCA CGAAATCTAT TTGGTGTTGT AGAAGTTATC

2041 CTTTTCTATA AAATTGATCA AATTTATGAT AACTTAGTTT TAGGAATTCA TTTATTTTAG

2101 GACAACTGAG GAAGTACATA TTTTTTAAGT CATCCACAAA GTAGTGGATC CAATTTATTA

2161 CATTACTCTA CTACTTCAAA CTGAACAAAA GCCTAATCCT GGTTATTTTT AGAGTGATTT

2221 TTTACAACAT CAGCAGTAGT CCAGAAAATG GGAGGACATT AATAAAAGTG AAAAGGAGCA

2281 GAAGAAAGAT TACGGTATTT TATTTGTGCT ATTTGTTTAA CTATTGGCAG TTTGGGACCG

2341 AAATAAATAA CTGTTCGTAG CTCTATATTT GTCGATTCAA AAAGTGTAAC GATGATTTTT

2401 GTGTTTCAAA AGAAAAATAA AGAAGTGCAC CAATGATTGG ATATCATAGG CTATATATGT

2461 TGGATTAATT GCATCCAACG TATATAGTGA AAATGCTTTT CAATCAAGTA ATCTTCGAGC

2521 GGTTACCAGT TTTAATAGTT GCGAGTCGTC GTTTTTTATG TACCCTAGGA CATATATATC

2581 CGCATGTAGA CGATGATGAG ACTAGCAAGT TTTTTTTTTT TTTTGAGCAA ATACATAATT

2641 ATTGGATTTG CAGGCCGTGA GATGATGTGC TACGAGCCCC CTGCCCCGTC CACGGGCATC

2701 CACCGTATGG TGCTGGTGCT ATTCCAGCAG CTTGGCCGTG ACACGGTGTT CGCGGCGCCG

2761 TCCAGGCGCC ACAACTTCAA CACCCGTGCC TTCGCCCGCC GCTACAACCT CGGCGCGCCC

2821 GTCGCCGCCA GTTCTTCAA CTGCCAGCGC CAGACCGGCT CCGGTGGCCC CAGGTTCACC

2881 GGGCCCTACA CCAGCCGACG TCGTGCGGGC TGA

(SEQ ID N0:2 Sb06g012260 - S. propinq um), or functional fragment, or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:2. In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in short day S. propinquum includes the nucleic acid sequence:

1 CCCTGACCCT TGTTGGGCAA CATTTAGAGT CGTTAGCTTT GCAATTCTTT GGTTCCAATG

61 GATGGTTATC ATTTAGACAT ATTGGTCATG CTTAGTCAAA ACTTTATTGT TCGGCTATAA

121 ACTTTTCAGT ACTTTGTAAT AATTGGCTCG A AGATGAAG CCGGGTATAA CATATCCTTT

181 ATCTAAAAAA ATTAGTTAAC ATGAACTTC TATTCAATTC TTCATATCTC ACT GCATCT

241 TTATTGTCTA GTTAGT TTG TAGCATTGC AAAAGCATGC AACTATATAC AATGAAACGG

301 AATAAAATTT CAGCTCT TT AATTTATATT TCAAATATAG GCCAC ATAG CCATATTTCG

361 TGCTCAAGGC CACAAAATCT TGCGTACT C CCTGTTGGTA CCAAAGAGAA GACGTTATTT

421 AACTTTGTTT GACTCTTCAA TATGGTTTGA ATCAGAAAAT TAGTTAAAAG AAAAGTGAGC

481 AC CCACGAC CTGTCATCAG CTCATGGTCA GCTCTACAAA CTTATAGATT GCATCGAGAT

541 CTAAGACTCA GGTACAAATC ATGTCAACAT CTAATGGTTT AGAAAATGAA AAGTTTTGAG

601 TTTCAAAATA TGATACGTGA TATTAACATT TGAACTTTTA GCAAGATCTG AAATAAAAAA

661 TTCAACTAGA TCATGTTAAC ATTGATATAA TCGCTTCCAA TCGCCTCCCA TCACTTCCGC

721 TAGAAAACTT TTTTTCTCGA TTTAATTAAT GAAAGGGTAA TAACATCATT GTACAAGATT

781 CTTTCAAACC TCAACCCCT TCATCGACGG TGACGGCTCC CTATAACACG CACTAGTGGA

8 1 CGCCGGGCGG GTGGAACCCT AAGAAGATTT AAAAAAACTT AAGAAGAAGA TTTTTATCTA

901 ACTAACTATA GTACTTATAT CATACACTAT ACTATTC AA A TTATTTT CACAATTATG

961 AATTTACCCT TTTACTCTTC ATTAAAAAAA TACGAAAAAA GAATCACCAC GTCTCTATTT

1021 AGGGTCCTAG TCCCCA AAT TTAAGAGGCG GTGAGAGACG ATGTGACGTC TATGGACCAC

1081 CGACCAAAGA CACACCTATC GTCTCCCATC GCCTTGCTTC CATCGCCTCT CATCGCTTTT

1141 CATATTCT G ATCCAGCGGC C T GACAC CCAATCGTTT CTCATCGCCT CTCCAACCAT

1201 TG AAAAATA TTTATAATTT TGATATAAAA TTTGTCTTCA CTTGAGTTC TGCCAAAAAA

1261 ATTATACATA TTATTTTCGT GTGAGAATTT AC GAAGTGG ACTCTTAAGA TGTCCAAATG

1321 TAAATGACCC TATTTATTAT GAGGCGCGGA TCTATAGGCC TGACTCTGAA AATGGATTAT

1381 GGATTTGAGA TAATAAATTT AAGGGCCTAT CTTCGCACAT AACATCT TA GTTCCTAAAT

1 41 TTTTTTTTAT TGTAGTAGTA GAACTTTTCT CCCTGTAAAC CAAGTTGACG CTGGGCTTTA

1501 TTTTGCGACA CAGAACACCA AATTGGTGGC TATGAACTCT TCCACCTGGG CAGGGAAAAC

1561 GGTTTATTAT GTTTCTCTTT AATTTATCTA TCGTGGCACT ATAACACAAC ATGGCTTTGC

1621 CGACACTTCC AACTATCGGC AAAGGGTACC TTTACCGACA CTTAACGTCT CACGAAAGGT

1681 TTTGCCGACA ATTTTCAAAC AGTCGCGGTA GAAGCAGTTG GCGAAACTTT TGCCGACAGT

1741 TAAAGGCATC GCCGACACAT TTTCTGTAGT CAAATGGCAT ACCTACGCCG ACAGTTGAAC

1801 TTTCACCGAC AGTGAACCCT TTGCCGACAG TTTGGACCTA CGCCGACAGT TTGGACCTTT

1861 TCCGACAGTT GGTATGTTAG CGAAACCGTT TCTAGGGTGT TTCATAAACC ATGCCTTGTC

1921 CAACAGTAGA AGTGTCGGCA AAACTATATT GCTAGGATGT AGATACAATT TAAATATTTT

1981 AATAAATACA CATCACATTG ATTGAGCAAA ATCACATGGT CTGTTTTCAC TAAAACTGTC

2041 AGAGGTACAC TCCAGTACT CCAGTACGTC GCCCGCACAG TGGCCAAGGA TTTTACTGCT

2101 ACTGTTGATT AACATAAGCA CTTGCGACTT TCCCTAAAAT CTTTTA AA ACAACGGCCG 2161 CAATAATATT GAACTATTTT TTTTCTAGTA CCAAAATT G AATT GATCC CTCACCTCAT 2221 TACATCCATA GTAACATGAC CAGA ATA TGGACAGGAT GGGATCACTC AGCGAGCAGA 2281 TACACTGAGC GATTCATAAT CAGATTTTTT AATTTCTTCT AGTGAAGTGG GGTTTTCCTA 23 1 GTCTTT AAC ATTCAAAATT TAGTACAAAC TTTCCCTAGT AAATGCCTTC TAGTAAAGAT 2401 TTCCTAGTAT TTTGACTAGC GATAGTGTTT TATTACTAAT TAAAAACATT AGAAGAACTC 2 61 CATTTAGTGA TTGGTTGTTT GGATTAGTCT TCTCACGTTA GACCTATA TGCAGGACAA 2521 CTCAAGCC G CATAAATATA TGAAATATCT TGGTGTTTGT TTGTCTGACA CAGGCAACCG 2581 CGTTTGGTAT AAATGTGTTT TCTTGTTTAC ATTTTACCAT CT TAGTCAT CTCAATGTTA 2641 TAT GTAGAG GCTTCATGTT TGTAGTAGA AAGGTAGAGA ATTGAGAATA TTTTATTTTT 2701 GTGCGACCAT CAA TTTATG TAATCTGCAT TGTCTAATGC TTTATTTGAC ATTTGAAACT 2761 ACTTAATTTG ACAGTTATGC AGGTCCGCAT GATCCTATGA AAGCAATTAA TTAGTACGGG

2821 TAAACTGCAC TACACAAGTT TGCTAGTACT ATTCTATTAA CCGACCTGTC AATATTACCT

2881 TAAGTTACTG ATTTCAATTA GAATCTAACA CATTCAGGAA AAGAAGTTTC ACTAGTACAA

294 1 AAATCATTTT CGTTGGCACG TTGTTTTTTT TTTCACAGGC AGTTCACAAT ATCATGGTGC

3001 TAGTAGAAAA ATTTCAACGG GCCCAACAAG AGAACCGCCA GGCGGTCTTC TTAATTCAAC

3061 CGCCTGTGTA AACTTTCCAT TTACATAGGC GGCTTACGAT AAAAACCGTG TGTATAAATA

3121 CCATTAACAC AGGCAGTCGA GTTACGACAA CCGCCTGTGT AAATGTGTCT TTTTACACAG

318 1 GCGGTTTGTA TAGAGGGCCG CCTGTGCTAA TATATTTACA CAGGCTATGA GCCGCCTGTG

324 1 TTAAGTCTTC TATAAATACC CTTCGTCCAC CTCCAGACAA GAACAGTTAC TCCCATGAGC

3301 TCTGCACACT GGCGGACCAG ACGATTCCAG TTTCCAAGGG GGGAGGTTTT GATTTTCATT

33 61 TCTTTGGTGA GAAACTTCCA AAAGGTTAGT TAGTGCCATT GATGCTATTT TTTAAGCGAT

342 1 TCTTTGGTTC AATTCTTGTA TTGGAGGTGC TCTAGATCTA GAGTTCATCA TGCATTCTTG

3481 CTTAGGGTTA GAGTTCATAG GGCAAAAAGA GAGAGATTTA GCTAAATTTT TATGTAAATT

354 1 CATAGTAAAT TGTAAAAATT ΑΑΑΑΑΑΑΆΤΑ AAAAATAAAT ACTTTTTAGA ATTCTTGTGA

3601 GTAGATCTAT ACAATAGAG AATGATGAGG ATATTTTGAA GTTTATAATT TTGATTCAGT

3661 TTTAGCTTTT CTTTTTTCAG ATGAATTAGA CTTTATAAAC TCAAACATTA AAATGTTGAA

372 1 AATCATAAAA TGGCAAATAA ATACTTTTTC AAATCTTTGT GCATAAATAC TTCATAGAAA

3781 TCCTTGAATT ATTCCTAAAT TTTATACAAT TGTTTCTTAT AATTATGAAA ATGAGTTTAA

3841 ACAATTATTT AAATTCCATA AATTGTAACT CCGTAAGGTG TAGGTTTTCA TCTCTGTTTA

3901 ATAGAAGGAG GTTAGTATCT TAGTTAAGTC TGTTTTCGGG GGTTATATTA GTTTTGTTTT

3961 TAGATTGACC TACATTAATT GTTCTTAACT AATTACAGCT AAATATGGAG AGGTCATTAT

4021 GGATGTACAA CTTATCAAGA TTGGACCTAT CATATGTAGT GCAGGTCCAA AAATTTATTG

4081 ATGTCGCAAA GATACATGCT CGCAGAACAA AGGCGAAGCA CATATGTTGT CCATGCGCAG

41 41 ACTGCAAAAA TATTATGGTA TTTGACAATG TAGAAGCAAT TACTTCCCAT CTGGTTTGAA

4201 GAGGATTTAT GGAGGACTAC TTGATTTGGA CAAAACATGG TGAGGGTAGT TTTGCACCTT

4261 ATATGCGGAC AACTGACAAC ACTGCAACTA ACATCAATGT GGAGGGTCCA ATGCCACCTC

4 321 TCAATGAATT TCATGCTATG CCAGATGTTA ATGAAACTCA TACGTCTGAT GTCAATGAAA

4381 CTCAGCATGC TAACACAGAT GTTGTTGAAG ATGCAGATTT CT AGAGGCA ATAATGAACC

44 4 1 GTTGTGCGGA TCCATCAATA TTCTTCATGA AGGGAATGAA AGCATTGAAG AAGGCAGCAG

4501 AGGACACTTT GTACGACGAG TCAAAAGGTT GTACCAAACA ATGGTCGACA TTATGTGTTG

4 561 TTCTTCAGTT TTTGACGATG AAGGCTAGAC ATGGTTGGTC CGATGCTAGC TTCAATGATT

4 621 TCTTGCGTGT ACTTGGAGAC CTTCTTCCTA AGGAGAACAA AGTGCCTGCT AACACATACT

4681 ATGCAAAGAA GCTAGTCAGT CCACTTACGA TAGGTGTTGA GAAGATCCAC GCATGTAGAA

474 1 ATCATTGTAT TCTATATCGA GGTGATCAAT ATAAAGACTT AGACAGTTGT CCAAACTGTG

4801 GTGCCAGTAG GTACAAGACA AACAAAGATT TTCGGGAGGA AGAGAATCTA GCCTCTGTTT

4861 CTACAGGGAG GAAGCGAAAG AAGACCCAAA CAAAGACTCA ACAAGACAAG CGCTCAAAGC

4921 CTAGTAGCAA TGAAGAAGTG GACTATTATG CATTGAGAAG AGTCTCCCTA TGAGCCAAAA

498 1 AAGGGGACAG CAGCAGGCAC AACTCTCTTT CTGAAAGGAC TTGGAAAGCA GCGGACGGCA

504 1 CGGCTCATTG AGCTCGAACC GTCACAGAAA AAGGAAGCCA CCGCCCAGTC AATAGAAGCC

5101 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTGAACAGCC ATCAAGTCAA

51 61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCTAGT

522 1 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

528 1 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

5341 GTTGATATAC CAACAGACAT GTTTGCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

5401 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

54 61 TGGTGCCTGT AAGTATCACT CATGCACACA CAATTATTAT ATATTAATAT GTAGTGTGAA

552 1 ACTCTAATAT GTAGATGTTG TCTGTAGTTT GCAAGATCAC GAGCAGATGT CATTATTATC

5581 TGCCGGATCG ATGGTCGGTT ATCTGAGCCC TATCAAGTTA CAAGAAAATA TGAACAAATT

5641 CGTATTATCA AAGGAAGATA GAGCAAAGAT AGAGGAAGAC AAAACACCAG GATAATTATG

570 1 CCATCTATCT TGGTAGATCA ATGCTGAGGT ATAAATATAG GGATTTTATA TTGGCACCAT

i¾ i¾

T T ¾_~ i¾ C T

87 61 ΑΑΤΤΪΑΤΑΤΪ TGGGTTTAAC AATTTCGGGC GCGTTTAGTG AGATTGGGTA ATTTCGGAGC

882 1 GAGGCCACCG GCCACACGAA AAATTCTATA CACGACTATA TGTGTACATG TACATGCATG

888 1 GCACCCTGAT AGGCTACCCC ATGGGGAAAA AATTGGAAAC GGACCATTCA TACGCAGTCG

894 1 TGGTGCAGAC TGTGGGCCAC AATAGCAGTG TAAACATAAT TACGGTAATC AAATACCCCA

9001 TGGGACCATA TATATCATCC ACAGATCCGT ACGGTGCTTC CGTGTGGATG GTCTACACCA

9061 GATCTTTTCC ACACCATAAG GGCAGCAATG CAGCATCATA TTCATATATG CACTAGTGAT

9121 GTACCATTTG GCTTATATCA TATTCAACCT AACTCCTTGG AAACATTATG ATATTCTATT

9181 GGGTTGAAGA TGTCACTACT ACAAAAAAAA ATCTTATGAG AGGTGTTTTG AAAACTGCCG

9241 GAGGTGCTTA AAGGAGACAG ACGAGTTAGG ACAACCGTCT CTATTAATGT GTACTAACTG

9301 AGGTAGTTAC CGTAACGTGC CTGACTTGAT TAACAGATTC AACCGTCTCA GTAAAGGCCA

9361 TGATTAACCG ¾¾i¾CPiG! Ί^ΐ C GAGAGTTTTC TTAAGTAGTT AAACTATTTT AATCTTCACC

942 1 GAACTTATAG AAAATGAAAG AGCTAACACC AATATTTATA AAAATAAATT AGTATCACTA

948 1 AATACATCAC GAAATCTATT TGGTGTTGTA GAAGTTATCC

AATTGATCAA

954 1 ATTTATGATA ACTTAGTTTT AGGAftTTCAT TTATTTTAGG ACAACTGAGG AAGTACATAT

9 601 TTTTTAAGTC ATCCACAAAG TAGTGGATCC AATTTATTAC ATTACTCTAC TACTTCAAAC

9661 TGAACAAAAG CCTAATCCTG GTTATTTTTA GAGTGATTTT TTACAACATC AGCAGTAGTC

9721 CAGAAAATGG GAGGACATTA ATAAAAGTGA AAAGGAGCAG AAGAAAGATT ACGGTATTTT

9781 ATTTGTGCTA TTTGTTTAAC TATTGGCAGT TTGGGACCGA AATAAATAAC TGTTCGTAGC

9841 TCTATATTTG TCGATTCGAA AGTGTAACGA TGATTTTTGT GTTTCAAAAG AAAAATAAAG

990 1 AAGTGCACCA ATGATTGGAT ATCATAGGCT ATATATGTTG GATTAATTGC ATCCAACGTA

9961 TATAGTGAAA ATGCTTTTCA ATCAAGTAAT CTTCGAGCGG TTACCAGTTT TAATAGTTGC

1002 1 GAGTCGTCGT TTTTTATGTA CCCTAGGACA TATATATCCG CATGTAGACG ATGATGAGAC

1008 1 TAGCAAGTTT TTTTTTTTTT TTGAGCAAAT ACATAATTAT TGGATTTGCA GGCCGTGAGA

10 14 1 TGATGTGCTA CGAGCCCCCT GCCCCGTCCA CGGGCATCCA CCGTATGGTG CTGGTGCTAT

10201 TCCAGCAGCT TGGCCGTGAC ACGGTGTTCG CGGCGCCGTC CAGGCGCCAC AACTTCAACA

10261 CCCGTGCCTT CGCCCGCCGC TACAACCTCG GCGCGCCCGT CGCCGCCATG TTCTTCAACT

10321 GCCAGCGCCA GACCGGCTCC GGTGGCCCCA GGTTCACCGG GCCCTACACC AGCCGACGTC

10381 GTGCGGGCTG ATGACGACGA TCGTCGTTAC GTCACGTGTA CCGTACACAT ATATGTATAG

10441 ATATACATGC ATGCATGTTC CATGGTATAG GATCGGTGAC AAAACGTCTA ATAATGTATA

10501 CACACACATG CATGGAATGC ATGTAATAAG AGAATATATG TATAATAAGT AGGGGAGAGC

10561 J T G C ' 'i^T? ¾ T TGTGTACACG CGTCCGATGC GTATAGCCCT TTACATTATT GTAGTTGTAA

1062 1 TCAG

(SEQ ID NO:3 Sb06g012260 (10.6KB) - S. propinquum), or functional fragment, or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:3. Each N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides.

The coding sequence of the maturity Mai gene of SEQ ID NO:3, including mtrons, can be:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TATACAACCG TTGACATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

12 1 TTGCGCGCTC CGGCGGTTTC TGACAGGCCA AGGGTTGAAA TTGGAGGAGA TGATTATCGA

181 GTTGCATATA CTCTGGTAAA CTCATGCCAT GTCAATTAAC TAGTAGTTGA AT TAGATGC

241 TGGTGGTATC GTGGATACAT GTACTATATG TTATGGTTGA TACATATTTG TTTAATTGAT

301 CGCAACACCA TTTGCGGTAA CTTCAAATTA CATTCTTTCA ATATAf GGT GATGGTCGAT

361 CCTGATGCTC CTAACCCAAG CAACCCAACC TTGAGGGAGT ACTTGCACTG GTAAGAGAAA

421 CCTATAGACG ACAATTATTG TTGTTGGCAT GTTTTGCCCA CATATACTTT GTGTGTGTAT 481 ATTTGTGCTT ATGCTTCTCC ATAAAATTTT GGTGTATGTC TCAAGAGAGA TAGGTATAGA

541 GGTTAGCAGT CCTTTAAAAA TGGTTTAATC CAGTAGTTTT TTTTCGGTCG GACTGCTCGA

601 ATTATTGTAT ATATGGAGAT CACATGCTAG TAACTTTTTC AATAATTTCA TGTTTCGAGC

661 AGGATGGTGA CTGACATCCC AGCATCAACT GATAATACAT ACGGTGAGTA CACCCCTATT

721 CCCATTTTGA AACAAGTAGA ATGTCTATTT TTATGATTTA GTATGTTCGT GACAATAGGC

781 TATAGCTATT TTGAAACTTC GGGAGCATAA AATAGTACTC GATTTTGTAT AACCATAAAC

841 ACACAGCTAG CCAATCTCTA TTCATATTTA TTTTAGTTTT ATTTGCCGAA CCATCCTCAA

901 CATCATAGCC ACTTGATCGA TCATCTCAAT CAGCGTTTGT ATCCTTGCCC GCTTGATTAT

961 CATCCATGGC AGTTCATATT TTTTTTCATT TCTTTCATGC TTGTTATAGT TTTATCTGAT

1021 GAATCCAAGA TGTTATTGAT CAATTAGTTC AGATGAGCAG TAATGCATGT TGGAGGTTTG

1081 GTAGTATATA TACGTTCAAA ATTTCACGAA ATCGGTAATT ACGGTGGGAG CCAAAAAAAA

1141 TTCCAAAATT TCGTATTACA TTAATAATGC ATGTGCTGTA GACTCATATT TTCTATGATT

1201 TCGATTCTGT CACCATCCTG CTCGAATATT TAAATCATGC TAATATTTTG TTTACATCTA

1261 AATCTTTTAT AAAAATTATA ATTTATATTT GGGTTTAACA ATTTCGGGCG CGTTTAGTGA

1321 GATTGGGTAA 7TTCGGAGCG AGGCCACCGG CCACACGAAA AATTCTATAC ACGACTATAT

1381 GTGTACATGT ACATGCATGG CACCCTGATA GGCTACCCCA TGGGGAAAAA ATTGGAAACG

1441 GACCATTCAT ACGCAGTCGT GGTGCAGACT GTGGGCCACA ATAGCAGTGT AAACATAATT

1501 ACGGTAATCA AATACCCCAT GGGACCATAT ATATCATCCA CAGATCCGTA CGGTGCTTCC

1561 GTGTGGATGG TCTACACCAG ATCTTTTCCA CACCATAAGG GCAGCAATGC AGCATCATAT

1621 TCATATATGC ACTAGTGATG TACCATTTGG CTTATATCAT ATTCAACCTA ACTCCTTGGA

1681 AACATTATGA TATTCTATTG GGTTGAAGAT GTCACTACTA CAAAAAAAAA TCTTATGAGA

1741 GGTGTTTTGA AAACTGCCGG AGGTGCTTAA AGGAGACAGA CGAGTTAGGA CAACCGTCTC

1801 TATTAATGTG TACTAACTGA GGTAGTTACC GTAACGTGCC TGACTTGATT AACAGATTCA

1861 ACCGTCTCAG TAAAGGCCAT GATTAACCGA AACAGATTCG AGAGTTTTCT TAAGTAGTTA

1921 AACTATTTTA ATCTTCACCG AACTTATAGA AAATGAAAGA GCTAACACCA ATATTTATAA

1981 AAATAAATTA GTATCACTAA ATACATCACG ¾J ¾T C T ΐ Τ T" T GGTGTTGTAG AAGTTATCCT

2041 TT *3T C 1Ί¾ T ATTGATCAAA TTTATGATAA CTTAGTTTTA GGAATTCATT TATTTTAGGA

2101 CAACTGAGGA AGTACATATT TTTTAAGTCA TCCACAAAGT AGTGGATCCA ATTTATTACA

2161 TTACTCTACT ACTTCAAACT GAACAAAAGC CTAATCCTGG TTATTTTTAG AGTGATTTTT

2221 TACAACATCA GCAGTAGTCC AGAAAATGGG AGGACAT AA TAAAAGTGAA AAGGAGCAGA

2281 AGAAAGATTA CGGTATTTTA TTTGTGCTAT TTGTTTAACT ATTGGCAGTT TGGGACCGAA

2341 ATAAATAACT GTTCGTAGCT CTATATTTGT CGATTCGAAA GTGTAACGAT GATTTTTGTG

2401 TTTCAAAAGA AAAATAAAGA AGTGCACCAA TGATTGGATA TCATAGGCTA TATATGTTGG

2461 •A.T TftftT "3? CCA TCCAACGTAT ATAGTGAAAA TGCTTTTCAA TCAAGTAATC TTCGAGCGGT

2521 TACCAGTTTT AATAGTTGCG AGTCGTCGTT TTTTATGTAC CCTAGGACAT ATATATCCGC

2581 ATGTAGACGA TGATGAGACT AGCAAGTTTT Ί T" T T T" T TGAGCAAATA CATAATTATT

2641 GGATTTGCAG GCCGTGAGAT GATGTGCTAC GAGCCCCCTG CCCCGTCCAC GGGCATCCAC

2701 CGTATGGTGC TGGTGCTATT CCAGCAGCTT GGCCGTGACA CGGTGTTCGC GGCGCCGTCC

2761 AGGCGCCACA ACTTCAACAC CCGTGCCTTC GCCCGCCGCT ACAACCTCGG CGCGCCCGTC

2821 GCCGCCATGT TCTTCAACTG CCAGCGCCAG ACCGGCTCCG GTGGCCCCAG GTTCACCGGG

2881 CCCTACACCA GCCGACGTCG TGCGGGCTGA

(SEQ ID NO:4 Sb06g012260 (10.6kb) - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%», 97%, 98%, or 99% sequence identity to SEQ ID NO:4. In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in short day S. propinquum includes the nucleic acid sequence:

¾ >J¾ c/

T . s X jftAiT ¾ T

ϋ\ ?¾ c 2761 TCTCAAGAGA GATAGGTATA GAGGTTAGCA GTCCTTTAAA AATGGTTTAA TCCAGTAGTT

282 1 TTTTTTCGGT CGGACTGCTC GAATTATTGT ATATATGGAG ATCACATGCT AGTAACTTTT

288 1 TCAATAATTT CATGTTTCGA GCAGGATGGT GACTGACATC CCAGCATCAA CTGATAATAC

294 1 ATACGGTGAG TACACCCCTA TTCCCATTTT GAAACAAGTA GAATGTCTAT TTTTATGATT

3001 TAGTATGTTC GTGACAATAG GCTATAGCTA TTTTGAAACT TCGGGAGCAT AAAATAGTAC

3061 TCGATTTTGT ATAACCATAA ACACACAGCT AGCCAATCTC Ί¹ ¾Ώ? C ΙΑΓ 'ΛΤ T TATTTTAGTT

3121 TTATTTGCCG AACCATCCTC AACATCATAG CCACTTGATC GATCATCTCA ATCAGCGTTT

318 GTATCCTTGC CCGCTTGATT ATCATCCATG GCAGTTCATA TTTTTTTTCA TTTCTTTCAT

3241 GCTTGTTATA GTTTTATCTG ATGAATCCAA GATGTTATTG ATCAATTAGT TCAGATGAGC

3301 AGTAATGCAT GTTGGAGGTT TGGTAGTATA TATACGTTCA AAATTTCACG AAATCGGTAA

3361 TTACGGTGGG AGCCAAAAAA AATTCCAAAA TTTCGTATTA CATTAATAAT GCATGTGCTG

342 1 TAGACTCATA TTTTCTATGA TTTCGATTCT GTCACCATCC TGCTCGAATA TTTAAATCAT

348 1 GCTAATATTT TGTTTACATC TAAATCTTTT ATAAAAATTA TAATTTATAT TTGGGTTTAA

354 1 CAATTTCGGG CGCGTTTAGT GAGATTGGGT AATTTCGGAG CGAGGCCACC GGCCACACGA

3601 AAAATTCTAT ACACGACTAT ATGTGTACAT GTACATGCAT GGCACCCTGA TAGGCTACCC

3661 CATGGGGAAA AAATTGGAAA CGGACCATTC ATACGCAGTC GTGGTGCAGA CTGTGGGCCA

3721 CAATAGCAGT GTAAACATAA TTACGGTAAT CAAATACCCC ATGGGACCAT ATATATCATC

3781 CACAGATCCG TACGGTGCTT CCGTGTGGAT GG CTACACC AGATCTTTTC CACACCATAA

3841 GGGCAGCAAT GCAGCATCAT ATTCATATAT GCACTAGTGA TGTACCATTT GGCTTATATC

3901 ftT-JV T ^j Oi¾ c c TAACTCCTTG GAAACATTAT GATATTCTAT TGGGTTGAAG ATGTCACTAC

3961 AATCTTATGA GAGGTGTTTT GAAAACTGCC GGAGGTGCTT AAAGGAGACA

4021 GACGAGTTAG GACAACCGTC TCTATTAATG TGTACTAACT GAGGTAGTTA CCGTAACGTG

4081 CCTGACTTGA TTAACAGATT CAACCGTCTC AGTAAAGGCC ATGATTAACC GAAACAGATT

4 141 CGAGAGTTTT CTTAAGTAGT TAAACTATTT TAATCTTCAC CGAACTTATA GAAAATGAAA

4201 GAGCTAACAC CAATATTTAT ΆΑΑΑΑΤΑΑΑΤ TAGTATCACT AAATACATCA CGAAATCTAT

42 61 TTGGTGTTGT AGAAGTTATC CTTTTCTATA AAATTGATCA AATTTATGAT AACTTAGTTT

4 321 TAGGAATTCA TTTATTTTAG GACAACTGAG GAAGTACATA TTTTTTAAGT CATCCACAAA

4381 GTAGTGGATC CAATTTATTA CATTACTCTA CTACTTCAAA CTGAACAAAA GCCTAATCCT

44 4 1 GGTTATTTTT AGAGTGATTT TTTACAACAT CAGCAGTAGT CCAGAAAATG GGAGGACA T

4501 AATAAAAGTG AAAAGGAGCA GAAGAAAGAT TACGGTATTT TATTTGTGCT ATTTGTTTAA

4561 CTATTGGCAG TTTGGGACCG AAATAAATAA CTGTTCGTAG CTCTATATTT GTCGATTCGA

4 621 AAGTGTAACG ATGATTTTTG TGTTTCAAAA GAAAAATAAA GAAGTGCACC AATGATTGGA

4 681 TATCATAGGC TATATATGTT GGATTAATTG CATCCAACGT ATATAGTGAA AATGCTTTTC

4741 TCTTCGAGCG GTTACCAGT TTAATAGTTG CGAGTCGTCG TTTTTTATGT

4801 ACCCTAGGAC ATATATATCC GCATGTAGAC GATGATGAGA CTAGCAAGTT T TTTTTTTT

4 8 61 TTTGAGCAAA TACATAATTA TTGGATTTGC AGGCCGTGAG ATGATGTGCT ACGAGCCCCC

4 921 TGCCCCGTCC ACGGGCATCC ACCGTATGGT GCTGGTGCTA TTCCAGCAGC TTGGCCGTGA

4 981 CACGGTGTTC GCGGCGCCGT CCAGGCGCCA CAACTTCAAC ACCCGTGCCT TCGCCCGCCG

5041 CTACAACCTC GGCGCGCCCG TCGCCGCCAT GTTCTTCAAC TGCCAGCGCC AGACCGGCTC

5101 CGGTGGCCCC AGGTTCACCG GGCCCTACAC CAGCCGACGT CGTGCGGGCT GATGACGACG

5161 ATCGTCGTTA CGTCACGTGT ACCGTACACA TATATGTATA GATATACATG CATGCATG T

522 1 CCATGGTATA GGATCGGTGA CAAAACGTCT AATAATGTA

(SEQ ID N0:5 Sb06g012260 (5.2kb) - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:5. N = 1, 2, 3, 4, or 5 nucleotides in length. The coding sequence of the maturity Mai gene of SEQ ID NO:5, including introns, can be:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TATACAACCG TTGACATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

121 TTGCGCGCTC CGGCGGTTTC TGACAGGCCA AGGGTTGAAA TTGGAGGAGA TGATTATCGA

181 GTTGCATATA CTCTGGTAAA CTCATGCCAT GTCAATTAAC TAGTAGTTGA ATTTAGATGC

241 TGGTGGTATC GTGGATACAT GTACTATATG TTATGGTTGA TACATATTTG TTTAATTGAT

301 CGCAACACCA TTTGCGGTAA CTTCAAATTA CATTCTTTCA ATATATAGGT GATGGTCGAT

361 CCTGATGCTC CTAACCCAAG CAACCCAACC TTGAGGGAGT ACTTGCACTG GTAAGAGAAA

421 CCTATAGACG ACAATTATTG TTGTTGGCAT GTTTTGCCCA CATATACTTT GTGTGTGTAT

481 ATTTGTGCTT ATGCTTCTCC ATAAAATTTT GGTGTATGTC TCAAGAGAGA TAGGTATAGA

541 GGTTAGCAGT CCTTTAAAAA TGGTTTAATC CAGTAGTTTT TTTTCGGTCG GACTGCTCGA

601 ATTATTGTAT ATATGGAGAT CACATGCTAG TAACTTTTTC AATAATTTCA TGTTTCGAGC

661 AGGATGGTGA CTGACATCCC AGCATCAACT GATAATACAT ACGGTGAGTA CACCCCTATT

721 CCCATTTTGA AACAAGTAGA ATGTCTATTT TTATGATTTA GTATGTTCGT GACAATAGGC

781 TATAGCTATT TTGAAACTTC GGGAGCATAA AATAGTACTC GATTTTGTAT AACCATAAAC

841 ACACAGCTAG CCAATCTCTA TTCATATTTA TTTTAGTTTT ATTTGCCGAA CCATCCTCAA

901 CATCATAGCC ACTTGATCGA TCATCTCAAT CAGCGTTTGT ATCCTTGCCC GCTTGATTAT

961 CATCCATGGC AGTTCATATT TTTTTTCATT TCTTTCATGC TTGTTATAGT TTTATCTGAT

1021 GAATCCAAGA TGTTATTGAT CAATTAGTTC AGATGAGCAG TAATGCATGT TGGAGGTTTG

1081 GTAGTATATA TACGTTCAAA ATTTCACGAA ATCGGTAATT ACGGTGGGAG CCAAAAAAAA

1141 TTCCAAAATT TCGTATTACA TTAATAATGC ATGTGCTGTA GACTCATATT TTCTATGATT

1201 TCGATTCTGT CACCATCCTG CTCGAATATT TAAATCATGC TAATATTTTG TTTACATCTA

1261 AATCTTTTAT AAAAATTATA ATTTATATTT GGGTTTAACA ATTTCGGGCG CGTTTAGTGA

1321 GATTGGGTAA TTTCGGAGCG AGGCCACCGG CCACACGAAA AATTCTATAC ACGACTATAT

1381 GTGTACA GT ACATGCATGG CACCCTGATA GGCTACCCCA TGGGGAAAAA ATTGGAAACG

1441 GACCATTCAT ACGCAGTCGT GGTGCAGACT GTGGGCCACA ATAGCAGTGT AAACATAATT

1501 ACGGTAATCA AATACCCCAT GGGACCATAT ATATCATCCA CAGATCCGTA CGGTGCTTCC

1561 GTGTGGATGG TCTACACCAG ATCTTTTCCA CACCATAAGG GCAGCAATGC AGCATCATAT

1621 TCATATATGC ACTAGTGATG TACCATTTGG CTTATATCAT ATTCAACCTA ACTCCTTGGA

1681 AACATTATGA TATTCTATTG GGTTGAAGAT GTCACTACTA TCTTATGAGA

1741 GGTGTTTTGA AAACTGCCGG AGGTGCTTAA AGGAGACAGA CGAGTTAGGA CAACCGTCTC

1801 TATTAATGTG TACTAACTGA GGTAGTTACC GTAACGTGCC TGACTTGATT AACAGATTCA

1861 ACCGTCTCAG TAAAGGCCAT GATTAACCGA AACAGATTCG AGAGTTTTCT TAAGTAGTTA

1921 AACTATTTTA ATCTTCACCG AACTTATAGA AAATGAAAGA GCTAACACCA ATATTTATAA

1981 AAATAAATTA GTATCACTAA ATACATCACG AAATCTATTT GGTGTTGTAG AAGTTATCCT

2041 TTTCTATAAA ATTGATCAAA TTTATGATAA CTTAGTTTTA GGAATTCATT TATTTTAGGA

2101 CAACTGAGGA AGTACATATT TTTTAAGTCA TCCACAAAGT AGTGGATCCA ATTTATTACA

2161 TTACTCTACT ACTTCAAACT GAACAAAAGC CTAATCCTGG TTATTTTTAG AGTGATTTTT

2221 TACAACATCA GCAGTAGTCC AGAAAATGGG AGGACATTAA TAAAAGTGAA AAGGAGCAGA

2281 AGAAAGATTA CGGTATTTTA TTTGTGCTAT TTGTTTAACT ATTGGCAGTT TGGGACCGAA

2341

GTTCGTAGCT CTATATTTGT CGATTCGAAA GTGTAACGAT GATTTTTGTG

2401 TTTCAAAAGA AAAATAAAGA AGTGCACCAA TGATTGGATA TCATAGGCTA TATATGTTGG

24 61 AT AATTGCA TCCAACGTAT ATAGTGAAAA TGCTTTTCAA TCAAGTAATC TTCGAGCGGT

2521 TACCAGTTT AATAGTTGCG AGTCGTCGTT TTTTATGTAC CCTAGGACAT ATATATCCGC

2581 ATGTAGACGA TGATGAGACT AGCAAGTTTT TTTTTTTTTT TGAGCAAATA CATAATTATT

2641 GGATTTGCAG GCCGTGAGAT GATGTGCTAC GAGCCCCCTG CCCCGTCCAC GGGCATCCAC

2701 CGTATGGTGC TGGTGCTATT CCAGCAGCTT GGCCGTGACA CGGTGTTCGC GGCGCCGTCC

2761 AGGCGCCACA ACTTCAACAC CCGTGCCTTC GCCCGCCGCT ACAACCTCGG CGCGCCCGTC 2821 GCCGCCATGT TCTTCAACTG CCAGCGCCAG ACCGGCTCCG GTGGCCCC G GTTCACCGGG 2881 CCCTACACCA GCCGACGTCG TGCGGGCTGA

(SEQ ID N0:6 Sb06g012260 (5.2kb) - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:6.

The coding sequence of the maturity Mai gene, without introns, as it is found in short-day S. propinquum can include the nucleic acid sequence:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TATACAACCG TTGACATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

121 TTGCGCGCTC CGGCGGTTTC TGACAGGCCA AGGGTTGAAA TTGGAGGAGA TGATTATCGA

181 GTTGCATATA CTCTGGTGAT GGTCGATCCT GATGCTCCTA ACCCAAGCAA CCCAACCTTG

241 AGGGAGTACT TGCACTGGAT GGTGACTGAC ATCCCAGCAT CAACTGATAA TACATACGGC

301 CGTGAGATGA TGTGCTACGA GCCCCCTGCC CCGTCCACGG GCATCCACCG TATGGTGCTG

361 GTGCTATTCC AGCAGCTTGG CCGTGACACG GTGTTCGCGG CGCCGTCCAG GCGCCACAAC

421 TTCAACACCC GTGCCTTCGC CCGCCGCTAC AACCTCGGCG CGCCCGTCGC CGCCATGTTC

481 TTCAACTGCC AGCGCCAGAC CGGCTCCGGT GGCCCCAGGT TCACCGGGCC CTACACCAGC

541 CGACGTCGTG CGGGCTGA

(SEQ ID NO:7, Sb06g012260 - S. propinquum, or fragment, or a variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:7.

A maturity Mai protein as it is found in short-day S, propinquum can include the amino acid sequence:

MAANDSLVTAHVIGDVLDPFYTTVDMMILFDGTPIISGMELRAPAVSDRPRVEIGGDDYRVAYTLVHVDPDA PMPSNPTLREYLHWMVTDIPASTDNTYGREMMCYEPPAPSTG1HRMVLVLFQQLGRDTVFAAPSRRHNFNTR AFARRYNLGAPVAAMFF CQRQTGSGGPRFTGPYTSRRRAG*

(SEQ ID NO: 8, Sb06g012260) or functional fragment, or variant thereof having at least 75%, 80%», 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 8.

In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in short day S. propinquum includes the nucleic acid sequence:

i CACTAGTACA AAAATCATTT TCGTTGGCAC GTTGTTTTTT TTTTCACAGG CAGTTCACAA

61 TATCATGGTG CTAGTAGAAA AATTTCAACG GGCCCAACAA GAGAACCGCC AGGCGGTCTT 121 CTTAATTCAA CCGCCTGTGT AAACTTTCCA TTTACATAGG CGGCTTACGA TAAAAACCGT

181 GTGTATAAAT ACCATTAACA CAGGCAGTCG AGTTACGACA ACCGCCTGTG TAAATGTGTC 241 TTTTTACACA GGCGGTTTGT ATAGAGGGCC GCCTGTGCTA ATATATTTAC ACAGGCTATG 301 AGCCGCCTGT GTTAAGTCTT CTATAAATAC CCTTCGTCCA CCTCCAGACA AGAACAGTTA 361 CTCCCATGAG CTCTGCACAC TGGCGGACCA GACGATTCCA GTTTCCAAGG GGGGAGGTTT 421 TGATTTTCAT TTCTTTGGTG AGAAACTTCC AAAAGGTTAG TTAGTGCCAT TGATGCTATT

481 TTTTAAGCGA TTCTTTGGTT CAATTCTTGT ATTGGAGGTG CTCTAGATCT AGAGTTCATC 54 1 ATGCATTCTT GCTTAGGGTT AGAGTTCATA GGGCAAAAAG AGAGAGATTT AGCTAAATTT

601 TTATGTAAAT TCATAGTAAA TTGTAAAAAT TAAAAAAAAT AAAAAATAAA TACTTTTTAG

661 AATTCTTGTG AGTAGATCTA TACAATAGAG TAATGATGAG GATATTTTGA AGTTTATAA

721 TTTGATTCAG TTTTAGCTTT TCTTTTTTCA GATGAATTAG ACTTTATAAA CTCAAACATT

781 AAAATGTTGA AAATCATAAA ATGGCAAATA AATACTTTTT CAAATCTTTG TGCATAAATA

841 CTTCATAGAA ATCCTTGAAT TATTCCTAAA TTTTATACAA TTGTTTCTTA TAATTATGAA

901 AATGAGTTTA AACAATTATT TAAATTCCAT AAATTGTAAC TCCGTAAGGT GTAGGTTTTC

961 ATCTCTGTTT AATAGAAGGA GGTTAGTATC TTAGTTAAGT CTG TTTCGG GGGTTATATT

1021 AGTTTTGTTT TTAGATTGAC CTACATTAAT TGTTCTTAAC TAATTACAGC TAAATATGGA

1061 GAGGTCATTA TGGATGTACA ACTTATCAAG ATTGGACCTA TCATATGTAG TGCAGGTCCA

1141 AAAATTTATT GATGTCGCAA AGATACATGC TCGCAGAACA AAGGCGAAGC ACATATGTTG

1201 TCCATGCGCA GACTGCAAAA ATATTATGGT ATTTGACAAT GTAGAAGCAA TTACTTCCCA

1261 TCTGGTTTGA AGAGGATTTA TGGAGGACTA CTTGATTTGG ACAAAACATG GTGAGGGTAG

1321 TTTTGCACCT TATATGCGGA CAACTGACAA CACTGCAACT AACATCAATG TGGAGGGTCC

1381 AATGCCACCT CTCAATGAAT TTCATGC AT GCCAGATGTT AATGAAACTC ATACGTCTGA

1441 TGTCAATGAA ACTCAGCATG CTAACACAGA TGTTGTTGAA GATGCAGATT TCTTAGAGGC

1501 AATAATGAAC CGTTGTGCGG ATCCATCAAT ATTCTTCATG AAGGGAATGA AAGCATTGAA

1561 GAAGGCAGCA GAGGACACTT TGTACGACGA GTCAAAAGGT TGTACCAAAC AATGGTCGAC

1621 ATTATGTGTT GTTCTTCAGT TTTTGACGAT GAAGGCTAGA CATGGTTGGT CCGATGCTAG

1681 CTTCAATGAT TTCTTGCGTG TACTTGGAGA CCTTCTTCCT AAGGAGAACA AAGTGCCTGC

1741 TAACACATAC TATGCAAAGA AGCTAGTCAG TCCACTTACG ATAGGTGTTG AGAAGATCCA

1801 CGCATGTAGA AATCATTGTA TTCTATATCG AGGTGATCAA TATAAAGACT TAGACAGTTG

1861 TCCAAACTGT GGTGCCAGTA GGTACAAGAC AAACAAAGAT TTTCGGGAGG AAGAGAATCT

1921 AGCCTCTGTT TCTACAGGGA GGAAGCGAAA GAAGACCCAA ACAAAGACTC AACAAGACAA

1981 GCGCTCAAAG CCTAGTAGCA ATGAAGAAGT GGACTATTAT GCATTGAGAA GAGTCTCCCT

2041 ATGAGCCAAA AAAGGGGACA GCAGCAGGCA CAACTCTCTT TCTGAAAGGA CTTGGAAAGC

23.01 AGCGGACGGC ACGGCTCATT GAGCTCGAAC CGTCACAGAA AAAGGAAGCC ACCGCCCAGT

2161 CAATAGAAGC CATGCCCCCA TCAAAGGAAG CCCCAAGTGG CGATGTACAT ATTGAACAGC

2221 CATCAAGTCA ACCATTGACC CTAAAGGATA TCAGAAAGCC AACGATTGAT GATTATGTCA

2281 ATGTCCCTAG TGACTATGTG CCCGGAAGGC CTATGCTCCA ATGGACGCTG CTCGATTAGA

2341 TTCAATGGCT GATAAAAAGG TTTCATGACT GGTACATGAG AGCAGTGCAT GCTAGCCTCC

2401 ATGGAATCAG AGTTGATATA CCAACAGACA TGTTTGCTAC TGGTAACAAA AAAAGCAAGA

2461 CATTTGTTAC CTTTGAGGAC ATGCACTTGT TATTGAACTA TAGGCGGCTT GACGTCCAAC

2521 T 0 Λ T c ¾j? x CTGGTGCCTG TAAGTATCAC TCATGCACAC ACAATTATTA TATATTAATA

2581 TGTAGTGTGA AACTCTAATA TGTAGATGTT GTCTGTAGTT TGCAAGATCA CGAGCAGATG

2641 TCATTATTAT CTGCCGGATC GATGGTCGGT TATCTGAGCC CTATCAAGTT ACAAGAAAAT

2701 ATGAACAAAT TCGTATTATC AA GGAAGAT AGAGCAAAGA TAGAGGAAGA CAAAACACCA

2761 GGATAATTAT GCCATCTATC TTGGTAGATC AATGCTGAGG TATAAATATA GGGATTTTAT

2821 ATTGGCACCA TACAACATTA GGTAAGCTTG ACTTCATATA CGTATTTCAA ATTATCGTGT

2881 AAACAATATA CATGTGTCGC TCACTCATTT ATTCATGCAG TGACCATTGG ATTGTTTTTT

2941 ATATTTATCC CTTCGAAGGG AAGGTGCTTG TCCTAGACTC TTTACATGTT CCTCCCGAGA

3001 AGTATCAACC ATTCTTGGTT CAATTAGAAA GGTGAGCCAA CATGAAACCA CATGCGTACT

3061 TATATAAATT AGAGTTTCAA AATAACTTTA GTGATTTAGG TTCGATATCT ACGGGGCATG

3121 GCGGTTTTAT AAGAAACAAA AGGGACCTGT CGACGCTGCA CGCTCAGATC CTAGGATCCC

3181 ATTGATGATA CAACACCACT ATCCGGTAAG TTTTCTGAAC ACATTTCATC ATATAAATAA

3241 TACATAAAGC ATGGCAAATT TAGAATAATC CGTTGCTCAT TATATAGTGC CACAAGCAAC

3301 CACCTGGATC GGTCTATTGT GGGTACTATG TCTGTGAGTT TATAAGGCAG CGGGGACGTT

3361 ACGTCAAGGA CAAAAATATG GTAAATAATA TCTATGTATG AAAGTTTTCT CATTAAAGCT

3421 GCAAAATTAT ATATTGAACA TGTGTCAATC ATGCTTTTAA ACTTTATTTT CAGCCGAAAA

3481 AGCAAGGAAA AGACGTGCCC TT ACACCAA AGACTCTGGA AGATATAGTA GCATACTTGT 3541 GTGGTTTTAT TATGAGAGAA ATAATTTCAA GTGACAGTGC ATATTTTGAT CATGAGGGCG

3601 ATTTAGCAAG TGATAAATTT AGAGTGCTGA CAGACATAGC AGGTCTAAAT CTGAAGCGAA

3661 ACGACATGTA AACATTGTAT GGTTGTGCGG ATAACATGCA TTGACGTGTA TATATATAAT

3721 TTTATGGTTG ATGTTTGATT TGTTTACAAT TCTATAATAT ATATATGTGG TGTATGTATG

3781 ATGTTGTGTG TGTATATATA TATATATATA TATATATATA TATATATATA TATATATATA

3841 TATATATATA TAATGTTTAG CACTGTGTTT GGTGGGAAAA ΆΤΤΑΑΑΆΤΤΤ

3901 TAAAAAATTA TTTACACAGA CAGTGTACGT GTCGAGCGTC GTCCTGTGCT

3961 ATTCTAACAG GCGGCTCGCC TTGTCCACCG GTCGGTTAAA AATACATTTC CACACNGGCC

4021 TGGCTGGGAG AGCCGCCTGT GAAAACATAA TTTTCACAGG CGGCTCGCAC AGCCCCGCCT

4081 GTACTGTGGT CCATTTTGTA CTGACCCCTG GTACAGGCGG TGGGCTTGGC CGCCTGTGAA

4141 GATGCTTTTA GCACCGCCTG TAAAAATGTT TTTTGTAGCA GTGTTT

(SEQ ID NO: 19 - Sb07g008600 - S. propinq um) or a functional fragment or variant thereof having 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99%> sequence identity to SEQ ID NO: 19.

The coding sequence of the maturity Mai gene of SEQ ID NO: 19, including introns, can be:

1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTG&ACAGCC ¾ T C i\J G C

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAft TGTCCCTAGT

121 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

181 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

241 GTTGATATAC CAACAGACAT GTTTGCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

301 TTTGAGGACA TGCACTTG T ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

361 TGGTGCCTGT AAGTATCACT CATGCACACA C & ¾T V T X J X i¾ 1? jiVT 1? GTAGTGTGAA

421 ACTCTAATAT GTAGATGTTG TCTGTAGTTT GCAAGATCAC GAGCAGATGT CATTATTATC

481 TGCCGGATCG ATGGTCGGTT ATCTGAGCCC TATCAAGTTA CAAGAAAATA TGAACAAATT

541 CGTATTATCA AAGGAAGATA GAGCAAAGAT AGAGGAAGAC AAAACACCAG GATAATTATG

601 CCATCTATCT TGGTAGATCA ATGCTGAGGT ATAAATATAG GGATTTTATA TTGGCACCAT

661 ACAACATTAG GTAAGCTTGA CTTCATATAC GTATTTCAAA TTATCGTGTA AACAATATAC

721 ATGTGTCGCT CACTCATTTA TTCATGCAGT GACCATTGGA TTGTTTTTTA TATTTA CCC

781 TTCGAAGGGA AGGTGCTTGT CCTAGACTCT TTACATGTTC CTCCCGAGAA GTATCAACCA

841 TTCTTGGTTC AATTAGAAAG GTGAGCCAAC ATGAAACCAC ATGCGTACTT ATATAAATTA

901 GAGTTTCAAA ATAACTTTAG TGATTTAGGT TCGATATCTA CGGGGCATGG CGGTTTTATA

961 GGGACCTGTC GACGCTGCAC GCTCAGATCC TAGGATCCCA TTGATGATAC

1021 AACACCACTA TCCGGTAAGT TTTCTGAACA CATTTCATCA TATAAATAAT ACATAAAGCA

1081 TGGCAAATTT AGAATAATCC GTTGCTCATT ATATAGTGCC ACAAGCAACC ACCTGGATCG

1141 GTCTATTGTG GGTACTATGT CTGTGAGTTT ATAAGGCAGC GGGGACGTTA CGTCAAGGAC

1201 AAAAATATGG TAAATAATAT CTATGTATGA AAGTTTTCTC ATTAAAGCTG CAAAATTATA

1261 TATTGAACAT GTGTCAATCA TGCTTTTAAA CTTTATTTTC AGCCGAAAAA GCAAGGAAAA

1321 GACGTGCCCT TTACACCAAA GACTCTGGAA GATATAGTAG CATACTTGTG TGGTTTTATT

1381 ATGAGAGAAA TAATTTCAAG TGACAGTGCA TATTTTGATC ATGAGGGCGA TTTAGCAAGT

1441 GATAAATTTA GAGTGCTGAC AGACATAGCA GGTCTAAATC TGAAGCGAAA CGACATGTAA

(SEQ ID NO:28 - Sb07g008600 - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99%» sequence identity to SEQ ID NO:28, The coding sequence of the maturity Mai gene of SEQ ID NO:28, without introns, can be:

1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTGAACAGCC ATCAAGTCAA

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCTAGT

121 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

181 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

241 GTTGATATAC CAACAGACAT GTTTGCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

301 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

361 TGGTGCCTGG ACCATTGGAT TGTTTTTTAT ATTTATCCCT TCGAAGGGAA GGTGCTTGTC

421 CTAGACTCTT TACATGTTCC TCCCGAGAAG TATCAACCAT TCTTGGTTCA ATTAGAAAGG

481 GCATGGCGGT TTTATAAGAA ACAAAAGGGA CCTGTCGACG CTGCACGCTC AGATCCTAGG

541 ATCCCATTGA TGATACAACA CCACTATCCG TGCCACAAGC AACCACCTGG ATCGGTCTAT

601 TGTGGGTACT ATGTCTGTGA GTTTATAAGG CAGCGGGGAC GTTACGTCAA GGACAAAAAT

661 ATGCCGAAAA AGCAAGGAAA AGACGTGCCC TTTACACCAA AGACTCTGGA AGATATAGTA

721 GCATACTTGT GTGGTTTTAT TATGAGAGAA ATAATTTCAA GTGACAGTGC ATATTTTGAT

781 C&TGAGGGCG ATTTAGCAAG TGATAAATTT AGAGTGCTGA CAGACATAGC AGGTCTAAAT

841 CTGAAGCGAA ACGACATGTA A

(SEQ ID NO:29 - Sb07g008600 - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%», 97%, 98%, or 99% sequence identity to SEQ ID NO:29.

In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in short day S. propinquum includes the nucleic acid sequence:

1 CACTAGTACA AAAATCATTT TCGTTGGCAC GTTGTTTTTT TTTTCACAGG CAGTTCACAA

61 TATC&TGGTG CTAGTAGAAA AATTTCAACG GGCCCAACAA GAGAACCGCC AGGCGGTCTT

121 CTTAATTCAA CCGCCTGTGT AAACTTTCCA TTTACATAGG CGGCTTACGA TAAAAACCGT

181 GTGTATAAAT ACCATTAACA CAGGCAGTCG AGTTACGACA ACCGCCTGTG TAAATGTGTC

241 TTTTTACACA GGCGGTTTGT ATAGAGGGCC GCCTGTGCTA ATATATTTAC ACAGGCTATG

301 AGCCGCCTGT GTTAAGTCTT CTATAAATAC CCTTCGTCCA CCTCCAGACA AGAACAGTTA

361 CTCCCATGAG CTCTGCACAC TGGCGGACCA GACGATTCCA GTTTCCAAGG GGGGAGGTTT

421 TGATTTTCAT TTCTTTGGTG AGAAACTTCC AAAAGGTTAG TTAGTGCCAT TGATGCTATT

481 TTTTAAGCGA TTCTTTGGTT CAATTCTTGT ATTGGAGGTG CTCTAGATCT AGAGTTCATC

541 ATGCATTCTT GCTTAGGGTT AGAGTTCATA GGGCAAAAAG AGAGAGATTT AGCTAAATTT

601 TTATGTAAAT TCATAGTAAA TTGTAAAAAT TAAAAAAAAT AAAAAATAAA TACTTTTTAG

661 AATTCTTGTG AGTAGATCTA TACAATAGAG TAATGATGAG GATATTTTGA AGTTTATAAT

721 TTTGATTCAG TTTTAGCTTT TCTTTTTTCA GATGAATTAG ACTTTATAAA CTCAAACATT

781 AAAATGTTGA AAATCATAAA ATGGCAAATA AATACTTTTT CAAATCTTTG TGCATAAATA

841 CTTCATAGAA ATCCTTGAAT X·¾Ί TCC TTTTATACAA TTGTTTCTTA TAATTATGAA

901 AATGAGTTTA AACAATTATT TAAATTCCAT AAATTGTAAC TCCGTAAGGT GTAGGTTTTC

961 ATCTCTGTTT AATAGAAGGA GGTTAGTATC TTAGTTAAGT CTGTTTTCGG GGGTTATATT

1021 AGTTTTGTTT TTAGATTGAC CTACATTAAT TGTTCTTAAC TAATTACAGC TAAATATGGA

1081 GAGGTCATTA TGGATGTACA ACTTATCAAG ATTGGACCTA TCATATGTAG TGCAGGTCCA

1141 AAAATTTATT GATGTCGCAA AGATACATGC TCGCAGAACA AAGGCGAAGC ACATATGTTG

1201 TCCATGCGCA GACTGCAAAA ATATTATGGT ATTTGACAAT GTAGAAGCAA TTACTTCCCA

1261 TCTGGTTTGA AGAGGATTTA TGGAGGACTA CTTGATTTGG ACAAAACATG GTGAGGGT G 10

15

20

25

30

35

40

45 (SEQ ID NO:20) or a functional fragment or variant thereof having 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:20 (Sb07g008600 - S. propinq um) . Each N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides.

The coding sequence of the maturity Mai gene of SEQ ID NO:20, including introns, can be:

1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTGAACAGCC ATCAAGTCAA

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCTAGT

121 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

181 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

241 GTTGATATAC CAACAGACAT GTT GCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

301 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

361 TGGTGCCTGT AAGTATCACT CATGCACACA CAATTATTAT ATATTAATAT GTAGTGTGAA

421 ACTCTAATAT GTAGATGTTG TCTGTAGTTT GCAAGATCAC GAGCAGATGT CATTATTATC

481 TGCCGGATCG ATGGTCGGTT ATCTGAGCCC TATCAAGTTA CAAGAAAATA TGAACAAATT

541 CGTATTATCA AAGGAAGATA GAGCAAAGAT AGAGGAAGAC AAAACACCAG GATAATTATG

601 CCATCTATCT TGGTAGATCA ATGCTGAGGT ATAAATATAG GGATTTTATA TTGGCACCAT

661 ACAACATTAG GTAAGCTTGA CTTCATATAC GTATTTCAAA TTATCGTGTA AACAATATAC

721 ATGTGTCGCT CACTCATTTA TTCATGCAGT GACCATTGGA TTGTTTTTTA TATTTATCCC

781 TTCGAAGGGA AGGTGCTTGT CCTAGACTCT TTACATGTTC CTCCCGAGAA GTATCAACCA

841 TTCTTGGTTC AATTAGAAAG GTGAGCCAAC ATGAAACCAC ATGCGTACTT ATATAAATTA

901 GAGTTTCAAA ATAACTTTAG TGATTTAGGT TCGATATCTA CGGGGCATGG CGGTTTTATA

961 AGAAACAAAA GGGACCTGTC GACGCTGCAC GCTCAGATCC TAGGATCCCA TTGATGATAC

1021 AACACCACTA TCCGGTAAGT TTTCTGAACA CATTTCATCA TATAAATAAT ACATAAAGCA

1081 TGGCAAATTT AGAATAATCC GTTGCTCATT ATATAGTGCC ACAAGCAACC ACCTGGATCG

1141 GTCTATTGTG GGTACTATGT CTGTGAGTTT ATAAGGCAGC GGGGACGTTA CGTCAAGGAC

1201 AAAAATATGG TAAATAATAT CTATGTATGA AGTTTTCTCA TTAAAGCTGC AAAATTATAT

1261 ATTGAACATG TGTCAATCAT GCTTTTAAAC TTTATTTTCA GCCGAAAAAG CAAGGAAAAG

1321 ACGTGCCCTT TACACCAAAG ACTCTGGAAG ATATAGTAGC ATACTTGTGT GGTTTTATTA

1381 TGAGAGAAAT AATTTCAAGT GACAGTGCAT ATTTTGATCA TGAGGGCGAT TTAGCAAGTG

1441 ATAAATTTAG AGTGCTGACA GACATAGCAG GTCTAAATCT GAAGCGAAAC GACATGTAA

(SEQ ID NO:30 - Sb07g008600 (10.6 kb) - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:30.

The coding sequence of the maturity Mai gene of SEQ ID NO:30, without introns, can be:

1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTGAACAGCC ATCAAGTCAA

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCTAGT

121 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

181 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

241 GTTGATATAC CAACAGACAT GTTTGCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

301 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

361 TGGTGCCTGG ACCATTGGAT TGTTTTTTAT ATTTATCCCT TCGAAGGGAA GGTGCTTGTC (SEQ ID N0:31 - Sb07g008600 - S. propinquum) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:31.

2. Sequences for Day-Neutral Flowing

The S. bicolor cultivar from which the sequences described below are derived are day-neutral, and have the recessive (loss of function) Mai allele. Sequences for a recessive Mai gene are therefore provided.

In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in day-neutral S. bicolor can include the nucleic acid sequence:

1561 TAGTGTTTTA TTACTAATTA AAAATATTAG AAGAACTCCA TCATTTTGGT AGTGATTGGT

1621 TGTTTGGATT AGTCTTCTCA CGTTAGACCT ATATATGCAG GACAACTCAA GCCAGCATAA

1681 ATATATGAAA TATCTTGGTG TTTGTTTGTC TGACACAGGC AACCGTGTTT GGTATAAATG

1741 TGTTTTCTTG TTTACGTTTT ACCATCTATA GTCATCTCAA TGTTTATATA GTAGAGACTT

1801 CATGTTTGTA GTAGATAAGG TAGAGAATTG AGAATATTTT ATTTTTGTGC GACCATCAAT

1861 TTTATGTAAT CTGCATTGTC TAATGCTTTA TTTGACATTT GAAACTACTT AATTTGACCG

1921 TTATGCAGGT CCGCATGATC CTATGAAAGC AATTAATTAG TACGGGTACT GCACTACACA

1981 AGTTTGCTAG TACTATTCTA TTAACCGACC TGTCAATATT ACCTTAAGTT ACTGATTTCA

2041 ATTAGAATCT AACACATTCA GGAAAAGAAG TTTTCCTTAT TAGTAGTAAC TTTTTATACT

2101 AATTAAGATT CAATAAAAAT TCACCATGAC ATCCCCATTG CCAAGAGAAT ATTTCGCCGC

2161 CCCTCAAAGC AGCCAAGGCT TTACTAAAAA GACTATCCAC GCAGTAGAGA TTTAGTCAAA

2221 ATATTCCAAT AGCAATTGTT TTCTGCCTGC TTGACCTTCG TCAGCCACTC ACTGTATAAA

2281 TATCGCACCA CGCCCTTTGC AGGCTTACAG AGCTTGTACT ACGTACTAAC AAGGCACACA

2341 CAATACCCTG TGTTCACCGG CCCTGCACAA AACTCAAGCA GTTATTACTA ACATGGCGGC

2401 TAACGATTCC TTGGTTACTG CTCATGTGAT AGGAGATGTC TTGGACCCCT TCTATACAAC

2461 CGTTGATATG ATGATCCTAT TCGATGGTAC TCCTATTATC AGCGGCATGG AGTTGCGTGC

2521 TCCGGCGGTT TCTGACAGGC CAAGGGTTGA GATTGGAGGA GATGATTATC GAGTTGCATA

2581 TACTCTGGTA AACTCATGTC ATGTCAATTA ACTAGTAGTT GAATTTAGAT GCTGGTCGTA

2641 TCGTGGATAC ATGAACTATA TGTTATGGTT GATACATATT TGTTTAATTG ATCGCAACAC

2701 CATTTGTGGT AACTTCAAAT AACATTCTTT CAATATATAG GTGATGGTCG ATCCTGATGC

2761 TCCTAACCCA AGCAACCCAA CCTTGAGGGA GTACTTGCAC TGGTAAGAGA AACCTATAGA

29 Ξ 1 CGACAATTAT TGTTGTTGGC ATGTTCTGCC CACATATACT TTGCTAGTGT GTGTATATTT

2881 GTGCTTATGC TTCTCCATAA ATTTTGGTGT ATGTCCCAAG AGAGATAGGT ATAGAGGTTA

2941 GCAGTCCTTT AAAAATGGTT TAATCCAGTA GTTTTTTTTC GGTCGGCCGG ACTGCTAGTA

3001 ACTTTCAATC ATTTCATGTT TCGAGCAGGA fGGTGACTGA CATCCCAGCA TCAACTGATA

3061 ATACATACGG TGAGATCACC CCTATTCCCA TTTTGAGACA AGTAGAATGT CTATTTTTAT

3121 GATCTAGTAT GTTCGTGACA ATAGGCTAGC TATTTTGAAA CTTCGGGAGC ATAAAATAGT

3181 ACTCGATTTT GTATAACCAT AAACACAGCT AGCCAATCTC TATTCATATT TATTTTAGTT

3241 TTATTTGCCG AACCATCCTC AACATCATAG CCACTTGATC GATCATCTCA ATCAGCGTTT

3301 GTATCCTTGC CCGCTTTGAT TATCATCCAT GACAGTTCAT ATTTTTTTTC ATTTCTTTCA

3361 TGCTTGTTAT AGTTTTATCT GATGAATCCG AGATGTTATT GATCAATTAG TTCAGATGAG

3421 CAGTAATGTA TGTTGGAGGT TTGGTAGTAT ATATACGTTC AATATTTCAC GAAATCGGTA

3481 ATTACGAAAA TCCCAAAATT TTGAATTACA TTAATAATGC ATGTGACTCA TATTTTCTAT

3541 GATTTCTATT CTGTTGCATA TCTTGTAC CAATAGATAT TTAAATCATG CTAATATTTT

3601 GTTTAGATCT AAATCTTTTA GAAAAATTAT AATTTATATT TGGG TTAAC AATTTCGGGC

3661 GCGTTTAGTG AGATTGGGTA ATTTCGGAGC GAGGCGGCCG CCGGCCACGA AAAATTCTAT

3721 ACACGACTAT ATGTGTACAT GTACATGCAT GGCACCTTGA TAGGCTACCC CGGCCCGCAT

3781 GGGGAAAAAA TTGGAAACGG ACCATTCATA CGCAGTCGTG GTGCCGACTG TGGGCCACAA

3841 TAGCAGTGTA AACATAATTA CGGTAATCAA ATACCCCGTG GGACCATATA TATCATCCAC

3901 AGATCCGTAC GGTGCTTCCG TGTGGATGGT CTACCCCAGA TCTTTTCCAC CCCATAAGGG

3961 CAGCAATGCA GCATCATATT CATATGCACT AGTGATGTAC CATTTGGCTT ATATCATATT

4021 CAACCTAACT CCTTGGAAAC ATTATGATGT TCTATTGGGG TGAAGATGTC ACTACTAAAA

4081 AAAGATCTTA TGAGAGGTGT TTTGAAAACT GCCCGAGGTG GTTAAAGGAG ACGGACGAGT

4141 TAGGACAACT GCCTCTATTA ATGTGTATTA ACCGAGGTAG TTACCGTAAC GTGCCTGACT

4201 TGATTAACAG ATTCAACCGT CTCAGTAAAG ACCATGATTA ACCGAAACGG AATCGAGAGT

4261 TTTCTCAAGT AGTTAAACTA TTTTAAACTG CACCGAACTT ATAAAAATGG TAGAGCTAAC

4321 ACCAATATTT ATAAAAATAA ATTAGTATCA CTAAATACAT CACGAAATCT ATTTGGTGTT

4381 GTAGAAGTTA TCCTTTTCTA TAAAATTGAT CAAATTTATG ATAACTTAGT TTTAGGAATT

4441 GATTTATTTT AGGACAACTA AGGAAGTACA TTTTTTAAAG TCATCCACAA AGTAGTGGAT

4501 CCAATTTATT ACATTACTCC ACTACTTCAA ACTGAACAAA AGCCTAATCC TGGTTATTTT

(SEQ ID NO:9, Sb06g012260 - S. bicolor), or a variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:9.

The coding sequence of the maturity Mai gene of SEQ ID NO: 10, including introns, can be:

T 1021 CAGATGAGCA GTAATGTATG TTGGAGGTTT GGTAGTATAT ATACGTTCAA TATTTCACGA

1081 AATCGGTAAT TACGAAAATC CCAAAATTTT GAATTACATT AATAA GCAT GTGACTCATA

1141 TTTTCTATGA TTTCTATTCT GTTGCATATT CTTGTACTCA ATAGATATTT AAATCATGCT

1201 AATATTTTGT TTAGATCTAA ATCTTTTAGA AAAATTATAA TTTATATTTG GGTTTAACAA

1261 TTTCGGGCGC GTTTAGTGAG ATTGGGTAAT TTCGGAGCGA GGCGGCCGCC GGCCACGAAA

1321 AATTCTATAC ACGACTATAT GTGTACATGT ACATGCATGG CACCTTGATA GGCTACCCCG

1381 GCCCGCATGG GGAAAAAATT GGAAACGGAC CATTCATACG CAGTCGTGGT GCCGACTGTG

1441 GGCCACAATA GCAGTGTAAA CATAATTACG GTAATCAAAT ACCCCGTGGG ACCATATATA

1501 TCATCCACAG ATCCGTACGG TGCTTCCGTG TGGATGGTCT ACCCCAGATC TTTTCCACCC

1561 CATAAGGGCA GCAATGCAGC ATCATATTCA TATGCACTAG TGATGTACCA TTTGGCTTAT

1621 ATCATATTCA ACCTAACTCC TTGGAAACAT TATGATGTTC TATTGGGGTG AAGATGTCAC

1681 TACTAAAAAA AGATCTTATG AGAGGTGTTT TGAAAACTGC CCGAGGTGGT TAAAGGAGAC

1741 GGACGAGTTA GGACAACTGC CTCTATTAAT GTGTATTAAC CGAGGTAGTT ACCGTAACGT

1801 GCCTGACTTG ATTAACAGAT TCAACCGTCT CAGTAAAGAC CATGATTAAC CGAAACGGAA

1861 TCGAGAGTTT TCTCAAGTAG TTAAACTATT TTAAACTGCA CCGAACTTAT AAAAATGGTA

1921 GAGCTAACAC C T i¾ TT T ¾T AAAAATAAAT TAGTATCACT AAATACATCA CGAAATCTAT

1981 TTGGTGTTGT AGAAGTTATC CTTTTCTATA AAATTGATCA AATfTATGAT AACTTAGTTT

2041 TAGGAATTGA TTTATTTTAG GACAACTAAG GAAGTACATT TTTTAAAGTC ATCCACAAAG

2101 TAGTGGATCC AATTTATTAC ATTACTCCAC TACTTCAAAC TGAACAAAAG CCTAATCCTG

2161 GTTATTTTGA GAGTGATTTT TTACAACATC AGCAGTAGTC CAGAAAATGG GAGGACATTA

2221 ATAAAAGTGA AAAGGAGCAG AAGAAAGATT ACGGTATTTT ATTTGTGCTA TTTGTTTAAC

2281 TATTGGCAGT TTGGGACCGA AAATAAATAA CTGTTCGTAG CTCTATATTT GTCCATTCGA

2341 AAGTGTAACG ATGATTATTG TGTTTCAAAA GATAAATAAA GAAGTGCACC AATGATTTGA

2401 TATCATAGGC TATATAATCC AACATGGTGA AAATGCTTTT CAATCAAGTA ATCTTCGAGC

2461 GGTTACCAGT TTTAATAGTT GCGAGTCGTC GTTTTTTATG TACCCTAGGA CATATATATA

2521 TCCGCATGTA GACGATGAGA CTAGCTAGTT TTTTTTTTTT TGAGCAAATA CATAATTATT

2581 GGATTTGCAG GCCGTGAGAT GATGTGCTAC GAGCCCCCTG CCCCGTCCAC GGGCATCCAC

2641 CGGATGGTGC TGGTGCTATT CCAGCAGCTT GGCCGTGACA CGGTGTTCGC GGCGCCGTCC

2701 AGGCGCCACA ACTTCAACAC CCGTGCCTTC GCCCGCCGCT ACAACCTCGG CGCGCCCGTC

2761 GCCGCCATGT TCTTCAACTG CCAGCGCCAG ACCGGCTCCG GTGGCCCCAG GTTCACCGGG

2821 CCCTACACCA GCCGCCGTCG TGCGGGCTGA

(SEQ ID NO: 10 Sb06g012260 - S. bicolor) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 10.

The coding sequence, without introns, of the maturity Mai gene as it is found in day-neutral S, bicolor can include the nucleic acid sequence:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TATACAACCG TTGATATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

121 TTGCGTGCTC CGGCGGTTTC TGACAGGCCA AGGGTTGAGA TTGGAGGAGA TGATTATCGA

181 GTTGCATATA CTCTGGTGAT GGTCGATCCT GATGCTCCTA ACCCAAGCAA CCCAACCTTG

241 AGGGAGTACT TGCACTGGAT GGTGACTGAC ATCCCAGCAT CAACTGATAA TACATACGGC

301 CGTGAGATGA TGTGCTACGA GCCCCCTGCC CCGTCCACGG GCATCCACCG GATGGTGCTG

361 GTGCTATTCC AGCAGCTTGG CCGTGACACG GTGTTCGCGG CGCCGTCCAG GCGCCACAAC

421 TTCAACACCC GTGCCTTCGC CCGCCGCTAC AACCTCGGCG CGCCCGTCGC CGCCATGTTC

481 TTCAACTGCC AGCGCCAGAC CGGCTCCGGT GGCCCCAGGT TCACCGGGCC CTACACCAGC

541 CGCCGTCGTG CGGGCTGA (SEQ ID N0:11, Sb06g012260 - S. bicolor), or a variant thereof, for example a codon optimized variant, having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:l 1.

In this embodiment, the maturity Mai protein as it is found in short-day - S. bicolor can include the amino acid sequence SEQ ID NO: 8, or a variant thereof having at least 95% sequence identity to SEQ ID NO: 8.

In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in day-neutral S. bicolor can include the nucleic acid sequence:

1 TTCCACCTGG GCAGGGAAAA CGGTTTATTA TGTTCCTCTT TAATTTATCT ATCGTGGTCT

61 GTTTTCACTA AAACTGTCAT ATTGCTACAC TCCAGTACTA CCAGTACGTC GCCCGCACAT

121 AGTGGCCAAG GATTTTACTG CTACTGTTGA TTAACATAAG CACTTGCGAC TTTCCCTAAC

181 ATCTTTTATA AAACAACGGC CGCAATAATA TTGAACTGTT TTTTTCTAGT ACCAAAAATA

241 GAATTTGATC CCTCACCTCA TTACATCCAT AGTAACATGA CCAGATATAT ATGGACAGGC

301 CGGGATCACT CGCCAGCAGA TACCCTGAGC GATTCATAAC CAGAATTTTT AATTTTTTCT

361 AGTGAAGTGG GGTTCTCCTA GTCCTTTAAC ATTCAAAATT TAGTACAAAC TTTCCTTAGT

421 AAATGTCTTC TAGTAAAGAT TTCCTAGTGT TTTGATTTGG TAGTGTTTTA TTACTAATTA

481 AAAATATTAG AAGAACTCCA TCATTTTGGT AGTGATTGGT TGTTTGGATT AGTCTTCTCA

541 CGTTAGACCT ATATATGCAG GACAACTCAA GCCAGCATAA ATATATGAAA TATCTTGGTG

601 TTTGTTTGTC TGACACAGGC AACCGTGTTT GGTATAAATG TGTTTTCTTG TTTACGTTTT

661 ACCATCTATA GTCATCTCAA TGTTTATATA GTAGAGACTT CATGTTTGTA GTAGATAAGG

721 TAGAGAATTG AGAATATTTT ATTTTTGTGC GACCATCAAT TTTATGTAAT CTGCATTGTC

781 TAATGCTTTA TTTGACATTT GAAACTACTT AATTTGACCG TTATGCAGGT CCGCATGATC

841 CTATGAAAGC AATTAATTAG TACGGGTACT GCACTACACA AGTTTGCTAG TACTATTCTA

901 TTAACCGACC TGTCAATATT ACCTTAAGTT ACTGATTTCA ATTAGAATCT AACACATTCA

961 GGAAAAGAAG TTTTCCTTAT TAGTAGTAAC TTTTTATACT AATTAAGATT CAATAAAAAT

1021 TCACCATGAC ATCCCCATTG CCAAGAGAAT ATTTCGCCGC CCCTCAAAGC AGCCAAGGCT

1081 TTACTAAAAA GACTATCCAC GCAGTAGAGA TTTAGTCAAA ATATTCCAAT AGCAATTGTT

1141 TTCTGCCTGC TTGACCTTCG TCAGCCACTC ACTGTATAAA TATCGCACCA CGCCCTTTGC

1201 AGGCTTAC&G AGCTTGTACT ACGTACTAAC AAGGCACACA CAATACCCTG TGTTCACCGG

1261 CCCTGCACAA AACTCAAGCA GTTATTACTA ACATGGCGGC TAACGATTCC TTGGTTACTG

1321 CTCATGTGAT AGGAGATGTC TTGGACCCCT TCTATACAAC CGTTGATATG ATGATCCTAT

1381 TCGATGGTAC TCCTATTATC AGCGGCATGG AGTTGCGTGC TCCGGCGGTT TCTGACAGGC

1441 CAAGGGTTGA GATTGGAGGA GATGATTATC GAGTTGCATA TACTCTGGTA AACTCATGTC

1501 ATGTCAATTA ACTAGTAGTT GAATTTAGAT GCTGGTCGTA TCGTGGATAC ¾T G C T ¾ X ¾.

1561 TGTTATGGTT GATACATATT TGTTTAATTG ATCGCAACAC CATTTGTGGT

1621 AACATTCTTT GTGATGGTCG ATCCTGATGC TCCTAACCCA AGCAACCCAA

1681 CCTTGAGGGA GTACTTGCAC TGGTAAGAGA AACCTATAGA CGACAATTAT TGTTGTTGGC

1741 ATGTTCTGCC C i\ C i¾ ' β.Ι' ¾ Ί^* TTGCTAGTGT GTGTATATTT GTGCTTATGC TTCTCCATAA

1801 ATTTTGGTGT ATGTCCCAAG AGAGATAGGT ATAGAGGTTA GCAGTCCTTT AAAAATGGTT

1861 TAATCCAGTA GTTTTTTTTC GGTCGGCCGG ACTGCTAGTA ACTTTCAATC ATTTCATGTT

1921 TCGAGCAGGA TGGTGACTGA CATCCCAGCA TCAACTGATA ATACATACGG CCGTGAGATC

1981 ACCCCTATTC CCATTTTGAG ACAAGTAGAA TGTCTATTTT TATGATCTAG TATGTTCGTG

2041 ACAATAGGCT AGCTATTTTG AAACTTCGGG AGCATAAAAT AGTACTCGAT TTTGTATAAC

2101 CATAAACACA GCTAGCCAAT CTCTATTCAT GTTTTATTTG CCGAACCATC

2161 CTCAACATCA TAGCCACTTG ATCGATCATC TCAATCAGCG TTTGTATCCT TGCCCGCTTT 2221 GATTATCATC CATGACAGTT CATATTTTTT TTCATTTCTT TCATGCTTGT TATAGTTTTA

2281 TCTGATGAAT CCGAGATGTT ATTGATCAAT TAGTTCAGAT GAGCAGTAAT GTATGTTGGA

2341 GGTTTGGTAG TATATATACG TTCAATATTT CACGAAATCG GTAATTACGA AAATCCCAAA

2401 ATTTTGAATT ACATTAATAA TGCATGTGAC TCATATTTTC TATGATTTCT ATTCTGTTGC

2461 AT&TTCTTGT ACTCAATAGA TATTTAAATC ATGCTAATAT TTTGTTTAGA TCTAAATCTT

2521 TTAGAAAAAT T j¾ Ί?.ί¾ <¾ TT T TVI¹ ATTTGGGTTT AACAATTTCG GGCGCGTTTA GTGAGATTGG

2581 GTAATTTCGG AGCGAGGCGG CCGCCGGCCA CGAAAAATTC TATACACGAC TATATGTGTA

2641 CATGTACATG CATGGCACCT TGATAGGCTA CCCCGGCCCG CATGGGG AA AAATTGGAAA

2701 CGGACCATTC ATACGCAGTC GTGGTGCCGA CTGTGGGCCA CAATAGCAGT GTAAACATAA

2761 TTACGGTAAT CAAATACCCC GTGGGACCAT ATATATCATC CACAGATCCG tACGGTGCTT

282 X CCGTGTGGAT GGTCTACCCC AGATCTTTTC CACCCCATAA GGGCAGCAAT GCAGCATCAT

2881 ATTCATATGC ACTAGTGATG TACCATTTGG CTTATATCAT ATTCAACCTA ACTCCTTGGA

2941 AACATTATGA TGTTCTATTG GGGTGAAGAT GTCACTACTA AAAAAAGATC TTATGAGAGG

3001 TGTTTTGAAA ACTGCCCGAG GTGGTTAAAG GAGACGGACG AGTTAGGACA ACTGCCTCTA

3061 TTAATGTGTA TTAACCGAGG TAGTTACCGT AACGTGCCTG ACTTGATTAA CAGATTCAAC

3121 CGTCTCAGTA AAGACCATGA TTAACCGAAA CGGAATCGAG AGTTTTCTCA AGTAGTTAAA

3181 CTATTTT AA CTGCACCGAA CTTATAAAAA TGGTAGAGCT AACACCAATA TTTATAAAAA

3241 TAAATTAGTA TCACTAAATA CATCACGAAA TCTATTTGGT GTTGTAGAAG TTATCCTTTT

3301 CTATAAAATT GATCAAATTT ATGATAACTf AGTTTTAGGA ATTGATTTAT TTTAGGACAA

3361 CTAAGGAAGT ACATTTTTTA AAGTCATCCA CAAAGTAGTG GATCCAATTT ATTACATTAC

3421 TCCACTACTT CAAACTGAAC AAAAGCCTAA TCCTGGTTAT TTTGAGAGTG ATTTTTTACA

3481 ACATCAGCAG TAGTCCAGAA AATGGGAGGA CATTAATAAA AGTGAAAAGG AGCAGAAGAA

3541 AGATTACGGT ATTTTATTTG TGCTATTTGT TTAACTATTG GCAGTTTGGG ACCGAAAATA

3601 AATAACTGTT CGTAGCTCTA TATTTGTCCA TTCGAAAGTG TAACGATGAT TATTGTGTTT

3661 CAAAAGATAA ATAAAGAAGT GCACCAATGA TTTGATATCA TAGGCTATAT AATCCAACAT

3721 GGTGAAAATG CTTTTCAATC AAGTAATCTT CGAGCGGTTA CCAGTTTTAA TAGTTGCGAG

3781 TCGTCGTTTT TTATGTACCC TAGGACATAT ATATATCCGC ATGTAGACGA TGAGACTAGC

3841 TAGTTTTTTT TTTTTTGAGC TTATTGGATT TGCAGGCCGT GAGATGATGT

3901 GCTACGAGCC CCCTGCCCCG TCCACGGGCA TCCACCGGAT GGTGCTGGTG CTATTCCAGC

3961 AGCTTGGCCG TGACACGGTG TTCGCGGCGC CGTCCAGGCG CCACAACTTC AACACCCGTG

4021 CCTTCGCCCG CCGCTACAAC CTCGGCGCGC CCGTCGCCGC CATGTTCTTC AACTGCCAGC

4081 GCCAGACCGG CTCCGGTGGC CCCAGGTTCA CCGGGCCCTA CACCAGCCGC CGTCGTGCGG

4141 GC GATGACG ACGATCGTCG TTACGTCACG TGTACCGTAC ATATATATGT AAGATATACA

4201 TGCATGTTCC ATGGTAAGGA TCGGTGACAA AACGTCTAAT AATGTATACA CACAXATGCA

4261 TGGAATGCAT GTAATAAGAG T i¾ Ti^T ¾ X G! T ¾. TAATAAGTAG GGGGGAGCAT GCATATATTG

4321 TACACGCGTC CGATGCGTAT ATAGCCCTAT ACATTATTGT AGTTGTAATC A

(SEQ ID NO: 12, Sb06g012260 - S, bicolor), or a variant, for example a codon optimized variant, thereof having at least at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 12.

The coding sequence of the maturity Mai gene of SEQ ID NO:12, including introns, can be:

1 ATGGCGGCTA ACGATTCCTT GGTTACTGCT CATGTGATAG GAGATGTCTT GGACCCCTTC

61 TAT CAACCG TTGATATGAT GATCCTATTC GATGGTACTC CTATTATCAG CGGCATGGAG

12 TTGCGTGCTC CGGGGGTfTC TGACAGGCCA AGGGTTGAGA TTGGAGGAGA TGATTATCGA

181 GTTGC ATA CTCTGGTAAA CTCATGTCAT GTCAATTAAC TAGTAGTTGA ATTTAGATGC

241 TGGTCGTATC GTGGATACAT GAACTATATG TTATGGTTGA TACATATTTG TTTAATTGAT

301 CGCAACACCA TTTGTGGTAA CTTCAAATAA CATTCTTTCA ATAT T GGT GATGGTCG T

361 CCTGATGCTC CTAACCCAAG CAACCCAACC TTGAGGGAGT ACTTGCACTG GTAAGAGAAA 421 CCTATAGACG ACAATTATTG TTGTTGGCAT GTTCTGCCCA CATATACTTT GCTAGTGTGT

481 GTATATTTGT GCTTATGCTT CTCCATAAAT TTTGGTGTAT GTCCCAAGAG AGATAGGTAT

541 AGAGGTTAGC AGTCCTTTAA AAATGGTTTA ATCCAGTAGT TTtTTTTCGG TCGGCCGGAC

601 TGCTAGTAAC TTTCAATCAT TTCATGTTTC GAGCAGGATG GTGACTGACA TCCCAGCATC

661 AACTGATAAT ACATACGGCC GTGAGATCAC CCCTATTCCC ATTTTGAGAC AAGTAGAATG

721 TCTATTTTTA TGATCTAGTA TGTTCGTGAC AATAGGCTAG CTATTTTGAA ACTTCGGGAG

781 CATAAAATAG TACTCGATTT TGTATAACCA TAAACACAGC TAGCCAATCT CTATTCATAT

841 TTATTTTAGT TTTATTTGCC GAACCATCCT GCCACTTGAT CGATCATCTC

901 AATCAGCGTT TGTATCCTTG CCCGCTTTGA TTATCATCCA TGACAGTTCA TATTTTTTTT

961 CATTTCTTTC ATGCTTGTTA TAGTTTTATC TGATGAATCC GAGATGTTAT TGATCAATTA

1021 GTTCAGATGA GCAGTAATGT ATGTTGGAGG TTTGGTAGTA TATATACGTT CAATATTTCA

1081 CGAAATCGGT AATTACGAAA ATCCCAAAAT TTTGAATTAC ATTAATAATG CATGTGACTC

1141 ATATTTTCTA TGATTTCTAT TCTGTTGCAT ATTCTTGTAC TCAATAGATA TTTAAATCAT

1201 GCTAATATTT TGTTTAGATC TAAATCTTTT AGAAAAATTA ΤΑΑΤΤΤΑΤΑΪ TTGGGTTTAA

1261 CAATTTCGGG CGCGTTTAGT GAGATTGGGT AATTTCGGAG CGAGGCGGCC GCCGGCCACG

1321 AAAAATTCTA TACACGACTA TATGTGTACA TGTACATGCA TGGCACCTTG ATAGGCTACC

1381 CCGGCCCGCA TGGGGAAAAA ATTGGAAACG GACCATTCAT ACGCAGTCGT GGTGCCGACT

1441 GTGGGCCACA ATAGCAGTGT AAACATAATT ACGGTAATCA AATACCCCGT GGGACCATAT

1501 ATATCATCCA CAGATCCGTA CGGTGCTTCC GTGTGGATGG TCTACCCCAG ATCTTTTCCA

1561 CCCCATAAGG GCAGCAATGC AGCATCATAT TCATATGCAC TAGTGATGTA CCATTTGGCT

1621 TATATCATAT TCAACCTAAC TCCTTGGAAA CATTATGATG TTCTATTGGG GTGAAGATGT

16S1 CACTACTAAA AAAAGATCTT ATGAGAGGTG TTTTGAAAAC TGCCCGAGGT GGTTAAAGGA

1741 GACGGACGAG TTAGGACAAC TGCCTCTATT AATGTGTATT AACCGAGGTA GTTACCGTAA

1801 CGTGCCTGAC TTGATTAACA GATTCAACCG TCTCAGTAAA GACCATGATT AACCGAAACG

1861 GSATCGAGAG TTTTCTCAAG TAGTTAAACT ATTTTAAACT GCACCGAACT TATAAAAATG

1921 GTAGAGCTAA CACCAATATT TATAAAAATA AATTAGTATC ACTAAATACA TCACGAAATC

1981 TATTTGGTGT TGTAGAAGTT ATCCTTTTCT ATAAAATTGA TCAAATTTAT GATAAC TAG

2041 TTTTAGGAAT TGAT7TATTT TAGGACAACT AAGGAAGTAC ATTTTTTAAA GTCATCCACA

2101 AAGTAGTGGA TCCAATTTAT TACATTACTC CACTACTTCA AACTGAACAA AAGCCTAATC

2161 CTGGTTATTT TGAGAGTGAT TTTTTACAAC ATCAGCAGTA GTCCAGAAAA TGGGAGGACA

2221 TTAATAAAAG TGAAAAGGAG CAGAAGAAAG ATTACGGTAT TTTATTTGTG CTATTTGTTT

2281 AACTATTGGC AGTTTGGGAC CGAAAATAAA TAACTGTTCG TAGCTCTATA TTTGTCCATT

2341 CGAAAGTGTA ACGATGATTA TTGTGTTTCA AAAGATAAAT AAAGAAGTGC ACCAATGATT

2401 TGATATCATA GGCTATATAA TCCAACATGG TGAAAATGCT TTTCAATCAA GTAATCTTCG

2461 AGCGGTTACC AGTTTTAATA GTTGCGAGTC GTCGTTTTTT ATGTACCCTA GGACATATAT

2521 ATATCCGCAT GTAGACGATG AGACTAGCTA GTTTTTTTTT TTTTGAGCAA ATACATAATT

2581 ATTGGATTTG CAGGCCGTGA GATGATGTGC TACGAGCCCC CTGCCCCGTC CACGGGCATC

2641 CACCGGATGG TGCTGGTGCT ATTCCAGCAG CTTGGCCGTG ACACGGTGTT CGCGGCGCCG

2701 TCCAGGCGCC CACCCGTGCC TTCGCCCGCC GCTACAACCT CGGCGCGCCC

2761 GTCGCCGCCA TGTTCTTCAA CTGCCAGCGC CAGACCGGCT CCGGTGGCCC CAGGTTCACC

2821 GGGCCCTACA CCAGCCGCCG TCGTGCGGGC TGA

(SEQ ID NO: 13 Sb06g012260 - S. bicolor) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 13.

In some embodiments, the maturity Mai gene (including non-coding sequence) as it is found in day-neutral S. bicolor can include the nucleic acid sequence: 1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATG TCAAACAGCC ATCAAGTCAA

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCCAGT

12 1 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TTGATAAGAT TCAATGGCCG

18 1 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTGGCCTCCA TGCAATCAGA

24 1 GTTGATATAC CAGCAAACGT GTTTGCTACT GGTAACGAAA AAAGCAAGGC ATTTGTTATC

301 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAAC TC

3 61 TGGTGTCTGT AAGTACCACT CATGCACACA CAATTATTAT TAATATGTAG TGTGAAACTC

421 TAATATGTAG ATGTTGTCTG TAGTTTGCAA GATCACGAGT AGAGGTCATT ATTATCTACC

481 GGATCAATGG TCGGTTATCT GAGCCCTATC AAGTTACAAG AAAATATGCA CAAATTTGTA

541 TTATCAAAGG AAGATAGAGC AAAGATAGAG GAAGACAAAA CACCAGAAAA AGTTGCAGAA

601 GCTATAAAAG AGTTGCAAAG GATAATTATG CCCTCTACCT TGGTAGATCA

661 ATGCTGAGGT ATAAGTATAG GGATTTTATA TTGGCACCTT AC CTTTAG GTAAGCTTGA

72 1 CTTCATATAC GTACTTCAAA TAATTATCGT GTAAACAATA TACATGTGTC GCTCACTCAT

78 1 TTATTCATGC AGTGACCATT GGATTGTTTT TTATATTTAT CCCTTCGAAA GGAAGGTGCT

841 TGTCCTAGAC TCTTTACATG TTCCTCCCGA GAAGTATCAA CCATTCTTGG TTCAATTAGA

901 AAGGTGAGCC AACATGAAAC CACATGCGTA CTTATATAAA TTAGAGTTTC AAAACAACTT

961 TAGTGATTTA TATTCGATAT CTACAGGGCA TGGCGGTTTT ATAAGAAACA AAAGGGACCG

1021 GTCGACGCCG CACGCTCAGA TCCTAGGGTG CCATTGATGA TACAACACCA CTATCCGGTA

108 1 AGTTGTCCGA ACACATTTCA TCATATA&AT

GCATGGCAAA TTTAGAATAA

114 1 TCCGTTGCTC ATTATATAGT GCCACAAGCA ACCATCTGGA TCGGTCTATT GTGGGTACTA

1201 TGTCTGTGAG TTTATAAGGC AGCGGGGACG TTACGTCACG GACAAAAATA TGGTAAATAA

1261 TATCTATGTA TGAAGTTTTC TCATTAAAGT TGCAAAATTA TATATTGAAC ATGTGTCAAT

132 1 CATGCTTTTA AACTTTGTTT CCAGCCAAAA AAGCAAAAAA AGGACGTGCC CTTTACACCA

1381 AAGACTCTGG AAGATATAGT AGCAGACTTG TGTGGTTTTA TTATGAGAGA AATAATTCCA

1441 AGTGACGGTG CATATTTTGA TCATGAGGGC GATTTAGCAA GTGATAAATT TAGAGTGCTG

1501 ACAGACATAG CAGGTCTAAA TCTGAAGCGA AATGACATG

(SEQ ID NO:32 - Sb07g008600 - S. bicolor) or functional fragment or variant, such as a codon optimized variant, thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:32.

The coding sequence, without introns, of the maturity Mai gene according to SEQ ID NO:32 as it is found in day-neutral S. bicolor can include the nucleic acid sequence:

1 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATG TCAAACAGCC ATCAAGTCAA

61 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCCAGT

121 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TTGATAAGAT TCAATGGCCG

181 ATAAAAAGGT TTCATGACTG GTACATGAGA GCAGTGCATG CTGGCCTCCA TGCAATCAGA

241 GTTGATATAC CAGCAAACGT GTTTGCTACT GGTAACGAAA AAAGCAAGGC ATTTGTTATC

301 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

361 TGGTGTCTGG ACCATTGGAT TGTTTTTTAT ATTTATCCCT TCGAAAGGAA GGTGCTTGTC

42 1 CTAGACTCTT TACATGTTCC TCCCGAGAAG TATCAACCAT TCTTGGTTCA ATTAGAAAGG

481 GCATGGCGG TTTATAAGAA ACAAAAGGGA CCGGTCGACG CCGCACGCTC AGATCCTAGG

54 1 GTGCCATTGA TGATACAACA CCACTATCCG TGCCACAAGC AACCATCTGG ATCGGTCTAT

601 TGTGGGTACT ATGTCTGTGA GTTTATAAGG CAGCGGGGAC GTTACGTCAC GGACAAAAAT

661 ATGCCAAAAA AGCAAAAAAA GGACGTGCCC TTTACACCAA AGACTCTGGA AGATATAGTA

721 GCAGACTTGT GTGGTTTTAT TATGAGAGAA ATAATTCCAA GTGACGGTGC ATATTTTGAT

781 CATGAGGGCG ATTTAGCAAG TGATAAATTT AGAGTGCTGA CAGACATAGC AGGTCTAAAT 841 CTGAAGCGAA ATGACATGTA A

(SEQ ID NO:33, Sb07g008600 - S. bicolor), or a variant thereof, for example a codon optimized variant, having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:33.

Therefore, a maturity Mai protein as it is found in short-day S. bicolor can include the amino acid sequence:

MPPSKEAPSGDVHV QPSSQPLTLKDIRKPTIDDYVHVPSDYVPGRPMLQWTLLDKIQ PI RFHDWYMRAV HAGLHAIRVDIPANVFATGNEKSKAFVIFEDMHLLLHYRRLDVQLITI CLDHWIVFYIYPFERKVLVLDSL HVPPE YQPFLVQLERAWRFYKKQKGPVDAARSDPRVPL IQHHYPCHKQPSGSVYCGYYVCEFIRQRGRYV TD IiMPKKQKKDVPFTPKTLEDIVADLCGFIMREIIPSDGAYFDHEGDLASDKFRVLTDIAGLNLKRNDM

(SEQ ID NO:34, Sb07g008600 - S. bicolor) or functional fragment, or variant thereof having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO 34.

A polynucleotide is therefore disclosed having the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 19, 20, 28, 29, 30, 31, 32, and 33. A polynucleotide having a nucleic acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 19, 20, 28, 29, 30, 31, 32, or 33 is also disclosed. A

polynucleotide that hybridizes under stringent conditions to a polynucleotide consisting of the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 1 1, 12, 13, 19, 20, 28, 29, 30, 31, 32, or 33 is also disclosed.

A polypeptide is therefore disclosed having the amino acid sequence SEQ ID NO: 8 and 34. A polypeptide having an amino acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to SEQ ID NO: 8 or 34 is also disclosed.

A polynucleotide that is a fragment of Mai gene is also disclosed.

Therefore, a polynucleotide having a nucleic acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to a fragment of SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 19, 20, 28, 29, 30, 31, 32, and 33 is disclosed. The fragment can be at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 50, 75, 100, 150, 200, 250, 300, 350, 400, 500, or more nucleotides shorter than SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 19, 20, 28, 29, 30, 31, 32, or 33.

A polypeptide that is a fragment of the Mai protein is also disclosed having the amino acid sequence SEQ ID NO: 8 or 34. A polypeptide having an amino acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to a fragment of SEQ ID NO: 8 or 34 is disclosed. The fragment can be at least 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acids shorter than SEQ ID NO: 8 or 34.

B. Photoperiod Sensitivity Expression Control

1. Photoperiod Sensitivity

The expression control sequences of Mai are also provided for use in putting expression of other plant genes under photoperiod control. For example, the expression control sequence of the Mai gene in the short-day S. propinquum having a dominant (functional) Mai allele can be used to induce photoperiod sensitivity of other plant genes.

The day-neutral haplotype of S. bicolor is characterized by a number of insertions, deletions and polymorphisms relative to S. propinquum. The mutations in S. bicolor include three deletions in the expression control sequence (5' UTR) and one deletion in the second intron: (1) a 423 nucleotide deletion beginning with nucleotide 1,132 numbering for the first nucleotide of SEQ ID NO: 1 or nucleotide 1597 numbering from the first nucleotide of SEQ ID NO:3; (2) a 4, 186 nucleotide deletion beginning with nucleotide 2,465 from SEQ ID NO:l, or 4,231 nucleotide deletion beginning with nucleotide 2,930 numbering from the first nucleotide of SEQ ID NO:3 (3) a 3 nucleotide deletion beginning with nucleotide 6,753 numbering from the first nucleotide of SEQ ID NO: 1 , or nucleotide 7,263 numbering from the first nucleotide of SEQ ID NO:3 or nucleotide 2,024 numbering from the first nucleotide of SEQ ID NO:5; (4) a 27 nucleotide deletion beginning with nucleotide number 7,563 numbering from the first nucleotide of SEQ ID NO:l_s or nucleotide 8,073 numbering from the first nucleotide of SEQ ID NO:3, or nucleotide 2,834 numbering from the first nucleotide of SEQ ID NO:5 (Figure 3B).

Other insertions, deletions, and polymorphisms in or around S.

bicolor Mai relative to S. propinquum Mai, and their association with photoperiod sensitivity can be determined by one of skill in the art using the compositions and methods described herein. For example, additional deletions, insertions, and polymorphisms can be determined by comparing SEQ ID NO: 1, 3, or 5 of S. propinquum Mai to SEQ ID NO: 9 or 12 of S. bicolor using global sequence alignment tools. A global alignment shows an end-to-end alignment of two sequences. Tools for preparing global alignments are available in the art, for example, using EMBOSS Needle software available at ebi.ac.uk/Tools/psa/ which creates a global alignment of two sequences using the Needleman-Wunsch algorithm.

Accordingly, one or more of the Mai expression control sequences in S. propinquum that are mutated or absent from S. bicolor can be operably linked to a plant gene coding sequence to impart photoperiod sensitive (i.e., short-day) control over the plant gene coding sequence.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 AAAAGAAAAG TGAGCACACC ACGACCTGTC ATCAGCTCAT GGTCAGCTCT ACAAACTTAT

61 AGATTGCATC GAGATCTAAG ACTCAGGTAC AAATCATGTC AACATCTAAT GGTTTAGAAA

121 ATGAAAAGTT TTGAGTTTCA AAATATGATA CGTGATATTA ACATTTGAAC TTTTAGCAAG

181 ATCTGAAATA AAAAATTCAA CTAGATCATG TTAACATTGA TATAATCGCT TCCAATCGCC

241 TCCCATCACT TCCGCTAGAA AACTTTTTTT CTCGATTTAA TTAATGAAAG GGTAATAACA

301 TCATTGTACA AGATTCTTTC AAACCTCAAC CCCTATCATC GACGGTGACG GCTCCCTATA

361 ACACGCACTA GTGGACGCCG GGCGGGTGGA ACCCTAAGAA GATTTAAAAA AACTTAAGAA

421 GAAGATTTTT ATCTAACTAA CTATAGTACT TATATCATAC ACTATACTAT TCAAAATATT

481 ATTTTCACAA TTATGAATTT ACCCTTTTAC TCTTCATTAA AAAAATACGA AAAAAGAATC

541 ACCACGTCTC tATTTAGGGT CCTAGTCCCC ATAATTTAAG AGGCGGTGAG AGACGATGTG

601 ACGTCTATGG ACCACCGACC AAAGACACAC CTATCGTCTC CCATCGCCTT GCTTCCATCG

661 CCTCTCATCG CTTTTCATAT TCTAGATCCA GCGGCCATAG ACACACCAAT CGTTTCTCAT

721 CGCCTCTCCA ACCATTGTAA AAATATTTAT AATTTTGATA TAAAATTTGT CTTCACTTGA

781 GTTCATGCCA AAAAAATTAT ACATATTATT TTCGTGTGAG AATTTACAGA AGTGGACTCT

841 TAAGATGTCC AAATGTAAAT GACCCTATTT ATTATGAGGC GCGGATCTAT AGGCCTGACT

901 CTGAAAATGG ATTATGGATT TGAGATAATA AATTTAAGGG CCTATCTTCG CACATAACAT

961 CTATAGTTCC TAAATTTTTT TTTATTGTAG TAGTAGAACT TTTCTCCCTG TAAACCAAGT

1021 TGACGCTGGG CTTTATTTTG CGACACAGAA CACCAAATTG GTGGCTATGA ACTCTTCCAC

1081 CTGGGCAGGG AAAACGGTTT ATTATGTTTC TCTTTAATTT ATCTATCGTG GCACTATAAC 1141 ACAACATGGC TTTGCCGACA CTTCCAACTA TCGGCAAAGG GTACCTTTAC CGACACTTAA

1201 CGTCTCACGA AAGGTTTTGC CGACAATTTT CAAACAGTCG CGGTAGAAGC AGTTGGCGAA

1261 ACTTTTGCCG ACAGTTAAAG GCATCGCCGA CACATTTTCT GTAGTCAAAT GGCATACCTA

1321 CGCCGACAGT TGAACTTTCA CCGACAGTGA ACCCTTTGCC GACAGTTTGG ACCTACGCCG

1381 ACAGTTTGGA CCTTTTCCGA CAGTTGGTAT GTTAGCGAAA CCGTTTCTAG GGTGTTTCAT

1441 AAACCATGCC TTGTCCAACA GTAGAAGTGT CGGCAAAACT ATATTGCTAG GATGTAGATA

1501 CAATTTAAAT ATTTTAATAA ATACACATCA CATTGAT GA GCAAAATCAC ATGGTCTGTT

1561 TTCACTAAAA CTGTCAGAGG TACACTCCAG TACTACCAGT ACGTCGCCCG CACAGTGGCC

1621 AAGGATTTTA CTGCTACTGT TGATTAACAT AAGCACTTGC GACTTTCCCT AAAATCTTTT

1681 ATAAAACAAC GGCCGCAATA ATATTGAACT ATTTTTTTTC TAGTACCAAA ATTAGAATTT

1741 GATCCCTCAC CTCATTACAT CCATAGTAAC ATGACCAGAT ATATATGGAC AGGATGGGAT

1801 CACTCAGCGA GCAGATACAC TGAGCGATTC ATAATCAGAT TTTTTAATTT CTTCTAGTGA

1861 AGTGGGGTTT TCCTAGTCTT TTAACATTCA AAATTTAGTA CAAACTTTCC CTAGTAAATG

1921 CCTTCTAGTA AAGATTTCCT AGTATTTTGA CTAGCGATAG TGTTTTATTA CTAATTAAAA

1981 ACATTAGAAG AACTCCATTT AGTGATTGGT TGTTTGGATT AGTCTTCTCA CGTTAGACCT

2041 ATATATGCAG GACAACTCAA GCCAGCATAA ATATATGAAA TATCTTGGTG TTTGTTTGTC

2101 TGACACAGGC AACCGCGTTT GGTATAAATG TGTTTTCTTG TTTACATTTT ACCATCTATA

2161 GTCATCTCAA TGTTATATAG TAGAGGCTTC ATGTTTGTAG TAGATAAGGT AGAGAATTGA

2221 GAATATTTTA TTTTTGTGCG ACCATCAATT TTATGTAATC TGCATTGTCT AATGCTTTAT

2281 TTGACATTTG AAACTACTTA ATTTGACAGT TATGCAGGTC CGCATGATCC TATGAAAGCA

2341 ATTAATTAGT ACGGGTAAAC TGCACTACAC AAGTTTGCTA GTACTATTCT ATTAACCGAC

2401 CTGTCAATAT TACCTTAAGT TACTGATTTC AATTAGAATC TAACACATTC AGGAAAAGAA

2461 GTTTCACTAG TACAAAAATC ATTTTCGTTG GCACGTTGTT TTTTTTTTCA CAGGCAGTTC

2521 ACAATATCA GGTGCTAGTA GAAAAATTTC AACGGGCCCA ACAAGAGAAC CGCCAGGCGG

2581 TCTTCTTAAT TCAACCGCCT GTGTAAACTT TCCATTTACA TAGGCGGCTT ACGATAAAAA

2641 CCGTGTGTAT AAATACCATT AACACAGGCA GTCGAGTTAC GACAACCGCC TGTGTAAATG

2701 TGTCTTTTTA CACAGGCGGT TTGTATAGAG GGCCGCCTGT GCTAATATAT TTACACAGGC

2761 TATGAGCCGC CTGTGTTAAG TCTTCTATAA ATACCCTTCG TCCACCTCCA GACAAGAACA

2821 GTTACTCCCA TGAGCTCTGC ACACTGGCGG ACCAGACGAT TCCAGTTTCC AAGGGGGGAG

2681 GTTTTGATTT TCATTTCTTT GGTGAGAAAC TTCCAAAAGG TTAGTTAGTG CCATTGATGC

2941 TATTTTTTAA GCGATTCTTT GGTTCAATTC TTGTATTGGA GGTGCTCTAG ATCTAGAGTT

3001 CATCATGCAT TCTTGCTTAG GGTTAGAGTT CATAGGGCAA AAAGAGAGAG ATTTAGCTAA

3061 ATTTTTATGT AAATTCATAG TAAATTGTAA AAATTAAAAA AAATAAAAAA TAAATACTTT

3121 TTAGAATTCT TGTGAGTAGA TCTATACAAT AGAGTAATGA TGAGGATATT TTGAAGTTTA

3181 TAATTTTGAT TCAGTTTTAG CTTTTCTTTT TTCAGATGAA TTAGACTTTA TAAACTCAAA

3241 CATTAAAATG TTGAAAATCA TAAAATGGCA AATAAATACT TTTTCAAATC TTTGTGCATA

3301 AATACTTCAT AGAAATCCTT GAATTATTCC TAAATTTTAT ACAATTGTTT CTTATAATTA

3361 TGAAAATGAG TTTAAACAAT TATTTAAATT CCATAAATTG TAACTCCGTA AGGTGTAGGT

3421 TTTCATCTCT GTTTAATAGA AGGAGGTTAG TATCTTAGTT AAGTCTGTTT TCGGGGGTTA

3481 TATTAGTTTT GTTTTTAGAT TGACCTACAT TAATTGTTCT TAACTAATTA CAGCTAAATA

3541 TGGAGAGGTC ATTATGGATG TACAACTTAT CAAGATTGGA CCTATCATAT GTAGTGCAGG

3601 TCCAAAAATT TATTGATGTC GCAAAGATAC ATGCTCGCAG AACAAAGGCG AAGCACATAT

3661 GTTGTCCATG CGCAGACTGC AAAAATATTA TGGTATTTGA CAATGTAGAA GCAATTACTT

3721 CCCATCTGGT TTGAAGAGGA TTTATGGAGG ACTACTTGAT TTGGACAAAA CATGGTGAGG

3781 GTAGTTTTGC ACCTTATATG CGGACAACTG ACAACACTGC AACTAACATC AATGTGGAGG

3841 GTCCAATGCC ACCTCTCAAT GAATTTCATG CTATGCCAGA TGTTAATGAA ACTCATACGT

3901 CTGATGTCAA TGAAACTCAG CATGCTAACA CAGATGTTGT GAAGATGCA GATTTCTTAG

3961 AGGCAATAAT GAACCGTTGT GCGGATCCAT CAATATTCTT CATGAAGGGA ATGAAAGCAT

4021 TGAAGAAGGC AGCAGAGGAC ACTTTGTACG ACGAGTCAAA AGGTTGTACC AAACAATGGT

4081 CGACATTATG TGTTGTTCTT CAGTTTTTGA CGATGAAGGC TAGACATGGT TGGTCCGATG 4141 CTAGCTTCAA TGATTTCTTG CGTGTACTTG GAGACCTTCT TCCTAAGGAG AACAAAGTGC

4201 CTGCTAACAC ATACTATGCA AAGAAGCTAG TCAGTCCACT TACGATAGGT GTTGAGAAGA

4261 TCCACGCATG TAGAAATCAT TGTATTCTAT ATCGAGGTGA TCAATATAAA GACTTAGACA

4321 GTTGTCCAAA CTGTGGTGCC AGTAGGTACA AGACAAACAA AGATTTTCGG GAGGAAGAGA

4381 ATCTAGCCTC TGTTTCTACA GGGAGGAAGC GAAAGAAGAC CCAAACAAAG ACTCAACAAG

4441 ACAAGCGCTC AAAGCCTAGT AGCAATGAAG AAGTGGACTA TTATGCATTG AGAAGAGTCT

4501 CCCTATGAGC CAAAAAAGGG GACAGCAGCA GGCACAACTC TCTTTCTGAA AGGACTTGGA

4561 AAGCAGCGGA CGGCACGGCT CATTGAGCTC GAACCGTCAC AGAAAAAGGA AGCCACCGCC

4621 CAGTCAATAG AAGCCATGCC CCCATCAAAG GAAGCCCCAA GTGGCGATGT ACATATTGAA

4681 CAGCCATCAA GTCAACCATT GACCCTAAAG GATATCAGAA AGCCAACGAT TGATGATTAT

4741 GTCAATGTCC CTAGTGACTA TGTGCCCGGA AGGCCTATGC TCCAATGGAC GCTGCTCGAT

4801 TAGATTCAAT GGCTGATAAA AAGGTTTCAT GACTGGTACA TGAGAGCAGT GCATGCTAGC

4861 CTCCATGGAA TCAGAGTTGA TATACCAACA GACATGTTTG CTACTGGTAA CAAAAAAAGC

4921 AAGACATTTG TTACCTTTGA GGACATGCAC TTGTTATTGA ACTATAGGCG GCTTGACGTC

4981 CAACTCATAA CAATCTGGTG CCTGTAAGTA TCACTCATGC ACACACAATT ΑΤΤΆΤΑΤΑΤΤ

5041 AATATGTAGT GTGAAACTCT AATATGTAGA TGTTGTCTGT AGTTTGCAAG ATCACGAGCA

5101 GATGTCATTA TTATCTGCCG GATCGATGGT CGGTTATCTG AGCCCTATCA AGTTACAAGA

5161 AAATATGAAC AAATTCGTAT TATCAAAGGA AGATAGAGCA AAGATAGAGG AAGACAAAAC

5221 ACCAGGATAA TTATGCCATC TATCTTGGTA GATCAATGCT GAGGTATAAA TATAGGGATT

5281 TTATATTGGC ACCATACAAC ATTAGGTAAG CTTGACTTCA TATACGTATT TCAAATTATC

5341 GTGTAAACAA TATACATGTG TCGCTCACTC ATTTATTCAT GCAGTGACCA TTGGATTGTT

5401 TTTTATATTT ATCCCTTCGA AGGGAAGGTG CTTGTCCTAG ACTCTTTACA TGTTCCTCCC

5461 GAGAAGTATC AACCATTCTT GGTTCAATTA GAAAGGTGAG CCAACATGAA ACCACATGCG

5521 TACTTATATA AATTAGAGTT TCAAAATAAC TTTAGTGATT TAGGTTCGAT ATCTACGGGG

5581 CATGGCGGTT TTATAAGAAA CAAAAGGGAC CTGTCGACGC TGCACGCTCA GATCCTAGGA

5641 TCCCATTGAT GATACAACAC CACTATCCGG TAAGTTTTCT GAACACATTT CATCATATAA

5701 ATAATACATA AAGCATGGCA AATTTAGAAT AATCCGTTGC TCATTATATA GTGCCACAAG

5761 CAACCACCTG GATCGGTCTA TTGTGGGTAC TATGTCTGTG AGTTTATAAG GCAGCGGGGA

5821 CGTTACGTCA AGGACAAAAA TATGGTAAAT AATATCTATG TATGAAAGTT TTCTCATTAA

5881 AGCTGCAAAA TTATATATTG AACATGTGTC AATCATGCTT TTAAACTTTA TTTTCAGCCG

5941 AAAAAGCAAG GAAAAGACGT GCCCTTTACA CCAAAGACTC TGGAAGATAT AGTAGCATAC

6001 TTGTGTGGTT TTATTATGAG AGAAATAATT TCAAGTGACA GTGCATATTT TGATCATGAG

6061 GGCGATTTAG CAAGTGATAA ATTTAGAGTG CTGACAGACA TAGCAGGTCT AAATCTGAAG

6121 CGAAACGACA TGTAAACATT GTATGGTTGT GCGGATAACA TGCATTGACG TGTATATATA

6181 TAATTTTATG GTTGATGTTT GATTTGTTTA CAATTCTATA ATATATATAT GTGGTGTATG

' 6241 TATGATGTTG TGTGTGTATA TATATATATA TATATATATA TATATATATA TATATATATA

6301 TATATATATA TATATAATGT TTAGCACTGT GTTTGGTGGG AAAAATTAAA ATTTGAAATA

6361 TATATAAAAA ATTATTTACA CAGACAGTGT ACGTGTCGAG CGTCGTCCTG TGCTATACAA

6421 ATACATTCTA ACAGGCGGCT CGCCTTGTCC ACCGGTCGGT TAAAAATACA TTTCCACACN

6481 GGCCTGGCTG GGAGAGCCGC CTGTGAAAAC ATAATTTTCA CAGGCGGCTC GCACAGCCCC

6541 GCCTGTACTG TGGTCCATTT TGTACTGACC CCTGGTACAG GCGGTGGGCT TGGCCGCCTG

6601 TGAAGATGCT TTTAGCACCG CCTGTAAAAA TGTTTTTTGT AGCAGTGTTT TTCTTATTAG

6661 TAGTATCTTT TATACTAATT AAGATTCAAT AAAAATTCAC CATGACATCC CCATTGCCAA

6721 GAGAATATTT CGCCGCCCCT CAAAGCAGCC AATAAGGCTT TACTAAAAAG ACTATCCACG

6781 CAGTAGAGAT TTAGTCAAAA TATTCCAATA GCAATTGTTT CCTGCCTGCT TGACCTTCGT

6841 CAGCCACTCA CTGTATAAAT ATCGCACCAC GCCCTTTGCA GGCTTACAGA GCTTGTATTA

6901 CGTACTAACA AGGCACACAC AGTACCCTGT GTTCACCGGC CCTGCACAAA ACTCAAGCAG

6961 TTATTACTAA C

(SEQ ID N0:14) or a functional fragment or variant thereof having 75, 80,

85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO: 14. In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CCCTGACCCT TGTTGGGCAA CATTTAGAGT CGTTAGCTTT GCAATTCTTT GGTTCCAATG

61 GATGGTTATC ATTTAGACAT ATTGGTCATG CTTAGTCAAA ACTTTATTGT TCGGCTATAA

121 ACTTTTCAGT ACTTTGTAAT AATTGGCTCG ATAGATGAAG CCGGGTATAA CATATCCTTT

1S1 ATCTAAAAAA ATTAGTTAAC ATGAACTTCA TATTCAATTC TTCATATCTC ACTAGCATCT

241 TTATTGTCTA GTTAGTTTTG TAGCATTGCA AAAAGCATGC AACTATATAC AATGAAACGG

301 AATAAAATTT CAGCTCTA T AATTTATATT TCAAATATAG GCCACTATAG CCATATTTCG

361 TGCTCAAGGC CACAAAATCT TGCGTACTTC CCTGTTGGTA CCAAAGAGAA GACGTTATTT

421 AACTTTGTTT GACTCTTCAA TATGGTTTGA ATCAGAAAAT TAGTTAAAAG AAAAGTGAGC

481 ACACCACGAC CTGTCATCAG CTCATGGTCA GCTCTACAAA CTTATAGAT GCATCGAGAT

541 CTAAGACTCA GGTACAAATC ATGTCAACAT CTAATGGTTT AGAAAATGAA AAGTTTTGAG

601 TTTCAAAATA TGATACGTGA TATTAACATT TGAACTTTTA GCAAGATCTG AAATAAAAAA

661 TTCAACTAGA TCATGTTAAC ATTGATATAA TCGCTTCCAA TCGCCTCCCA TCACTTCCGC

721 TAGAAAACTT TTTTTCTCGA TTTAATTAAT GAAAGGGTAA TAACATCATT GTACAAGATT

781 CTTTCAAACC TCAACCCCTA TCATCGACGG TGACGGCTCC CTATAACACG CACTAGTGGA

841 CGCCGGGCGG GTGGAACCCT AAGAAGATTT AAAAAAACTT AAGAAGAAGA TTTTTATCTA

901 ACTAACTATA GTACTTATAT CATACACTAT ACTATTCAAA ATATTATTTT CACAATTATG

961 AATTTACCCT TTTACTCTTC ATTAAAAAAA TACGAAAAAA GAATCACCAC GTCTCTATTT

1021 AGGGTCCTAG TCCCCATAAT TTAAGAGGCG GTGAGAGACG ATGTGACGTC TATGGACCAC

1081 CGACCAAAGA CACACCTATC GTCTCCCATC GCCTTGCTTC CATCGCCTCT CATCGCTTTT

1141 CATATTCTAG ATCCAGCGGC CATAGACACA CCAATCGTTT CTCATCGCCT CTCCAACCAT

1201 TGTAAAAATA TTTATAATTT TGATATAAAA TTTGTCTTCA CTTGAGTTCA TGCCAAAAAA

1261 ATTATACATA TTATTTTCGT GTGAGAATTT ACAGAAGTGG ACTCTTAAGA TGTCCAAATG

1321 TAAATGACCC TATTTATTAT GAGGCGCGGA TCTATAGGCC TGACTCTGAA AATGGATTAT

1381 GGATTTGAGA TAATAAATTT AAGGGCCTAT CTTCGCACAT AACATCTATA GTTCCTAAAT

1441 TTTTTTTTAT TGTAGTAGTA GAACTTTTCT CCCTGTAAAC CAAGTTGACG CTGGGCTTTA

1S01 TTTTGCGACA CAGAACACCA AATTGGTGGC TATGAACTCT TCCACCTGGG CAGGGAAAAC

1561 GGTTTATTAT GTTTCTCTTT AATTTATCTA TCGTGGCACT A AACACAAC ATGGCTTTGC

1621 CGACACTTCC AACTATCGGC AAAGGGTACC TTTACCGACA CTTAACGTCT CACGAAAGGT

1681 TTTGCCGACA ATTTTCAAAC AGTCGCGGTA GAAGCAGTTG GCGAAACTTT TGCCGACAGT

1741 TAAAGGCATC GCCGACACAT TTTCTGTAGT CAAATGGCAT ACCTACGCCG ACAGTTGAAC

1801 TTTCACCGAC AGTGAACCCT TTGCCGACAG TTTGGACCTA CGCCGACAGT TTGGACCTTT

1861 TCCGACAGTT GGTATGTTAG CGAAACCGTT TCTAGGGTGT TTCATAAACC ATGCCTTGTC

1921 CAACAGTAGA AGTGTCGGCA AAACTATATT GCTAGGATGT AGATACAATT TAAATATT T

1981 AATAAATACA CATCACATTG ATTGAGCAAA ATCACATGGT CTGTTTTCAC TAAAACTGTC

2041 AGAGGTACAC TCCAGTACTA CCAGTACGTC GCCCGCACAG TGGCCAAGGA TTTTACTGCT

2101 ACTGTTGATT AACATAAGCA CTTGCGACTT TCCCTAAAAT CTTTTATAAA ACAACGGCCG

2161 CAATAATATT GAACTATTTT TTTTCTAGTA CCAAAATTAG AATTTGATCC CTCACCTCAT

2221 TACATCCATA GTAACATGAC CAGATATATA TGGACAGGAT GGGATCACTC AGCGAGCAGA

2281 TACACTGAGC GATTCATAAT CAGATTTTTT AATTTCTTCT AGTGAAGTGG GGTTTTCCTA

2341 GTCTTTTAAC ATTCAAAATT TAGTACAAAC TTTCCCTAGT AAATGCCTTC TAGTAAAGAT

2401 TTCCTAGTAT TTTGACTAGC GATAGTGTTT TATTACTAAT TAAAAACATT AGAAGAACTC

2461 CATTTAGTGA TTGGTTGTTT GGATTAGTCT TCTCACGTTA GACCTATATA TGCAGGACAA

2521 CTCAAGCCAG CATAAATATA TGAAATATCT TGGTGTTTGT TTGTCTGACA CAGGCAACCG

2581 CGTTTGGTAT AAATGTGTTT TCTTGTTTAC ATTTTACCAT CTATAGTCAT CTCAATGTTA

2641 TATAGTAGAG GCTTCATGTT TGTAGTAGAT AAGGTAGAGA ATTGAGAATA TTTTATTTTT

2701 GTGCGACCAT CAATTTTATG TAATCTGCAT TGTCTAATGC TTTATTTGAC ATTTGAAACT 2761 ACTTAATTTG ACAGTTATGC AGGTCCGCAT GATCCTATGA AAGCAATTAA TAGTACGGG

2821 TAAACTGCAC TACACAAGTT TGCTAGTACT ATTCTATTAA CCGACCTG C AATATTACCT

28S1 TAAGTTACTG ATTTCAATTA GAATCTAACA CATTCAGGAA AAGAAGTTTC ACTAGTACAA

2941 AAATCATTTT CGTTGGCACG TTGTTTTTTT TTTCACAGGC AGTTCACAAT ATCATGGTGC

3001 TAGTAGAAAA ATTTCAACGG GCCCAACAAG AGAACCGCCA GGCGGTCTTC TTAATTCAAC

3061 CGCCTGTGTA AACTTTCCAT TTACATAGGC GGCTTACGAT AAAAACCGTG TGTATAAATA

3121 CCATTAACAC AGGCAGTCGA GTTACGACAA CCGCCTGTGT AAATGTGTCT TTTTACACAG

3181 GCGGTTTGTA TAGAGGGCCG CCTGTGCTAA TATATTTACA CAGGCTATGA GCCGCCTGTG

3241 TTAAGTCTTC TATAAATACC CTTCGTCCAC CTCCAGACAA GAACAGTTAC TCCCATGAGC

3301 TCTGCACACT GGCGGACCAG ACGATTCCAG TTTCCAAGGG GGGAGGTTTT GATTTTCATT

3361 TCTTTGGTGA GAAACTTCCA AAAGGTTAGT TAGTGCCATT GATGCTATTT TTTAAGCGAT

3421 TCTTTGGTTC AATTCTTGTA ^' TTGGAGGTGC TCTAGATCTA GAGTTCATCA TGCATTCTTG

3481 CTTAGGGTTA GAGTTCATAG GGCAAAAAGA GAGAGATTTA GCTAAATTTT TATGTAAATT

3541 CATAGTAAAT TGTAAAAATT AAAAAAAATA AAAAATAAAT ACTTTTTAGA TTCTTGTGA

3601 GTAGATCTAT ACAATAGAGT AATGATGAGG ATATTTTGAA GTTTATAATT TTGATTCAGT

3661 TTTAGCTTTT CTTTTTTCAG ATGAATTAGA CTTTATAAAC TCAAACATTA AAATGTTGAA

3721 AATCATAAAA TGGCAAATAA ATACTTTTTC AAATCTTTGT GCATAAATAC TTCATAGAAA

3781 TCCTTGAATT ATTCCTAAAT TTTATACAAT TGTTTCTTAT AATTATGAAA ATGAGTTTAA

3841 ACAATTATTT AAATTCCATA AATTGTAACT CCGTAAGGTG TAGGTTTTCA TCTCTGTTTA

3901 ATAGAAGGAG GTTAGTATCT TAGTTAAGTC TGTTTTCGGG GGTTATATTA GTTTTGTTTT

3961 TAGATTGACC TACATTAATT GTTCTTAACT AATTACAGCT AAATATGGAG AGGTCATTAT

4021 GGATGTACAA CTTATCAAGA TTGGACCTAT CATATGTAGT GCAGGTCCAA AAATTTATTG

4081 ATGTCGCAAA GATACATGCT CGCAGAACAA AGGCGAAGCA CATATGTTGT CCATGCGCAG

4141 ACTGCAAAAA TATTATGGTA TTTGACAATG TAGAAGCAAT TACTTCCCAT CTGGTTTGAA

4201 GAGGATTTAT GGAGGACTAC TTGAT TGGA CAAAACATGG TGAGGGTAGT TTGCACCTT

4261 ATATGCGGAC AACTGACAAC ACTGCAACTA ACATCAATGT GGAGGGTCCA ATGCCACCTC

4321 TCAATGAATT TCATGCTATG CCAGATGTTA ATGAAACTCA TACGTCTGAT GTCAATGAAA

4381 CTCAGCATGC TAACACAGAT GTTGTTGAAG ATGCAGATTT CTTAGAGGCA ATAATGAACC

4441 GTTGTGCGGA TCCATCAATA TTCTTCATGA AGGGAATGAA AGCATTGAAG AAGGCAGCAG

4501 AGGACACTTT GTACGACGAG TCAAAAGGTT GTACCAAACA ATGGTCGACA TTATGTGTTG

4561 TTCTTCAGTT TTTGACGATG AAGGCTAGAC ATGGTTGGTC CGATGCTAGC TTCAATGATT

4621 TCTTGCGTGT ACTTGGAGAC CTTCTTCC A AGGAGAACAA AGTGCCTGCT AACACATACT

4681 ATGCAAAGAA GCTAGTCAGT CCACTTACGA TAGGTGTTGA GAAGATCCAC GCATGTAGAA

4741 ATCATTGTAT TCTATATCGA GGTGATCAAT ATAAAGACTT AGACAGTTGT CCAAACTGTG

4801 GTGCCAGTAG GTACAAGACA AACAAAGATT TTCGGGAGGA AGAGAATCTA GCCTCTGTTT

4861 CTACAGGGAG GAAGCGAAAG AAGACCCAAA CAAAGACTCA ACAAGACAAG CGCTCAAAGC

4921 CTAGTAGCAA TGAAGAAGTG GACTATTATG CATTGAGAAG AGTCTCCCTA TGAGCCAAAA

4981 AAGGGGACAG CAGCAGGCAC AACTCTCTTT CTGAAAGGAC TTGGAAAGCA GCGGACGGCA

5041 CGGCTCATTG AGCTCGAACC GTCACAGAAA AAGGAAGCCA CCGCCCAGTC AATAGAAGCC

5101 ATGCCCCCAT CAAAGGAAGC CCCAAGTGGC GATGTACATA TTGAACAGCC ATCAAGTCAA

5161 CCATTGACCC TAAAGGATAT CAGAAAGCCA ACGATTGATG ATTATGTCAA TGTCCCTAGT

5221 GACTATGTGC CCGGAAGGCC TATGCTCCAA TGGACGCTGC TCGATTAGAT TCAATGGCTG

5281 ATAAAAAGGT T CATGACTG GTACATGAGA GCAGTGCATG CTAGCCTCCA TGGAATCAGA

5341 GTTGATATAC CAACAGACAT GTTTGCTACT GGTAACAAAA AAAGCAAGAC ATTTGTTACC

5401 TTTGAGGACA TGCACTTGTT ATTGAACTAT AGGCGGCTTG ACGTCCAACT CATAACAATC

5461 TGGTGCCTGT AAGTATCACT CATGCACACA CAATTATTAT ATATTAATAT GTAGTGTGAA

5521 ACTCTAATAT GTAGATGTTG TCTGTAGTTT GCAAGATCAC GAGCAGATGT CATTATTATC

5581 TGCCGGATCG ATGGTCGGTT ATCTGAGCCC TATCAAGTTA CAAGAAAATA TGAACAAATT

5641 CGTATTATCA AAGGAAGATA GAGCAAAGAT AGAGGAAGAC AAAACACCAG GATAATTATG

5701 CCATCTATCT TGGTAGATCA ATGCTGAGGT ATAAATATAG GGATTTTATA TTGGCACCAT 5761 ACAACATTAG GTAAGCTTGA CTTCATATAC G ATTTCAAA TTATCGTGTA AACAATATAC

5821 ATGTGTCGCT CACTCATTTA TTCATGCAGT GACCATTGGA TTGTTTTTTA TATTTA CCC

5881 TTCGAAGGGA AGGTGCTTGT CCTAGACTCT TTACATGTTC CTCCCGAGAA GTATCAACCA

5941 TTCTTGGTTC AATTAGAAAG GTGAGCCAAC ATGAAACCAC ATGCGTACTT

6001 GAGTTTCAAA ATAACTTTAG TGATTTAGGT TCGATATCTA CGGGGCATGG CGGTTTTATA

6061 AGAAACAAAA GGGACCTGTC GACGCTGCAC GCTCAGATCC TAGGATCCCA TTGATGATAC

6121 AACACCACTA TCCGGTAAGT TTTCTGAACA CATTTCATCA TATAAATAAT ACATAAAGCA

6181 TGGCAAATTT AGAATAATCC GTTGCTCATT ATATAGTGCC ACAAGCAACC ACCTGGATCG

6241 GTCTATTGTG GGTACTATGT CTGTGAGTTT ATAAGGCAGC GGGGACGTTA CGTCAAGGAC

6301 AAAAATATGG TAAATAATAT CTATGTATGA AGTTTTCTCA TTAAAGCTGC AAAATTATAT

6361 ATTGAACATG TGTCAATCAT GCTTTTAAAC TTTATTTTCA GCCGAAAAAG CAAGGAAAAG

6421 ACGTGCCCTT TACACCAAAG ACTCTGGAAG ATATAGTAGC ATACTTGTGT GGTTTTATTA

6481 TGAGAGAAAT AATTTCAAGT GACAGTGCAT ATTTTGATCA TGAGGGCGAT TTAGCAAGTG

6541 ATAAATTTAG AGTGCTGACA GACATAGCAG GTCTAAATCT GAAGCGAAAC GACATGTAAA

6601 CATTGTATGG TTGTGCGGAT AACATGCATT GACGTGTATA TATATAATTT TATGGTTGAT

6661 GTTTGATTTG TTTACAATTC TATAATATAT ATATGTGGTG TATGTATGAT GTTGTGTGTG

6721 TATATATATA TATATATATA TATATATATA TATATATATA TATATATATA TATATATATA

6781 ATGTTTAGCA CTGTGTTTGG TGGGAAAAAT TAAAATTTGA AATATATATA AAAAATTATT

6841 TACACAGACA GTGTAGTGTG AGCTGCCTGT GTAAAAATAC ATTTATACAG GCGGCTCACC

6901 TTGTCNNNNC AGGCGGTGCT AAAAGCATCT TCACAGGCGG CCAAGCCCAC CGCCTGTACC

6961 AGGGGTCAGT ACAAAATGGA CCACAGTACA GGCGGGGCTG TGCGAGCCGC CTGTGAAAAC

7021 ATAATTTTCA CAGGCGGCTC GCACAGCCCC GCCTGTACTG TGGTCCATTT TGTACTGACC

7081 CCTGGTACAG GCGGTGGGCT TGGCCGCCTG TGAAGATGCT TTTAGCACCG CCTGTAAAAA

7141 TGTTTTTTGT AGCAGTGTTT TTCTTATTAG TAGTATCTTT TATACTAATT AAGATTCAAT

7201 AAAAATTCAC CATGACATCC CCATTGCCAA GAGAATATTT CGCCGCCCCT CAAAGCAGCC

7261 AATAAGGCTT TACTAAAAAG ACTATCCACG CAGTAGAGAT TTAGTCAAAA ΊΆ T'T C C T ¾-

7321 GCAATTGTTT CCTGCCTGCT TGACCTTCGT CAGCCACTCA CTGTATAAAT ATCGCACCAC

7381 GCCCTTTGCA GGCTTACAGA GCTTGTATTA CGTACTAACA AGGCACACAC AGTACCCTGT

7441 GTTCACCGGC CCTGCACAAA ACTCAAGCAG TTATTACTAA C

(SEQ ID NO: 15) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO: 15. Each N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CTATGCTCCA ATGGACGCTG CTCGATTAGA TTCAATGGCT GATAAAAAGG TTTCATGACT

61 GGTACATGAG AGCAGTGCAT GCTAGCCTCC ATGGAATCAG AGTTGATATA CCAACAGACA

121 TGTTTGCTAC TGGTAACAAA AAAAGCAAGA CATTTGTTAC CTTTGAGGAC ATGCACTTGT

181 TATTGAACTA TAGGCGGCTT GACGTCCAAC TCATAACAAT CTGGTGCCTG TAAGTATCAC

24 1 TCATGCACAC ACAATTATTA TATATTAATA TGTAGTGTGA AACTCTAATA TGTAGATGTT

301 GTCTGTAGTT TGCAAGATCA CGAGCAGATG CATTATTAT CTGCCGGATC GATGGTCGGT

361 TATCTGAGCC CTATCAAGTT ACAAGAAAAT ATGAACAAAT TCGTATTATC AAAGGAAGAT

421 AGAGCAAAGA TAGAGGAAGA C i¾ i ¾ . C ¾ 00 ¾ GGATAATTAT GCCATCTATC TTGGTAGATC

481 AATGCTGAGG TATAAATATA GGGATTTTAT ATTGGCACCA TACAACATTA GGTAAGCTTG

541 ACTTCATATA CGTATTTCAA ATTATCGTGT AAACAATATA CATGTGTCGC TCACTCATTT

601 ATTCATGCAG TGACCATTGG ATTGTTTTTT ATATTTATCC CTTCGAAGGG AAGGTGCTTG

661 TCCTAGACTC TTTACATGTT CCTCCCGAGA AGTATCAACC ATTCTTGGTT CAATTAGAAA 721 GGTGAGCCAA CATGAAACCA CATGCGTACT TATATAAATT AGAGTTTCAA AATAACTTTA

781 GTGATTTAGG TTCGATATCT ACGGGGCATG GCGGTTTTAT AAGAAACAAA AGGGACCTGT

841 CGACGCTGCA CGCTCAGATC CTAGGATCCC ATTGATGATA CAACACCACT &TCCGGTAAG

901 TTTTCTGAAC ACATTTCATC ATATAAATAA TACATAAAGC ATGGCAAATT TAGAATAATC

961 CGTTGCTCAT TATATAGTGC CACAAGCAAC CACCTGGATC GGTCTATTGT GGGTACTATG

1021 TCTGTGAGTT TATAAGGCAG CGGGGACGTT ACGTCAAGGA CAAAAATATG GTAAATAATA

1081 TCTATGTATG AAGTTTTCTC ATTAAAGCTG CAAAATTATA TATTGAACAT GTGTCAATCA 14 TGCTTTTAAA CTTTATTTTC AGCCGAAAAA GCAAGGAAAA GACGTGCCCT TTACACCAAA

1201 GACTCTGGAA GATATAGTAG CATACTTGTG TGGTTTTATT ATGAGAGAAA TAATTTCAAG

1261 TGACAGTGCA TATTTTGATC ATGAGGGCGA TTTAGCAAGT GATAAATTTA GAGTGCTGAC

1321 AGACATAGCA GGTCTAAATC TGAAGCGAAA CGACATGTAA ACATTGTATG GTTGTGCGGA

1381 TAACATGCAT TGACGTGTAT ATATATAATT TTATGGTTGA TGTTTGATTT GTTTACAATT

1441 CTATAATATA TATATGTGGT GTATGTATGA TGTTGTGTGT GTATATATAT ATATATATAT

1501 ATATATATAT ATATATATAT ATATATATAT ATATATATAT AATGTTTAGC ACTGTGTTTG

1561 GTGGGAAAAA TTAAAATTTG AAATATATAT AAAAAATTAT TTACACAGAC AGTGTAGTGT

1621 GAGCTGCCTG TGTAAAAATA CATTTATACA GGCGGCTCAC CTTGTNNNNN CAGGCGGTGC

1681 TAAAAGCATC TTCACAGGCG GCCAAGCCCA CCGCCTGTAC CAGGGGTCAG TACAAAATGG

1741 ACCACAGTAC AGGCGGGGCT GTGCGAGCCG CCTGTGAAAA CATAATTTTC ACAGGCGGCT

1801 CGCACAGCCC CGCCTGTACT GTGGTCCATT TTGTACTGAC CCCTGGTACA GGCGGTGGGC

1861 TTGGCCGCCT GTGAAGATGC TTTTAGCACC GCCTGTAAAA ATGTTTTTTG TAGCAGTGTT

1921 TTTCTTATTA GTAGTATCTT TTATACTAAT TAAGATTCAA TAAAAATTCA CCATGACATC

1981 CCCATTGCCA AGAGAATATT TCGCCGCCCC TCAAAGCAGC CAATAAGGCT TTACTAAAAA

2041 GACTATCCAC GCAGTAGAGA TTTAGTCAAA ATATTCCAAT AGCAATTGTT TCCTGCCTGC

2101 TTGACCTTCG TCAGCCACTC ACTGTATAAA TATCGCACCA CGCCCTTTGC AGGCTTACAG

2161 AGCTTGTATT ACGTACTAAC AAGGCACAGA CAGTACCCTG TGTTCACCGG CCCTGCACAA

2221 AACTCAAGCA GTTATTACTA AC

(SEQ ID NO: 16) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO: 16. Each N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides. In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CACTATAACA CAACATGGCT TTGCCGACAC TTCCAACTAT CGGCAAAGGG TACCTTTACC

61 GACACTTAAC GTCTCACGAA AGGTTTTGCC GACAATTTTC AAACAGTCGC GGTAGAAGCA

121 GTTGGCGAAA CTTTTGCCGA CAGTTAAAGG CATCGCCGAC ACATTTTCTG TAGTCAAATG

181 GCATACCTAC GCCGACAGTT GAACTTTCAC CGACAGTGAA CCCTTTGCCG ACAGTTTGGA

241 CCTACGCCGA CAGTTTGGAC CTTTTCCGAC AGTTGGTATG TTAGCGAAAC CGTTTCTAGG

301 GTGTTTCATA AACCATGCCT TGTCCAACAG TAGAAGTGTC GGCAAAACTA TATTGCTAGG

361 ATGTAGATAC ΑΆΤΤΤΑΑΑΤΑ TTTTAATAAA TACACATCAC ATTGATTGAG CAAAATCACA

421 TGGTCTGTTT TCACTAAAAC TGTCAGAGGT ACACTCCAGT ACTACCAGTA CGTCGCCCGC

481 ACAGTGGCCA AGGATTTTAC TGCTACTGTT GATTAACATA AGCACTTGCG ACTTTCCCTA

541 AAATCTTTTA TAAAACAACG GCCGCAATAA TATTGAACTA TTTTTTTTCT AGTACCAAAA

601 TTAGAATTTG ATCCCTCACC TCATTACATC CATAGTAACA TGACCAGATA TATATGGACA

661 GGATGGGATC ACTCAGCGAG CAGATACACT GAGCGATTCA TAATCAGATT TTTTAATTTC

721 TTCTAGTGAA GTGGGGTTTT CCTAGTCTTT TAACATTCA AATTTAGTAC AAACTTTCCC

781 TAGTAAATGC CTTCTAGTAA AGATTTCCTA GTATTTTGAC TAGCGATAGT GTTTTATTAC

841 TAATTAAAAA CATTAGAAGA ACTCCATTTA GTGATTGGTT GTTTGGATTA GTCTTCTCAC 901 GTTAGACCTA TATATGCAGG ACAACTCAAG CCAGCATAAA TATATGAAAT ATCTTGGTGT

961 TTGTTTGTCT GACACAGGCA ACCGCGTTTG GTATAAATGT GTTTTCTTGT TTACATTTTA

1021 CCATCTATAG TCATCTCAAT GTTATATAGT AGAGGCTTCA TGTTTGTAGT AGATAAGGTA

1081 GAGAATTGAG AATATTTTAT TTTTGTGCGA CCATCAATTT TATGTAATCT GCATTGTCTA

1141 ATGCTTTATT TGACATTTGA AACTACTTAA TTTGACAGTT ATGCAGGTCC GCATGATCCT

1201 ATGAAAGCAA TTAATTAGTA CGGGTAAACT GCACTACACA AGTTTGCTAG TACTATTCTA

1261 TTAACCGACC TGTCAATATT ACCTTAAGTT ACTGATTTCA ATTAGAATCT AACACATTCA

1321 GGAAAAGAAG TTTCACTAGT ACAAAAATCA TTTTCGTTGG CACGTTGTTT TTTTTTTCAC

1381 AGGCAGTTCA CAATATCATG GTGCTAGTAG AAAAATTTCA ACGGGCCCAA CAAGAGAACC

1441 GCCAGGCGGT CTTCTTAATT CAACCGCCTG TGTAAACTTT CCATTTACAT AGGCGGCTTA

1501 CGATAAAAAC CGTGTGTATA AATACCATTA ACACAGGCAG TCGAGTTACG ACAACCGCCT

1561 GTGTAAATGT GTCTTTTTAC ACAGGCGGTT TGTATAGAGG GCCGCCTGTG CTAATATATT

1621 TACACAGGCT ATGAGCCGCC TGTGTTAAGT CTTCTATAAA TACCCTTCGT CCACCTCCAG

1681 ACAAGAACAG TTACTCCCAT GAGCTCTGCA CACTGGCGGA CCAGACGATT CCAGTTTCCA

1741 AGGGGGGAGG TTTTGATTTT CATTTCTTTG GTGAGAAACT TCCAAAAGGT TAGTTAGTGC

1801 CATTGATGCT ATTTTTTAAG CGATTCTTTG GTTCAATTCT TGTATTGGAG GTGCTCTAGA

1861 TCTAGAGTTC ATCATGCATT CTTGCTTAGG GTTAGAGTTC ATAGGGC AA AAGAGAGAGA

1921 TTTAGCTAAA TTTTTATGTA AATTCATAGT AAATTGTAAA AATTAAAAAA AATAAAAAAT

1981 AAATACTTTT TAGAATTCTT GTGAGTAGAT CTATACAATA GAGTAATGAT GAGGATATTT

2041 TGAAGTTTAT AATTTTGATT CAGTTTTAGC TTTTCTTTTT TCAGATGAAT TAGACTTTAT

2101 AAACTCAAAC ATTAAAATGT TGAAAATCAT AAAATGGCAA ATAAATACTT TTTCAAATCT

2161 TTGTGCATAA ATACTTCATA GAAATCCTTG AATTATTCCT AAATTTTATA CAATTGTTTC

2221 ΤΤΑΪΑΑΤΤΑΤ GAAAATGAGT TTAAACAATT ATTTAAATTC CATAAATTGT AACTCCGTAA

2281 GGTGTAGGTT TTCATCTCTG TTTAATAGAA GGAGGTTAGT ATCTTAGTTA AGTCTGTTTT

2341 CGGGGGTTAT ATTAGTTTTG TTTTTAGATT GACCTACATT AATTGTTCTT AACTAATTAC

2401 AGCTAAATAT GGAGAGGTCA TTATGGATGT ACAACTTATC AAGATTGGAC CTATCATATG

2461 TAGTGCAGGT CCAAAAATTT ATTGATGTCG CAAAGATACA TGCTCGCAGA ACAAAGGCGA

2521 AGCACATATG TTGTCCATGC GCAGACTGCA AAAATATTAT GGTATTTGAC AATGTAGAAG

2581 CAATTACTTC CCATCTGGTT TGAAGAGGAT TTATGGAGGA CTACTTGATT TGGACAAAAC

2641 ATGGTGAGGG TAGTTTTGCA CCTTATATGC GGACAACTGA CAAC'ACTGCA ACTAACATCA

2701 ATGTGGAGGG TCCAATGCCA CCTCTCAATG AATTTCATGC TATGCCAGAT GTTAATGAAA

2761 CTCATACGTC TGATGTCAAT GAAACTCAGC ATGCTAACAC AGATGTTGTT GAAGATGCAG

2821 ATTTCTTAGA GGCAATAATG AACCGTTGTG CGGATCCATC AATATTCTTC ATGAAGGGAA

2881 TGAAAGCATT GAAGAAGGCA GCAGAGGACA CTTTGTACGA CGAGTCAAAA GGTTGTACCA

2941 AACAATGGTC GACATTATGT GTTGTTCTTC AGTTTTTGAC GATGAAGGCT AGACATGGTT

3001 GGTCCGATGC TAGCTTCAAT GATTTCTTGC GTGTACTTGG AGACCTTCTT CCTAAGGAGA

3061 ACAAAGTGCC TGCTAACACA TACTATGCAA AGAAGCTAGT CAGTCCACTT ACGATAGGTG

3121 TTGAGAAGAT CCACGCATGT AGAAATCATT GTATTCTATA TCGAGGTGAT CAATATAAAG

3181 ACTTAGACAG TTGTCCAAAC TGTGGTGCCA GTAGGTACAA GACAAACAAA GATTTTCGGG

3241 AGGAAGAGAA TCTAGCCTCT GTTTCTACAG GGAGGAAGCG AAAGAAGACC CAAACAAAGA

3301 CTCAACAAGA CAAGCGCTCA AAGCCTAGTA GCAATGAAGA AGTGGACTAT TATGCATTGA

3361 GAAGAGTCTC CCTATGAGCC AAAAAAGGGG ACAGCAGCAG GCACAACTCT CTTTCTGAAA

3421 GGACTTGGAA AGCAGCGGAC GGCACGGCTC ATTGAGCTCG AACCGTCACA GAAAAAGGAA

3481 GCCACCGCCC AGTCAATAGA AGCCATGCCC CCATCAAAGG AAGCCCCAAG TGGCGATGTA

3541 CATATTGAAC AGCCATCAAG TCAACCATTG ACCCTAAAGG ATATCAGAAA GCCAACGATT

3601 GATGATTATG TCAATGTCCC AGTGACTAT GTGCCCGGAA GGCCTATGCT CCAATGGACG

3661 CTGCTCGATT AGATTCAATG GCTGATAAAA AGGTTTCATG ACTGGTACAT GAGAGCAGTG

3721 CATGCTAGCC TCCATGGAAT CAGAGTTGAT ATACCAACAG ACATGTTTGC TACTGGTAAC

3781 AAAAAAAGCA AGACATTTGT TACCTTTGAG GACATGCACT TGTTATTGAA CTATAGGCGG

3841 CTTGACGTCC AACTCATAAC AATCTGGTGC CTGTAAGTAT CACTCATGCA CACACAATTA 3901 TTATATATTA ATATGTAGTG TGAAACTCTA ATATGTAGAT GTTGTCTGTA GTTTGCAAGA

3961 TCACGAGCAG ATGTCATTAT TATCTGCCGG ATCGATGGTC GGTTATCTGA GCCCTATCAA

4021 GTTACAAGAA AATATGAACA AATTCGTATT ATCAAAGGAA GATAGAGCAA AGATAGAGGA

4081 AGACAAAACA CCAGGATAAT TATGCCATCT ATCTTGGTAG ATCAATGCTG AGGTATAAAT

4141 ATAGGGATTT TATATTGGCA CCATACAACA TTAGGTAAGC TTGACTTCAT ATACGTATTT

4201 CAAATTATCG TGTAAACAAT ATACATGTGT CGCTCACTCA TTTATTCATG CAGTGACCAT

4261 TGGATTGTTT TTTATATTTA TCCCTTCGAA GGGAAGGTGC TTGTCCTAGA CTCTTTACAT

4321 GTTCCTCCCG AGAAGTATCA ACCATTCTTG GTTCAATTAG AAAGGTGAGC CAACATGAAA

4381 CCACATGCGT ACTTATATAA ATTAGAGTTT CAAAATAACT TAGTGATTT AGGTTCGATA

4441 TCTACGGGGC ATGGCGGTTT TATAAGAAAC AAAAGGGACC TGTCGACGCT GCACGCTCAG

4501 ATCCTAGGAT CCCATTGATG ATACAACACC ACTATCCGGT AAGTTTTCTG AACACATTTC

4561 ATCATATAAA TAATACATAA AGCATGGCAA ATTTAGAATA ATCCGTTGCT CATTATATAG

4621 TGCCACAAGC AACCACCTGG ATCGGTCTAT TGTGGGTACT ATGTCTGTGA GTTTATAAGG

4681 CAGCGGGGAC GTTACGTCAA GGACAAAAAT ATGGTAAATA ATATCTATGT ATGAAAGTTT

4741 TCTCATTAAA GCTGCAAAAT TATATATTGA ACATGTGTCA A CATGCTTT TAAACTTTAT

4801 TTTCAGCCGA AAAAGCAAGG AAAAGACGTG CCCTTTACAC CAAAGACTCT GGAAGATATA

4861 GTAGCATACT TGTGTGGTTT TATTATGAGA GAAATAATTT CAAGTGACAG TGCATATTTT

4921 GATCATGAGG GCGATTTAGC AAGTGATAAA TTTAGAGTGC TGACAGACAT AGCAGGTCTA

4981 AATCTGAAGC GAAACGACAT GTAAACATTG TATGGTTGTG CGGATAACAT GCATTGACGT

5041 GTATATATAT AATTTTATGG TTGATGTTTG ATTTGTTTAC AATTCTATAA TATATATATG

5101 TGGTGTATGT ATGATGTTGT GTGTGTATAT ATATATATAT ATATATATAT ATATATATAT

5161 ATATATATAT ATATATATAT ATATAATGTT TAGCACTGTG TTTGGTGGGA AAAATTAAAA

5221 TTTGAAATAT ATATAAAAAA TTATTTACAC AGACAGTGTA CGTGTCGAGC GTCGTCCTGT

5281 GCTATACAAA TACATTCTAA CAGGCGGCTC GCCTTGTCCA CCGGTCGGTT AAAAATACAT

5341 TTCCACACHG GCCTGGCTGG GAGAGCCGCC TGTGAAAACA TAATTTTCAC AGGCGGCTCG

5401 CACAGCCCCG CCTGTACTGT GGTCCATTTT GTACTGACCC CTGGTACAGG CGGTGGGCTT

5461 GGCCGCCTGT GAAGATGCTT TTAGCACCGC CTGTAAAAAT GTTTTTTGTA GCAGTGTTTT

5521 TCTTATTAGT AGTATCTTTT ATACTAA TA AGATTCAATA AAAATTCACC ATGACATCCC

5581 CATTGCCAAG AGAATATTTC GCCGCCCCTC AAAGCAGCCA AT

(SEQ ID NO: 17) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO: 17.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CACTATAACA CAACATGGCT TTGCCGACAC TTCCAACTAT CGGCAAAGGG TACCTTTACC

61 GACACTTAAC GTCTCACGAA AGGTTTTGCC GACAATTTTC AAACAGTCGC GGTAGAAGCA

121 GTTGGCGAAA CTTTTGCCGA CAGTTAAAGG CATCGCCGAC ACATTTTCTG TAGTCAAATG

181 GCATACCTAC GCCGACAGTT GAACTTTCAC CGACAGTGAA CCCTTTGCCG ACAGTTTGGA

241 CCTACGCCGA CAGTTTGGAC CTTTTCCGAC AGTTGGTATG TTAGCGAAAC CGTTTCTAGG

301 GTGTTTCATA AACCATGCCT TGTCCAACAG TAGAAGTGTC GGCAAAACTA TATTGCTAGG

361 ATGTAGATAC AATTTAAATA TTTTAATAAA TACACATCAC ATTGATTGAG CAAAATCACA

421 TGGTCTGTTT TCACTAAAAC TGTCAGAGGT ACACTCCAGT ACTACCAGTA CGTCGCCCGC

481 ACAGTGGCCA AGGATTTTAC TGCTACTGTT GATTAACATA AGCACTTGCG ACTTTCCCTA

541 AAATCTTTTA TAAAACAACG GCCGCAATAA TATTGAACTA TTTTTTTTCT AGTACCAAAA

60 TTAGAATTTG ATCCCTCACC TCATTACATC CATAGTAACA TGACCAGATA TATATGGACA

661 GGATGGGA C ACTCAGCGAG CAGATACACT GAGCGATTCA TAATCAGATT TTTTAATTTC

721 TTCTAGTGAA GTGGGGTTTT CCTAGTCTTT TAACATTCAA AATTTAGTAC AAACTTTCCC

781 TAGTAAATGC CTTCTAGTAA AGATTTCCTA GTATTTTGAC TAGCGATAGT GTTTTATTAC 841 AATTAAAAA CATTAGAAGA ACTCCATTTA GTGATTGGTT GTTTGGATTA GTCTTCTCAC

901 GTTAGACCTA TATATGCAGG ACMCTCAAG CCAGCATAAA TATATGAAAT ATCTTGGTGT

961 TTGTTTGTCT GACACAGGCA ACCGCGTTTG GTATAAATGT GTTTTCTTGT TTACATTTTA

1021 CCATCTATAG TCATCTCAAT GTTATATAGT AGAGGCTTCA TGTTTGTAGT AGATAAGGTA

1031 GAGAATTGAG AATATTTTAT TTTTGTGCGA CCATCAATTT TATGTAATCT GCATTGTCTA

1141 ATGCTTTATT TGACATTTGA AACTACTTAA TTTGACAGTT ATGCAGGTCC GCATGATCCT

1201 ATGAAAGCAA TTAATTAGTA CGGGTAAACT GCACTACACA AGTTTGCTAG TACTATTCTA

1261 TTAACCGACC TGTCAATATT ACCTTAAGTT ACTGATTTCA ATTAGAATCT AACACATTCA

1321 GGAAAAGAAG TTTCACTAGT ACAAAAATCA TTTTCGTTGG CACGTTGT T TTTTTTTCAC

1381 AGGCAGTTCA CAATATCATG GTGCTAGTAG AAAAATTTCA ACGGGCCCAA CAAGAGAACC

1441 GCCAGGCGGT CTTCTTAATT CAACCGCCTG TGTAAACTTT CCATTTACAT AGGCGGCTTA

1501 CGATAAAAAC CGTGTGTATA AATACCATTA ACACAGGCAG TCGAGTTACG ACAACCGCCT

1561 GTGTAAATGT GTCTTTTTAC ACAGGCGGTT TGTATAGAGG GCCGCCTGTG CTAATATATT

1621 TACACAGGCT ATGAGCCGCC TGTGTTAAGT CTTCTATAAA TACCCTTCGT CCACCTCCAG

1681 ACAAGAACAG T ACTCCCAT GAGCTCTGCA CACTGGCGGA CCAGACGATT CCAGTTTCCA

1741 AGGGGGGAGG TTTTGATTTT CATTTCTTTG GTGAGAAACT TCCAAAAGGT TAGTTAGTGC

1801 CATTGATGCT ATTTTTTAAG CGATTCTTTG GTTCAATTCT TGTATTGGAG GTGCTCTAGA

1861 TCTAGAGTTC ATCATGCATT CTTGCTTAGG GTTAGAGTTC ATAGGGCAAA AAGAGAGAGA

1921 TTTAGCTAAA TTTTTATGTA AATTCATAGT AAATTGTAAA AATTAAAAAA ΑΑΤΑΑΑΑΑΛΪ

1981 AAATACTTTT TAGAATTCTT GTGAGTAGAT CTATACAATA GAGTAATGAT GAGGATATTT

2041 TGAAGTTTAT AATTTTGATT CAGTTTTAGC TTTTCTTTTT TCAGATGAAT TAGACTTTAT

2101 AAACTCAAAC ATTAAAATGT TGAAAATCAT AAAATGGCAA ATAAATACTT TTTCAAATCT

2161 TTGTGCATAA ATACTTCATA GAAATCCTTG AATTATTCCT AAATTTTATA CAATTGTTTC

2221 TTATAATTAT GAAAATGAGT TTAAACAATT ATTTAAATTC CATAAATTGT AACTCCGTAA

2281 GGTGTAGGTT TTCATCTCTG TTTAATAGAA GGAGGTTAGT ATCTTAGTTA AGTCTGTTTT

2341 CGGGGGTTAT ATTAGTTTTG TTTTTAGATT GACCTACATT AATTGTTCTT AACTAATTAC

2401 AGCTAAATAT GGAGAGGTCA TTATGGATGT ACAACTTATC AAGATTGGAC CTATCATATG

2461 TAGTGCAGGT CCAAAAATTT ATTGATGTCG CAAAGATACA TGCTCGCAGA ACAAAGGCGA

2521 AGCACATATG T GTCCATGC GCAGACTGCA AAAATATTAT GGTATTTGAC AATGTAGAAG

2581 CAATTACTTC CCATCTGGTT TGAAGAGGAT TTATGGAGGA CTACTTGATT TGGACAAAAC

2641 ATGGTGAGGG TAGTTTTGCA CCTTATATGC GGACAACTGA CAACACTGCA ACTAACATCA

2701 ATGTGGAGGG TCCAATGCCA CCTCTCAATG AATTTCATGC TATGCCAGAT GTTAATGAAA

2761 CTCATACGTC TGATGTCAAT GAAACTCAGC ATGCTAACAC AGATGTTGTT GAAGATGCAG

2821 ATTTCTTAGA GGCAATAATG AACCGTTGTG CGGATCCATC AATATTCTTC ATGAAGGGAA

2881 TGAAAGCATT GAAGAAGGCA GCAGAGGACA CTTTGTACGA CGAGTCAAAA GGTTGTACCA

2941 AACAATGGTC GACATTATGT GTTGTTCTTC AGTTTTTGAC GATGAAGGCT AGACATGGTT

3001 GGTCCGATGC TAGCTTCAAT GATTTCTTGC GTGTACTTGG AGACCTTCTT CCTAAGGAGA

3061 ACAAAGTGCC TGCTAACACA TACTATGCAA AGAAGCTAGT CAGTCCACTT ACGATAGGTG

3121 TTGAGAAGAT CCACGCATGT AGAAATCATT GTATTCTATA TCGAGGTGAT CAATATAAAG

3181 ACTTAGACAG TTGTCCAAAC TGTGGTGCCA GTAGGTACAA GACAAACAAA GATTTTCGGG

3241 AGGAAGAGAA TCTAGCCTCT GTTTCTACAG GGAGGAAGCG AAAGAAGACC CAAACAAAGA

3301 CTCAACAAGA CAAGCGCTCA AAGCCTAGTA GCAATGAAGA AGTGGACTAT TATGCATTGA

3361 GAAGAGTCTC CCTATGAGCC AAAAAAGGGG ACAGCAGCAG GCACAACTCT CTTTCTGAAA

3421 GGACTTGGAA AGCAGCGGAC GGCACGGCTC ATTGAGCTCG AACCGTCACA GAAAAAGGAA

3481 GCCACCGCCC AGTCAATAGA AGCCATGCCC CCATCAAAGG AAGCCCCAAG TGGCGATGTA

3541 CATATTGAAC AGCCATCAAG TCAACCATTG ACCCTAAAGG ATATCAGAAA GCCAACGATT

3601 GATGATTATG TCAATGTCCC TAGTGACTAT GTGCCCGGAA GGCCTATGCT CCAATGGACG

3661 CTGCTCGATT AGATTCAATG GCTGATAAAA AGGTTTCATG ACTGGTACAT GAGAGCAGTG

3721 CATGCTAGCC TCCATGGAAT CAGAGTTGAT ATACCAACAG ACATGTTTGC TACTGGTAAC

3781 AAAAAAAGCA AGACATTTGT TACCTTTGAG GACATGCACT TGTTATTGAA CTATAGGCGG 3841 CTTGACGTCC AACTCATAAC AATCTGGTGC CTGTAAGTAT CACTCATGCA CACACAATTA

3901 TTATATATTA ATATGTAGTG TGAAACTCTA ATATGTAGAT GTTGTCTGTA GTTTGCAAGA

3961 TCACGAGCAG ATGTCATTAT TATCTGCCGG ATCGATGGTC GGTTATCTGA GCCCTATCAA

4021 GTTACAAGAA AATATGAACA AATTCGTATT ATCAAAGGAA GATAGAGCAA AGATAGAGGA

4081 AGACAAAACA CCAGGATAAT TATGCCATCT ATCTTGGTAG ATCAATGCTG AGGTATAAAT

4141 ATAGGGATTT TATATTGGCA CCATACAACA TTAGGTAAGC TTGACTTCAT ATACGTATTT

4201 CAAATTATCG TGTAAACAAT ATACATGTGT CGCTCACTCA TTTATTCATG CAGTGACCAT

4261 TGGATTGTTT TTTATATTTA TCCCTTCGAA GGGAAGGTGC TTGTCCTAGA CTGTTTACAT

4321 GTTCCTCCCG AGAAGTATCA ACCATTCTTG GTTCAATTAG AAAGGTGAGC CAACATGAAA

4381 CCACATGCGT ACTTATATAA ATTAGAGTTT TTAGTGATTT AGGTTCGATA

4441 TCTACGGGGC ATGGCGGTTT TATAAGAAAC AAAAGGGACC TGTCGACGCT GCACGCTCAG

4501 ATCCTAGGAT CCCATTGATG ATACAACACC ACTATCCGGT AAGTTTTCTG AACACATTTC

4561 ATCATATAAA TAATACATAA AGCATGGCAA ATTTAGAATA ATCCGTTGCT CATTATATAG

, 4621 TGCCACAAGC AACCACCTGG ATCGGTCTAT TGTGGGTACT ATGTCTGTGA GTTTATAAGG

4681 CAGCGGGGAC GTTACGTCAA GGACAAAAAT ATGGTAAATA ATATCTATGT ATGAAGTTTT

4741 CTCATTAAAG CTGCAAAATT ATATATTGAA CATGTGTCAA TCATGCTTTT AAACTTTATT

4801 TTCAGCCGAA AAAGCAAGGA AAAGACGTGC CCTTTACACC AAAGACTCTG GAAGATATAG

4861 TAGCATACTT GTGTGGTTTT ATTATGAGAG AAATAATTTC AAGTGACAGT GCATATTTTG

4921 ATCATGAGGG CGATTTAGCA AGTGATAAAT TTAGAGTGCT GACAGACATA GCAGGTCTAA

4981 ATCTGAAGCG AAACGACATG TAAACATTGT ATGGTTGTGC GGATAACATG CATTGACGTG

5041 TATATATATA ATTTTATGGT TGATGTTTGA TTTGTTTACA ATTCTATAAT ATATATATGT

5101 GGTGTATGTA TGATGTTGTG TGTGTATATA TATATATATA TATATATATA TATATATATA

5161 TATATATATA TATATATATA TATAATGTTT AGCACTGTGT TTGGTGGGAA AAATTAAAAT

5221 TTGAAATATA TATAAAAAAT TATTTACACA GACAGTGTAG TGTGAGCTGC CTGTGTAAAA

5281 ATACATTTAT ACAGGCGGCT CACCTTGTCN HNNCAGGCGG TGCTAAAAGC ATCTTCACAG

5341 GCGGCCAAGC CCACCGCCTG TACCAGGGGT CAGTACAAAA TGGACCACAG TACAGGCGGG

5401 GCTGTGCGAG CCGCCTGTGA AAACATAATT TTCACAGGCG GCTCGCACAG CCCCGCCTGT

5461 ACTGTGGTCC ATTTTGTACT GACCCCTGGT ACAGGCGGTG GGCTTGGCCG CCTGTGAAGA

5521 TGCTTTTAGC ACCGCCTGTA AAAATGTTTT TTGTAGCAGT GTTTTTCTTA TTAGTAGTAT

5581 CTTTTATACT AATTAAGATT CAATAAAAAT TCACCATGAC ATCCCCATTG CCAAGAGAAT

5641 ATTTCGCCGC CCCTCAAAGC AGCCAAT

(SEQ ID NO: 18) or a functional fragment or variant thereof having 75, 80,

85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO: 18. Eac N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CACTAGTACA AAAATCATTT TCGTTGGCAC GTTGTTTTTT TTTTCACAGG CAGTTCACAA

61 TATCATGGTG CTAGTAGAAA AATTTCAACG GGCCCAACAA GAGAACCGCC AGGCGGTCTT

121 CTTAATTCAA CCGCCTGTGT AAACTTTCCA TTTACATAGG CGGCTTACGA TAAAAACCGT

181 GTGTATAAAT ACCATTAACA CAGGCAGTCG AGTTACGACA ACCGCCTGTG AAATGTGTC

241 TTTTTACACA GGCGGTTTGT ATAGAGGGCC GCCTGTGCTA ATATATTTAC ACAGGCTATG

301 AGCCGCCTGT GTTAAGTCTT CTATAAATAC CCTTCGTCCA CCTCCAGACA AGAACAGTTA

361 CTCCCATGAG CTCTGCACAC TGGCGGACCA GACGATTCCA GTTTCCAAGG GGGGAGGTTT

421 TGATTTTCAT TTCTTTGGTG AGAAACTTCC AAAAGGTTAG TTAGTGCCAT TGATGCTATT

481 TTTTAAGCGA TTCTTTGGTT CAATTCTTGT ATTGGAGGTG CTCTAGATCT AGAGTTCATC

541 ATGCATTCTT GCTTAGGGTT AGAGTTCATA GGGCAAAAAG AGAGAGATTT AGCTAAATTT 601 TTATGTAAAT TCATAGTAAA TTGTAAAAAT TAAAAAAAAT AAAAAATAAA TACTTTTTAG

661 AATTCTTGTG AGTAGATCTA TACAATAGAG TAATGATGAG GATATTTTGA AGTTTATAAT

721 TTTGATTCAG TTTTAGCTTT TCTTTTTTCA GATGAATTAG ACTTTATAAA CTCAAACATT

781 AAAATGTTGA AAATCATAAA ATGGCAAATA AATACTTTTT CAAATCTTTG TGCATAAATA

841 CTTCATAGAA ATCCTTGAAT TATTCCTAAA TTTTATACAA TTGTTTCTTA TAATTATGAA

901 AATGAGTTTA AACAATTATT TAAATTCCAT AAATTGTAAC TCCGTAAGGT GTAGGTTTTC

961 ATCTCTGTTT AATAGAAGGA GGTTAGTATC TTAGTTAAGT CTGTTTTCGG GGGTTATATT

1021 AGTTTTGTTT TTAGATTGAC CTACATTAAT TGTTCTTAAC TAATTACAGC TAAATATGGA

1081 GAGGTCATTA TGGATGTACA ACTTATCAAG ATTGGACCTA TCATATGTAG TGCAGGTCCA

1141 AAAATTTATT GATGTCGCAA AGATACATGC TCGCAGAACA AAGGCGAAGC ACATATGTTG

1201 TCCATGCGCA GACTGCAAAA ATATTATGGT ATTTGACAAT GTAGAAGCAA TTACTTCCCA

1261 TCTGGTTTGA AGAGGATTTA TGGAGGACTA CTTGATTTGG ACAAAACATG GTGAGGGTAG

1321 TTTTGCACCT TATATGCGGA CAACTGACAA CACTGCAACT AACATCAATG TGGAGGGTCC

1381 AATGCCACCT CTCAATGAAT TTCATGCTAT GCCAGATGTT AATGAAACTC ATACGTCTGA

1441 TGTCAATGAA ACTCAGCATG CTAACACAGA TGTTGTTGAA GATGCAGATT TCTTAGAGGC

1501 AATAATGAAC CGTTGTGCGG ATCCATCAAT ATTCTTCATG AAGGGAATGA AAGCATTGAA

1561 GAAGGCAGCA GAGGACACTT TGTACGACGA GTCAAAAGGT TGTACCAAAC AATGGTCGAC

1621 ATTATGTGTT GTTCTTCAGT TTTTGACGAT GAAGGCTAGA CATGGTTGGT CCGATGCTAG

1681 CTTCAATGAT TTCTTGCGTG TACTTGGAGA CCTTCTTCCT AAGGAGAACA AAGTGCCTGC

1741 TAACACATAC TATGCAAAGA AGCTAGTCAG TCCACTTACG ATAGGTGTTG AGAAGATCCA

1801 CGCATGTAGA AATCATTGTA TTCTATATCG AGGTGATCAA TATAAAGACT TAGACAGTTG

1861 TCCAAACTGT GGTGCCAGTA GGTACAAGAC AAACAAAGA.T TTTCGGGAGG AAGAGAATCT

1921 AGCCTCTGTT TCTACAGGGA GGAAGCGAAA GAAGACCCAA ACAAAGACTC AACAAGACAA

1981 GCGCTCAAAG CCTAGTAGCA ATGAAGAAGT GGACTATTAT GCATTGAGAA GAGTCTCCCT

2041 ATGAGCCAAA AAAGGGGACA GCAGCAGGCA CAACTCTCTT TCTGAAAGGA CTTGGAAAGC

2101 AGCGGACGGC ACGGCTCATT GAGCTCGAAC CGTCACAGAA AAAGGAAGCC ACCGCCCAGT

2161 CAATAGAAGC CATGCCCCCA TCAAAGGAAG CCCCAAGTGG CGATGTACAT ATTGAACAGC

2221 CATCAAGTCA ACCATTGACC CTAAAGGATA TCAGAAAGCC AACGATTGAT GATTATGTCA

2281 ATGTCCCTAG TGACTATGTG CCCGGAAGGC CTATGCTCCA ATGGACGCTG CTCGATTAGA

2341 TTCAATGGCT GATAAAAAGG TTTCATGACT GGTACATGAG AGCAGTGCAT GCTAGCCTCC

2401 ATGGAATCAG AGTTGATATA CCAACAGACA TGTTTGCTAC TGGTAACAAA AAAAGCAAGA

2461 CATTTGTTAC CTTTGAGGAC ATGCACTTGT TATTGAACTA TAGGCGGCTT GACGTCCAAC

2521 TCATAACAAT CTGGTGCCTG TAAGTATCAC TCATGCACAC ACAATTATTA TATATTAATA

2581 TGTAGTGTGA AACTCTAATA TGTAGATGTT GTCTGTAGTT TGCAAGATCA CGAGCAGATG

2641 TCATTATTAT CTGCCGGATC GATGGTCGGT TATCTGAGCC CTATCAAGTT ACAAGAAAAT

2701 ATGAACAAAT TCGTATTATC AAAGGAAGAT AGAGCAAAGA TAGAGGAAGA CAAAACACCA

2761 GGATAATTAT GCCATCTATC TTGGTAGATC AATGCTGAGG GGGATTTTAT

2821 ATTGGCACCA TACAACATTA GGTAAGCTTG ACTTCATATA CGTATTTCAA ATTATCGTGT

2881 AAACAATATA CATGTGTCGC TCACTCATTT ATTCATGCAG TGACCAT GG ATTGTTTTTT

2941 ATATTTATCC CTTCGAAGGG AAGGTGCTTG TCCTAGACTC TTTACATGTT CCTCCCGAGA

3001 AG ATCAACC ATTCTTGGTT CAATTAGAAA GGTGAGCCAA CATGAAACCA CATGCGTACT

3061 TATATAAATT AGAGTTTCAA AATAACTTTA GTGATTTAGG TTCGATATCT ACGGGGCATG

3121 GCGGTTTTAT AAGAAACAAA AGGGACCTGT CGACGCTGCA CGCTCAGATC CTAGGATCCC

3181 ATTGATGATA CAACACCACT ATCCGGTAAG TTTTCTGAAC ACATTTCATC ATATAAATAA

3241 TACATAAAGC ATGGCAAATT TAGAATAATC CGTTGCTCAT TATATAGTGC CACAAGCAAC

3301 CACCTGGATC GGTCTATTGT GGGTACTATG TCTGTGAGTT TATAAGGCAG CGGGGACGTT

3361 ACGTCAAGGA CAAAAATATG GTAAATAATA TCTATGTATG AAAGTTTTCT CATTAAAGCT

3421 GCAAAATTAT ATATTGAACA TGTGTCAATC ATGCTTTTAA ACTTTATTTT CAGCCGAAAA

3481 AGCAAGGAAA AGACGTGCCC TTTACACCAA AGACTCTGGA AGATATAGTA GCATACTTGT

3541 GTGGTTTTAT TATGAGAGAA ATAATTTCAA GTGACAGTGC ATATTTTGAT CATGAGGGCG 3601 ATTTAGCAAG TGATAAATTT AGAGTGCTGA CAGACATAGC AGGTCTAAAT CTGAAGCGAA

3661 ACGACATGTA AACATTGTAT GGTTGTGCGG ATAACATGCA TTGACGTGTA TATATATAAT

3721 TTTATGGTTG ATGTTTGATT TGTTTACAAT TCTATAATAT ATATATGTGG TGTATGTATG

3781 ATGTTGTGTG TGTATATATA TATATATATA TATATATATA TATATATATA TATATATATA

3841 TATATATATA TAATGTTTAG CACTGTGTTT GGTGGGAAAA ATTAAAATTT GAAATATATA

3901 ΤΑΑΆΑΑΑΤΤΑ TTTACACAGA CAGTGTACGT GTCGAGCGTC GTCCTGTGCT ATACAAATAC

3961 ATTCTAACAG GCGGCTCGCC TTGTCCACCG GTCGGTTAAA AATACATTTC CACACNGGCC

4021 TGGCTGGGSG AGCCGCCTGT GAAAACATAA TTTTCACAGG CGGCTCGCAC AGCCCCGCCT

4081 GTACTGTGGT CCATTTTGTA CTGACCCCTG GTACAGGCGG TGGGCTTGGC CGCCTGTGAA

4141 GATGCTTTTA GCACCGCCTG TAAAAATGTT TTTTGTAGCA GTGTTT

(SEQ ID NO: 19) or a functional fragment or variant thereof having 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:19.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control has the nucleic acid sequence:

1 CACTAGTACA AAAATCATTT TCGTTGGCAC Gl*TGTT1 TT TTTTCACAGG CAGTTCACAA

61 TATCATGGTG CTAGTAGAAA AATTTCAACG GGCCCAACAA GAGAACCGCC AGGCGGTCTT

121 CTTAATTCAA CCGCC GTGT AAACTTTCCA TTTACATAGG CGGCTTACGA TAAAAACCGT

181 GTGTATAAAT ACCATTAACA CAGGCAGTCG AGTTACGACA ACCGCCTGTG TAAATGTGTC

241 TTTTTACACA GGCGGTTTGT ATAGAGGGCC GCCTGTGCTA ATATATTTAC ACAGGCTATG

301 AGCCGCCTGT GTTAAGTCTT CTATAAATAC CCTTCGTCCA CCTCCAGACA AGAACAGTTA

361 CTCCCATGAG CTCTGCACAC TGGCGGACCA GACGATTCCA GTTTCCAAGG GGGGAGGTTT

421 TGATTTTCAT TTCTTTGGTG AGAAACTTCC AAAAGGTTAG TTAGTGCCAT TGATGCTATT

481 TTTTAAGCGA TTCTTTGGTT CAATTCTTGT ATTGGAGGTG CTCTAGATCT AGAGTTCATC

541 ATGCATTCTT GCTTAGGGTT AGAGTTCATA GGGCAAAAAG AGAGAGATTT AGCTAAATTT

601 TTATGTAAAT TCATAGTAAA TTGTAAAAAT TAAAAAAAAT TACTTTTTAG

661 AATTCTTGTG AGTAGATCTA TACAATAGAG TAATGATGAG GATATTTTGA AGTTTATAAT

721 TTTGATTCAG TTTTAGCTTT TCTTTTTTCA GATGAATTAG ACTTTATAAA CTCAAACATT

781 AAAATGTTGA AAATCATAAA ATGGCAAATA AATACTTTTT CAAATCTTTG TGCATAAATA

841 CTTCATAGAA ATCCTTGAAT TATTCCTAAA TTTTATACAA TTGTTTCTTA TAATTATGAA

901 AATGAGTTTA AACAATTATT TAAATTCCAT AAATTGTAAC TCCGTAAGGT GTAGGTTTTC

961 ATCTCTGTTT AATAGAAGGA GGTTAGTATC TTAGTTAAGT CTGTTTTCGG GGGTTATATT

1021 AGTTTTGTTT TTAGATTGAC CTACATTAAT TGTTCTTAAC TAATTACAGC TAAATATGGA

1081 GAGGTCATTA TGGATGTACA ACTTATCAAG ATTGGACCTA TCATATGTAG TGCAGGTCCA

1141 GATGTCGCAA AGATACATGC TCGCAGAACA AAGGCGAAGC ACATATGTTG

1201 TCCATGCGCA GACTGCAAAA ATATTATGGT ATTTGACAAT GTAGAAGCAA TTACTTCCCA

1261 TCTGGTTTGA AGAGGATTTA TGGAGGACTA CTTGATTTGG ACAAAACATG GTGAGGGTAG

1321 TTTTGCACCT TATATGCGGA CAACTGACAA CACTGCAACT AACATCAATG TGGAGGGTCC

1381 AATGCCACCT C CAATGAAT TTCATGCTAT GCCAGATGTT AATGAAACTC ATACGTCTGA

1441 TGTCAATGAA ACTCAGCATG CTAACACAGA TGTTGTTGAA GATGCAGATT TCTTAGAGGC

1501 AATAATGAAC CGTTGTGCGG ATCCATCAAT ATTCTTCATG AAGGGAATGA AAGCATTGAA

1561 GAAGGCAGCA GAGGACACTT TGTACGACGA GTCAAAAGGT TGTACCAAAC AATGGTCGAC

1621 ATTATGTGTT GTTCT CAGT TTTTGACGAT GAAGGCTAGA CATGGTTGGT CCGATGCTAG

1681 CTTCAATGAT TTCTTGCGTG TACTTGGAGA CCTTCTTCCT AAGGAGAACA AAGTGCCTGC

1741 TAACACATAC TATGCAAAGA AGCTAGTCAG TCCACTTACG ATAGGTGTTG AGAAGATCCA

1801 CGCATGTAGA AATCATTGTA TTCTATATCG AGGTGATCAA TATAAAGACT TAGACAGTTG 1861 TCCAAACTGT GGTGCCAGTA GGTACAAGAC AAACAAAGAT TTTCGGGAGG AAGAGAATCT

1921 AGCCTCTGTT TCTACAGGGA GGAAGCGAAA GAAGACCCAA ACAAAGACTC AACAAGACAA

1981 GCGCTCAAAG CCTAGTAGCA ATGAAGAAGT GGACTATTAT GCATTGAGAA GAGTCTCCCT

2041 ATGAGCCAAA AAAGGGGACA GCAGCAGGCA CAACTCTCTT TCTGAAAGGA CTTGGAAAGC

2101 AGCGGACGGC ACGGCTCATT GAGCTCGAAC CGTCACAGAA AAAGGAAGCC ACCGCCCAGT

2161 CAATAGAAGC CATGCCCCCA TCAAAGGAAG CCCCAAGTGG CGATGTACAT ATTGAACAGC

2221 CATCAAGTCA ACCATTGACC CTAAAGGATA TCAGAAAGCC AACGATTGAT GATTATGTCA

2281 ATGTCCCTAG TGACTATGTG CCCGGAAGGC CTATGCTCCA ATGGACGCTG CTCGATTAGA

2341 TTCAATGGCT GATAAAAAGG TTTCATGACT GGTACATGAG AGCAGTGCAT GCTAGCCTCC

2401 ATGGAATCAG AGTTGATATA CCAACAGACA TGTTTGCTAC TGGTAACAAA AAAAGCAAGA

2461 CATTTGTTAC CTTTGAGGAC ATGCACTTGT TATTGAACTA TAGGCGGCTT GACGTCCAAC

2521 TCATAACAAT CTGGTGCCTG TAAGTATCAC TCATGCACAC ACAATTATTA TATATTAATA

2581 TGTAGTGTGA AACTCTAATA TGTAGATGTT GTCTGTAGTT TGCAAGATCA CGAGCAGATG

2641 TCATTATTAT CTGCCGGATC GATGGTCGGT TATCTGAGCC CTATCAAGTT ACAAGAAAAT

2701 ATGAACAAAT TCGTATTATC AAAGGAAGAT AGAGCAAAGA TAGAGGAAGA CAAAACACCA

2761 GGATAATTAT GCCATCTATC TTGGTAGATC AATGCTGAGG TATAAATATA GGGATTTTAT

2821 ATTGGCACCA TACAACATTA GGTAAGCTTG ACTTCATATA CGTATTTCAA ATTATCGTGT

2881 AAACAATATA CATGTGTCGC TCACTCATTT ATTCATGCAG TGACCATTGG ATTGTTTTTT

2941 ATATTTATCC CTTCGAAGGG AAGGTGCTTG TCCTAGACTC TTTACATGTT CCTCCCGAGA

3001 AGTATCAACC ATTCTTGGTT CAATTAGAAA GGTGAGCCAA CATGAAACCA CATGCGTACT

3061 TATATAAATT AGAGTTTCAA AATAACTTTA GTGATTTAGG TTCGATATCT ACGGGGCATG

3121 GCGGTTTTAT AAGAAACAAA AGGGACCTGT CGACGCTGCA CGCTCAGATC CTAGGATCCC

3181 ATTGATGATA CAACACCACT ATCCGGTAAG TTTTCTGAAC ACATTTCATC ATATAAATAA

3241 TACATAAAGC ATGGCAAATT TAGAATAATC CGTTGCTCAT TAT TAGTGC CACAAGCAAC

3301 CACCTGGATC GGTCTATTGT GGGTACTATG TCTGTGAGTT TATAAGGCAG CGGGGACGTT

3361 ACGTCAAGGA CAAAAATATG GTAAATAATA TCTATGTATG AAGTTTTCTC ATTAAAGCTG

3421 CAAAATTATA TATTGAACAT GTGTCAATCA TGCTTTTAAA CTTTATTTTC AGCCGAAAAA

3431 GCAAGGAAAA GACGTGCCCT TTACACCAAA GACTCTGGAA GATATAGTAG CATACTTGTG

3541 TGGTTTTATT ATGAGAGAAA TAATTTCAAG TGACAGTGCA TATTTTGATC ATGAGGGCGA

3601 TTTAGCAAGT GATAAATTTA GAGTGCTGAC AGACATAGCA GGTCTAAATC TGAAGCGAAA

3661 CGACATGTAA ACATTGTATG GTTGTGCGGA TAACATGCAT TGACGTGTAT ATATATAATT

3721 TTATGGTTGA TGTTTGATTT GTTTACAATT CTATAATATA TATATGTGGT GTATGTATGA

3781 TGTTGTGTGT GTATATATAT ATATATATAT ATATATATAT ATATATATAT ATATATATAT

3841 ATATATATAT AATGTTTAGC ACTGTGTTTG GTGGGAAAAA TTAAAATTTG AAATATATAT

3901 AAAAAATTAT TTACACAGAC AGTGTAGTGT GAGCTGCCTG TGTAAAAATA CATTTATACA

3961 GGCGGCTCAC CTTGTCNNNN CAGGCGGTGC TAAAAGCATC TTCACAGGCG GCCAAGCCCA

4021 CCGCCTGTAC CAGGGGTCAG TACA7AAATGG ACCACAGTAC AGGCGGGGCT GTGCGAGCCG

4081 CCTGTGAAAA CATAATTTTC ACAGGCGGCT CGCACAGCCC CGCCTGTACT GTGGTCCATT

4141 TTGTACTGAC CCCTGGTACA GGCGGTGGGC TTGGCCGCCT GTGAAGATGC TTTTAGCACC

4201 GCCTGTAAAA ATGTTTTTTG TAGCAGTGTT T

(SEQ ID NO:20) or a functional fragment or variant thereof having 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO:20. Each N = can be any nucleotide or combination of any 2, 3, 4, or 5 nucleotides.

C ACTA elements have been implicated as a mechanism of movement of genes and gene fragments in sorghum (Paterson AH et al. Nature, 457(7229):551-56 (2009)). In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes the CACTA element of SEQ ID NO: 1 or a functional fragment or variant thereof. For example, in some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes the nucleic acid sequence:

1 CACTATAACA CAACATGGCT TTGCCGACAC TTCCAACTAT CGGCAAAGGG TACCTTTACC 61 GACACTTAAC GTCTCACGAA AGGTTTTGCC GACAATTTTC AAACAGTCGC GGTAGAAGCA 121 GTTGGCGAAA CTTTTGCCGA CAGTTAAAGG CATCGCCGAC ACATTTTCTG TAGTCAAATG 181 GCATACCTAC GCCGACAGTT GAACTTTC C CGACAGTGAA CCCTTTGCCG ACAGTTTGGA 2 1 CCTACGCCGA CAGTTTGGAC CTTTTCCGAC AGTTGGTATG TTAGCGAAAC CGTTTCTAGG 301 GTGTTTCATA AACCATGCCT TGTCCAACAG TAGAAGTGTC GGCAAAACTA TATTGCTAGG 361 ATGTAGATAC AATTTAAATA TTTTAATAAA TACACATCAC ATTGATTGAG CAAAATCACA 421 TGG

(SEQ ID NO:21) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:21.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes the nucleic acid sequence:

1 TTCCACCTGG GCAGGGAAAA CGGTTTATTA TGTTCCTCTT TAATTTATCT ATCGTGGCAC

61 TATAACACAA CATGGCTTTG CCGACACTTC CAACTATCGG CAAAGGGTAC CTTTGCCGAC

121 ACTTAACGTC TCACGAAAGG TTTTGCCGAC AATTTTCAAA CAGTCGCGGT AGAAGCAGTC

181 GGCGAAACTT TTGCCGACAG TTAAAGGAGG ACACATTTTC TGTAGTCAAA TGGGCATGCC

241 TCCCGCGTTG ACTTTCACCG ACAGTGAACC CTTTGCCGAC AGTTTGGACC TACGCCGACA

301 GTTTGGATCT TTTCCGACAG TTGGTATGTT AGCGAAACCG TTTCTAGGGT GTTTCATAAA

361 CCATGCCTTG TCCAACAGTA GAAGTGTCGG C ?¾>7Vi¾J\ C Ί /ΑΤ ¾ TTGCAGATAG TAGGGTGTAG

421 ATACAATTTA AATATTTTAA TAAATACACA TCACATTGAT CGAGCAAAAT CACATGGTCT

481 GTTTTCACTA AAACTGTCAT AGGTACACTC CAGTACTACC AGTACGTCGC CCGCACATAG

54 1 TGGCCAAGGA TTTTACTGCT ACTGTTGATT AACATAAGCA CTTGCGACTT TCCCTAAAAT

601 CTTTTATAAA ACAACGGCCG CAATAATATT GAACTATTTT TGTTCTAGTA CCAAAATTAG

661 AATTTGATCC CTCACCTCAT TACATCCATA G

(SEQ ID NO:22) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:22.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes the nucleic acid sequence:

1 TGGCACTATA ACACAACATG GCTTTGCCGA CACTTCCAAC TATCGGCAAA GGGTACCTTT

61 GCCGACACTT AACGTCTCAC GAAAGGTTTT GCCGACAATT TTCAAACAGT CGCGGTAGAA

121 GCAGTCGGCG AAACTTTTGC CGACAGTTAA AGGAGGACAC ATTTTCTGTA GTCAAATGGG

181 CATGCCTCCC GCGTTGACTT TCACCGACAG TGAACCCTTT GCCGACAGTT TGGACCTACG

24 1 CCGACAGTTT GGATCTTTTC CGACAGTTGG TATGTTAGCG AAACCGTTTC TAGGGTGTTT

301 CATAAACCAT GCCTTGTCCA ACAGTAGAAG TGTCGGCAAA ACTATATTGC AG T GTAGG 361 GTGTAGATAC AATTTAAATA ΤΤΤΤΆΑΤΑΑΑ TACACATCAC ATTGATCGAG CAAAATCACA 4 2 1 TGG

(SEQ ID NO:23) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:23.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes a functional CAAT box, for example the CAAT box of SEQ ID NO: 12 or a functional fragment or variant thereof. In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod control includes the nucleic acid sequence: GCCAAT (SEQ ID NO:24) or a variant thereof, for example a consensus CAAT Box sequence such as GGCCAATCT (SEQ ID NO:25). The CAAT box of a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control is typically between 50 and 250 bases upstream of the initial transcription site.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photoperiod (short-day) control includes the nucleic acid sequence;

1 TTCTTATTAG TAGTATCTTT TATACTAATT AAGATTCAAT AAAAATTCAC CATGACATCC 61 CCATTGCCAA GAGAATATTT CGCCGCCCCT CAAAGCAGCC AATAAGGCTT TACTAAAAAG

12 1 ACTATCCACG CAGTAGAGAT TTAGTCAAAA TATTCCAATA GCAATTGTTT CCTGCCTGCT

181 TGACCTTCGT CAGCCACTCA CTGTATAAAT ATCGCACCAC GCCCTTTGCA GGCTTACAGA

241 GCTTGTATTA CGTACTAACA AGGCACACAC AGTACCCTGT GTTCACCGGC CCTGCACAAA

301 ACTCAAGCAG TTATTACTAA C

(SEQ ID NO:26) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:26.

A polynucleotide having a nucleic acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to a fragment of SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26 is also disclosed. The Mai gene in the day- neutral S. bicolor has a recessive (loss of function) Mai allele characterized by one or more mutations or deletions in the 5'UTR relative to the 5'UTR of S. propinquum that results in loss of photoperiod sensitivity. Therefore, the nucleic acids in SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 can be present in short-day expression control sequences. Therefore, in some embodiments, the photoperiod sensitive Mai expression control sequence has 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 250, 300 or more of the nucleic acids in SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26, and is capable of inducing short-day expression of a target gene.

2. Photoperiod Insensitivity

The expression control sequence of the Mai gene in the day-neutral S. bicolor having a recessive (functional) Mai allele can be used to induce photoperiod insensitivity of other plant genes. Accordingly, the Mai expression control sequences from S. bicolor can be operably linked to a plant gene coding sequence to impart photo-insensitive (i.e., day-neutral) control over the plant gene coding sequence.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photo-insensitive (day neutral) control has the nucleic acid sequence:

1 AAAAGAAAAG TGAGCACACC ACGACCTATC ATCAGCTCAT GGTCAGCTCT ACAAACTTAT

61 AGATTGCATC GAGATCTAAG ACTCAGGTAC AAATCATGTC ¾¾c ϋ τ C T¾¾ X GGTTTAGAAA

121 ATGAAAAAAG T T T Gj¾G Ί¹ T Ϊ" CAAAATATGA TACTTGAAAT TAACATTTGA ACTTTTTAGC

181 AAGATCTGAA AATAAAAAAT TCAACTAAAA AATTTATAGA TCATGTTAAC ATTGATATAA

241 TCGCTTCCAA TCGCCTCCCA TCGCTTCAGC TAGAAAACTT TTTTTCTCGA TTTAATTAAT

301 TAACGTCATT GTACAAGATT CTTTCAAACC CCAACCCCTA TCATCGACGG

361 TGAGGGCTCC TATAATATGC ACTAGTGGAC GCCGGGTGGG TGGAACCTAA GAAGATTTTA

421 AAAAAAAAAT TAAGAAGAAG ATTTTTATCT AACTAACTAT ATATAGIACT TATATCATAC

481 ACTATACTAT TCAAAATATT ATTTTCACAA TTATGAATTT ACCCTTTTAC TCTTTATTAA

54 1 AAAAATATGA ATAAAGAATT ATCACGCCTC TATTTAGGGT CCTAATCCCC ATAATTTAAG

601 AGGCGATGAG AGGCGATGTG ACATCTATGG CCCACCGACC AAAGACACAA CTATCGCCTC

661 CCATCACCTT GCTTCTATCG CCTCTCATAG CTTTTCATAT TCTAGGTCCA CCGGCCATAG

721 ACACACCAAT CGCTTATCAT CGCCTTTTCC AACCATTGTA AAAATATTCA TAATTTTGAT

781 ATAAAATTTG TCTTCACTTG AGTATGGGAA AAAAATTATA CATAATGTTT TCGTGTGAGA

841 ATTTACAGGA ATGAACCCTT AAGATGTCCA AATGTAAATG ACCCTATTTA TTAAGAGGAG

901 CGGATCTATA GGCCTGGCTC TGAAAATGGA TTATGGATTG GAGATACTAA ATTTAAGGGC

961 CTATCTTCGC ACATAACATC TATAGTTCCT AAATAATTTT TTAtTGTAGT AGTAGAACTT

1021 TTCTCCCTGT AAACCATAAA CCAAGTTGAC GCTGGGCTTT ATTTTGCGAC ACAGAACACC

1081 AAATTGG£GG CTATGAACTC TTCCACCTGG GCAGGGAAAA CGGTTTATTA TGTTCCTCTT

1141 TAATTTATCT ATCGTGGTCT GTTTTCACTA AAACTGTCAT ATTGCTACAC TCCAGTACTA

1201 CCAGTACGTC GCCCGCACAT AGTGGCCAAG GATTTTACTG CTACTGTTGA TTAACATAAG

1261 CACTTGCGAC TTTCCCTAAC ATCTTTTATA AAACAACGGC CGCAATAATA TTGAACTGTT

1321 TTTTTCTAGT ■¾ C C fi>¾ ¾i¾ i P ϋ¾ GAATTTGATC CCTCACCTCA TTACATCCAT AGTAACATGA

1381 C C J GJ&T ϊ v¾ ATGGACAGGC CGGGATCACT CGCCAGCAGA TACCCTGAGC GATTCATAAC

1441 CAGAATTTTT AATTTTTTCT AGTGAAG GG GGTTCTCCTA GTCCT TAAC ATTCAAAATT

1501 TAGTACAAAC TTTCCTTAGT AAATGTCTTC TAGTASAGAT TTCCTAGTGT TTTGATTTGG

1561 TAGTGTTTTA TTACTAATTA AAAATATTAG AAGAACTCCA TCATTTTGGT AGTGATTGGT

1621 TGTTTGGATT AGTCTTCTCA CGTTAGACCT ATATATGCAG GACAACTCAA GCCAGCATAA 1681 ATATATGAAA TATCTTGGTG TTTGTTTGTC TGACACAGGC AACCGTGTTT GGTATAAATG

1741 TGTTTTCTTG TTTACGTTTT ACCATCTATA GTCATCTC&A TGTTTATATA GTAGAGACTT

1801 CATGTTTGTA GTAGATAAGG TAGAGAATTG AGAATATTTT ATTTTTGTGC GACCATCAAT

1861 TTTATGTAAT CTGCATTGTC TAATGCTTTA TTTGACATTT GAAACTACTT AATTTGACCG

1921 TTATGCAGGT CCGCATGATC CTATGAAAGC AATTAATTAG TACGGGTACT GCACTACACA

1981 AGTTTGCTAG TACTATTCTA TTAACCGACC TGTCAATATT SCCTTAAGTT ACTGATTTCA

2041 ATTAGAATCT AACACATTCA GGAAAAGAAG TTTTCCTTAT TAGTAGTAAC TTTTTATACT

2101 AATTAAGATT CAATAAAAAT TCACCATGAC ATCCCCATTG CCAAGAGAAT ATTTCGCCGC

2161 CCCTCAAAGC AGCCAAGGCT TTACTAAAAA GACTATCCAC GCAGTAGAGA TTTAGTCAAA

2221 ATATTCCAAT AGCAATTGTT TTCTGCCTGC TTGACCTTCG TCAGCCACTC ACTGTATAAA

2281 TATCGCACCA CGCCCTTTGC AGGCTTACAG AGCTTGTACT ACGTACTAAC AAGGCACACA

2341 CAATACCCTG TGTTCACCGG CCCTGCACAA AACTCAAGCA GTTATTACTA AC

(SEQ ID NO:27) or a functional fragment or variant thereof having 75, 80,

85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:27.

In some embodiments, a functional Mai expression control sequence capable of placing a target gene under photo-insensitive (day neutral) control has the nucleic acid sequence:

1 TCCTTATTAG TAGTAACTTT TTATACTAAT TAAGATTCAA TAAAAATTCA CCATGACATC

61 CCCATTGCCA AGAGAATATT TCGCCGCCCC TCAAAGCAGC CAAGGCTTTA CTAAAAAGAC 121 TATCCACGCA GTAGAGATTT AGTCAAAATA TTCCAATAGC AATTGTTTTC TGCCTGCTTG

181 ACCTTCGTCA GCCACTCACT GTATAAA T CGCACCACGC CCTTTGCAGG CTTACAGAGC

24 1 TTGTACTACG TACTAACAAG GCACACACAA TACCCTGTGT TCACCGGCCC TGCACAAAAC

301 TCAAGCAGTT ATTACTAAC

(SEQ ID NO:35) or a functional fragment or variant thereof having 75, 80, 85, 90, 95, 96, 97, 98, or 99% sequence identity to SEQ ID NO:35.

A polynucleotide having a nucleic acid sequence at least 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to a fragment of SEQ ID NO:27 or 35 is also disclosed. The Mai gene in the day-neutral S. bicolor has a recessive (loss of function) Mai allele characterized by one or more mutations or deletions in the 5'UTR relative to the 5'UTR of S. propinquum that results in loss of photoperiod sensitivity. Therefore, in some embodiments, the photo- insensitive Mai expression control sequence has 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 250, 300 or more of the nucleic acids in SEQ ID NO: 27 or 35, and is capable of controlling day-neutral expression of the target gene. III. Methods of Modulating Photoperiod Sensitivity

Methods of modulating photoperiod sensitivity and flowering time in sorghum are disclosed. The methods can be used, for example, to increase high biomass production, by extending the growing period.

Methods are also disclosed for modulating photoperiod sensitivity involving operably linking the expression control sequence of a Mai gene from a photoperiod sensitive Sorghum variety or cultivar to the endogenous maturity gene in the plant. Methods are disclosed for imposing photoperiod sensitivity on other genes that are not normally controlled by photoperiod by operably linking the expression control sequence of a Mai gene from a photoperiod sensitive Sorghum variety or cultivar to the endogenous gene in the plant. Similarly, methods are also disclosed for imposing photoperiod s insensitivity on other genes that are normally controlled by photoperiod by operably linking the expression control sequence of a Mai gene from a photoperiod insensitive Sorghum variety or cultivar to the endogenous gene in the plant.

The disclosed method can involve modulating the expression or activity of a Mai gene in a plant. Activities of a gene include transcriptional activation of the gene and activities of the resulting encoded protein. The method can involve modulating the activity of a protein encoded by the Maturity gene. Activities of a protein include, for example, transcription, translation, intracellular translocation, secretion, phosphorylation by kinases, cleavage by proteases, homophilic and heterophilic binding to other proteins, ubiquitination.

In some embodiments, the method involves increasing photoperiod sensitivity in a plant. For example, in some embodiments, the method involves introducing to a plant a nucleic acid sequence that promotes photoperiod dependent expression of a functional Mai maturity gene. As a result of this method, the transgenic plant preferably has higher photoperiod sensitivity to flowering compared to control (e.g., wild-type) plant of the same species.

In some embodiments, the method involves inhibiting photoperiod sensitivity in a plant. In some embodiments, the method involves engineering a transgenic plant to express the Mai under the control of photoperiod insensitive control sequence of Mai. As a result of this method, the transgenic plant preferably has reduced photoperiod sensitivity to flowering compared to control (e.g., wild-type) plant of the same species.

In some embodiments, the method involves engineering a transgenic plant to inhibit gene expression of the Mai gene or translation of the Mai protein. In other embodiments, the method involves introducing to the plant a composition that silences gene expression. For example, the composition can include an antisense, RNAi, dsR A, miRNA, or siRNA that targets the maturity gene in the plant and inhibits translation of the encoded protein. In still other embodiments, the method involves introducing to the plant a composition that binds to the protein encoded by the maturity gene and inhibits one or more of the protein's activities.

In some embodiments, the method involves introducing to the plant or plant cell a nucleic acid sequence that silences expression of the maturity gene in the plant. Preferably, the nucleic acid is operably linked to an expression control sequence. The expression control sequence can be a heterologous control sequence. Selection of this control sequence can be used to select the amount of gene-silencing nucleic acid expressed and therefore control photoperiod sensitivity in the plant. As a result of this method, the transgenic plant preferably has lower photoperiod sensitivity compared to control (e.g., wild-type) plant of the same species. In some embodiments, the nucleic acid can silence a polynucleotide having the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 35 or a nucleic acid encoding the polypeptide of SEQ ID NO: 8 or 34, for fragments or variants thereof.

In some embodiments, photoperiod sensitivity can be modulated by elements within the nucleic acid sequence. For instance, as discussed above, wild type short day flowering sorghum contains at least four additional non- coding segments not found in day-neutral sorghum: a segment of about 400 base pairs in the 5' UTR, a segment of about 4.2 kb in the 5' UTR, a segment of 3 base pairs in the 5' UTR, and a segment of 27 base pairs in the second intron of the coding sequence.

Methods of interfering with the non-coding segments can be used to modulate the photoperiod sensitivity of short day plants. Deleting or altering some or all of the non-coding segments or inserting additional nucleotides into the non-coding segments can be effective. Deleting, mutating, or inserting nucleotides in one or more of the Mai expression control sequences disclosed herein can decrease the photoperiod sensitivity of a gene or polynucleotide of interest. Therefore, in some embodiments deleting or mutating nucleotides in one or more of these regions of the Mai expression control sequence with shift the plant from short-day flowering to day-neutral flowering. For example, in some embodiments insertions, mutations, or deletions are introduced into a polynucleotide having SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 , 32, 33, 35 or a functional fragment, variant, or complement thereof to reduce the photoperiod sensitivity of the expression control sequence. In a preferred embodiment, mutations or deletions are introduced into a CAAT box, for example a polynucleotide having the sequence of SEQ ID NO: 23, 24, or 25 or a functional fragment, variant, or complement thereof. The insertions, mutations or deletions can shift the plant from short-day flowering to day- neutral flowering, or make the plant less photoperiod sensitive.

Inhibiting the regulatory function of the non-coding segments can also be used to modulate photoperiod sensitivity. For instance, inhibiting or preventing the interaction of one or more of the non-coding segments with another nucleic acid sequence or protein.

The additional nucleotides can be dependent or independent on a functional copy of the flowering gene. In some forms, one or more of the non-coding segments is insufficient to produce the short day trait alone. However, the combination of one or more of the non-coding segments and a functional copy of the flowering gene can result in a short day flowering plant. The non-coding segments can interact with the gene it resides within. The interaction can be non-linear. This interaction can be based on one or more of the non-coding segments containing a gene regulatory feature that confers the short day sensing mechanism.

In some embodiments, the photoperiod sensitivity of expression control sequences disclosed herein is increased. Deleting, mutating, or inserting nucleotides in one or more of these regions of the Mai expression control sequences disclosed herein can increase the photoperiod sensitivity of a gene or polynucleotide of interest. For example, in some embodiments deleting, mutating, or inserting nucleotides in one or more of these regions of the Mai expression control sequence with shift the plant from day-neutral flowering to short-day flowering. For example, in some embodiments insertions, mutations or deletions are introduced into a polynucleotide having SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 28, 29, 30, 31, 32, 33, 35 or a functional fragment, variant, or complement thereof to increase the photoperiod sensitivity of the control sequence. In a preferred embodiment, an insertion includes multiple copies of a C AAT box, for example a polynucleotide having the sequence of SEQ ID NO: 23, 24, or 25 or a functional fragment, variant, or complement thereof. In some embodiments the additional CAAT boxes, include, but not limited to one or more copies of SEQ ID NO: 23, 24, or 25. The inserted sequences can be added sequentially to the promoter region of the gene or polynucleotide of interest. For example, in some embodiments, one or more CAAT boxes are added beginning between about 50 and 250 nucleotides upstream of the "ATG" start site of a plant gene such as Mai . The insertions, mutations or deletions can shift the plant from day-neutral flowering to short-day flowering plants, or increase the photoperiod sensitivity of the plant.

In some embodiments, photoperiod sensitivity can be modulated by using the Mai control sequences of S. bicolor. For example, in some embodiments, the control sequences of S. bicolor, including by not limited to SEQ ID NO:27 or 35, are inserted upstream of a coding sequence of a gene of interest and cause photoperiod insensitive, or day neutral expression of the gene of interest. In some embodiments the gene of interest is Mai .

Methods of modifying the photoperiod sensitivity of Mai by replacing or supplementing the endogenous control sequences of Mai with heterologous control sequences are also disclosed. The expression control sequences of Mai can be altered or replaced with an expression control sequence that reduces photosensitivity, but wherein expression of Mai is still photoperiod sensitive relative to Mai expression in S, bicolor. The expression control sequences of Mai can also be altered or replaced with an expression control sequence that increases photosensitivity of Mai expression relative to Mai expression in S. propinquum. For example, in some embodiments, the expression control sequence of Mai is replaced with an expression control sequence from another photoperiod sensitive gene. Cis-regulatory elements in the promoter of photoperiod-responsive genes, coordinated motifs integrating hormones and stresses to photoperiod responses, and photo-responsive genes and their promoters are known in art, and can be used to alter the photosensitivity Mai , see for example,

Mongkolsiriwatana C, i¾ et tJ (Nat. Set) 43: 164-177 (2009).

A. Recombinant Plant Gene Expression

Compositions and methods are therefore provided for operably linking plant genes to a Mai expression control sequence. Therefore, methods of imposing photoperiod sensitivity or insensitivity on a plant process are disclosed. The methods can involve producing a recombinant nucleic acid molecule that contains a plant gene responsible for the plant process operably linked to an Mai expression control sequence, for example a polynucleotide having the sequence of SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, or a functional fragment or variant thereof. The plant process can be naturally photoperiod sensitive, or photoperiod insensitive. In some embodiments a photoperiod sensitive control sequence of Mai, for example SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, or a functional fragment or variant thereof is operably linked to a plant gene to impart photoperiod sensitive control over the gene. In some embodiments a photoperiod insensitive control sequence of Mai, for example SEQ ID NO: 27, or a functional fragment or variant thereof is operably linked to a plant gene or coding sequence thereof to impart photoperiod sensitive control over the polypeptide encoded by the gene. A transgenic plant or transgenic plant cell is also disclosed that has a photoperiod sensitive or msensitive plant process. These plants can contain a plant gene controlling the plant process that is operably linked to a Mai expression control sequence, for example a polynucleotide having the sequence of SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, or a functional fragment or variant thereof, as described above.

Nucleic acid vectors are also disclosed that include the Mai expression control sequence, for example a polynucleotide having the sequence of SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 6, or a functional fragment or variant thereof. In some embodiments, the vectors also include an insertion site, such as a multiple cloning site, for insertion of a plant gene of interest. The insertion site can include, for example, one or more restriction enzyme digestion sites for operably linking a gene to the expression control sequence.

Methods of modifying a plant gene to be under photoperiod control are also disclosed. The method generally involves operably linking the plant gene to a functional Mai expression control sequence. The Mai sequence can in some embodiments be from any Sorghum plant variety or cultivar that is photoperiod sensitive. Likewise, the optimum conditions for photoperiod selectivity can be selected for the plant gene by selecting a Mai expression control sequence from a Sorghum variety or cultivar that flowers under the desired photoperiod conditions. Therefore, Sorghum varieties having undesirable photoperiod sensitivity can be optimized by modifying or replacing the expression control sequence of the endogenous Mai gene according to the disclosed method.

As an example, SEQ ID NOs: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26 contain Mai expression control sequences from a short-day cultivar of S. propinqu m, i.e., flowers when the days are short. This expression control sequence can in some embodiments be used to impose short-day photoperiodic control on other valuable plant processes. B. Constructs and Vectors

1. Recombinant Expression of Mai

Vectors and constructs containing a Mai gene, or coding sequence, operably linked to an endogenous or heterologous expression control sequence are also disclosed. The constructs can include an expression cassette containing an Mai gene or a Mai coding, for example SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, or a nucleic acid encoding the amino acid sequence of SEQ ID NO:8 or 34. The expression sequences can be used to cause flowering in plants as described in more detail below.

2. Genes of Interest

Methods of modifying a plant gene, polynucleotide, or coding sequence to be photoperiod sensitive or insensitive are also disclosed. The method generally involves operably linking the polynucleotide to a Mai photoperiod sensitive or insensitive expression control sequence to polynucleotide or interest. The polynucleotide of interest can be a coding sequence for example a sequence encoding a polypeptide (with or without introns), or non-coding sequence such as an antisense or inhibitory nucleic acid. In some embodiments the polynucleotide includes a cDNA of a polypeptide of interest.

Plant genes and coding sequences that can be engineered to be photoperiod sensitive or insensitive are known in the art, and including, but are not limited to, those gene and coding sequences that influence traits such as germination, flowering, ripening, senescence, and combinations thereof. For example, in some embodiments it is desirable to make more or less photoperiod sensitive, genes or coding sequences that regulate or contribute to remobilization of plant constituents from vegetative tissues to harvested organs; to underground parts such as roots; rhizomes to sustain future regrowth; or combinations thereof.

3. Antisense

Mai antisense oligonucleotides are also disclosed. Mai antisense oligonucleotides can be used to delay, inhibit, or prevent expression of Mai in plants. Antisense molecules are designed to interact with a target nucleic acid molecule through either canonical or non-canonical base pairing. The interaction of the antisense molecule and the target molecule is designed to promote the destruction of the target molecule through, for example, RNAseH mediated RNA-DNA hybrid degradation. Alternatively the antisense molecule is designed to interrupt a processing function that normally would take place on the target molecule, such as transcription or replication. Antisense molecules can be designed based on the sequence of the target molecule, for example Mai coding sequences including, but not limited to SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 35 or a nucleic acid encoding the amino acid sequence of SEQ ID NO: 8 or 34. Antisense molecules are known in the art include, but are not limited to, RNA interference (RNAi) and siRNA. Methods of designing antisense molecules directed to a target sequence, for example SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 35 or a nucleic acid encoding the amino acid sequence of SEQ ID NO:8 or 34 are well also well known in the art. See for example, Elbashir, et al, Methods, 26:199-213 (2002).

The production of siRN A from a vector is more commonly done through the transcription of a short hairpin RNAs (shRNAs). Accordingly, vectors and constructs containing a nucleic acid sequence that silences Mai gene expression (e.g., siRNA, RNAi, shRNA) operably linked to a heterologous^" expression control sequence are also disclosed.

4. Transformation Constructs

Transformation constructs can be engineered such that transformation of the nuclear genome and expression of transgenes from the nuclear genome occurs. Alternatively, transformation constructs can be engineered such that transformation of the plastid genome and expression of the plastid genome occurs.

An exemplary construct contains a nucleic acid sequence containing an Mai gene operatively linked in the 5' to 3' direction to a promoter that directs transcription of the nucleic acid sequence, and a 3' polyadenylation signal sequence. Typically, the construct will increase the amount of Mai in the plant by at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 percent. Another exemplary construct contains a nucleic acid sequence that silences Mai gene expression operatively linked in the 5' to 3' direction to a promoter that directs transcription of the nucleic acid sequence, and a 3' polyadenylation signal sequence. Typically, the transcribed nucleic acid sequence can result in at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 percent inhibition of the Mai gene.

Another exemplary construct contains a nucleic acid sequence containing a polynucleotide of interest operatively linked in the 5' to 3' direction to a Mai expression control sequence that directs transcription of the polynucleotide, and a 3' polyadenylation signal sequence. The Mai expression control sequence can impart photoperiod sensitivity or photoperiod insensitivity to the polynucleotide of interest.

Generally, nucleic acid sequences containing an Mai gene, a Mai coding sequence, or a nucleic acid sequence that silences an Mai gene, are first assembled in expression cassettes behind a suitable promoter expressible in plants. The expression cassettes may also include any further sequences required or selected for the expression of the transgene. Such sequences include, but are not restricted to, transcription terminators, extraneous sequences to enhance expression such as introns, vital sequences, and sequences intended for the targeting of the gene product to specific organelles and cell compartments. In some embodiments the expression cassettes includes a Mai expression control sequence discussed above. These expression cassettes can then be easily transferred to the plant transformation vectors. Representative plant transformation vectors are described in plant transformation vector options available (Gene Transfer to Plants (1995), Potrykus, I. and Spangenberg, G. eds. Springer-Verlag Berlin Heidelberg New York; "Transgenic Plants: A Production System for Industrial and Pharmaceutical Proteins" (1996), Owen, M.R.L. and Pen, J. eds. John Wiley & Sons Ltd. England and Methods in Plant Molecular biology-a laboratory course manual (1995), Maliga, P., lessig, D. F., Cashmore, A. R._; Gruissem, W. and Varner, J. E. eds. Cold Spring

Laboratory Press, New York). An additional approach is to use a vector to specifically transform the plant plastid chromosome by homologous recombination (U.S. Pat. No. 5,545,818 to McBride, et al.), in which case it is possible to take advantage of the prokaryotic nature of the plastid genome and insert a number of transgenes as an operon.

The following is a description of various components of typical expression cassettes.

1. Promoters

Plant promoters can be selected to control the expression of the transgene in different plant tissues or organelles, for all of which methods are known to those skilled in the art (Gasser & Fraley, Science 244:1293-99 (1989)). In a preferred embodiment, promoters are selected from those of plant or prokaryotic origin that are known to yield high expression in piastids. In certain embodiments the promoters are inducible. Inducible plant promoters are known in the art.

The transgenes can be inserted into an existing transcription unit (such as, but not limited to, psbA) to generate an operon. However, other insertion sites can be used to add additional expression units as well, such as existing transcription units and existing operons {e.g., atpE, accD). Such methods are described in, for example, U.S. Pat. App. Pub. 2004/0137631, which is incorporated herein by reference in its entirety. For an overview of other insertion sites used for integration of transgenes into the tobacco plastome, see Staub (Staub, J.M., "Expression of Recombinant Proteins via the Plastid Genome," in: Vinci VA, Parekh SR (eds.) Handbook of Industrial Cell Culture: Mammalian, and Plant Cells, pp. 259-278, Humana Press Inc., Totowa, NJ (2002)).

In general, the promoter can be from any class I, II or III gene. For example, any of the following plastidial promoters and/or transcription regulation elements can be used for expression in piastids. Sequences can be derived from the same species as that used for transformation. Alternatively, sequences can be derived from other species to decrease homology and to prevent homologous recombination with endogenous sequences. For instance, the following plastidial promoters can be used for expression in plastids.

PrbcL promoter (Allison LA, Simon LD, Maliga P, EMBO J.

15:2802-2809 (1996); Shiina T, Allison L, Maliga P_s Plant Cell 10:1713- 1722 (1998));

PpsbA promoter (Agrawal GK, Kato H, Asayama M, Shirai M, Nucleic Acids Research 29:1835-1843 (2001));

Prrn 16 promoter (Svab Z, Maliga P, Proc. Natl Acad. Sci. USA 90:913-917 (1993); Allison LA, Simon LD, Maliga P, EMBO J. 15:2802- 2809 (1996));

PaccD promoter (Hajdukiewicz PTJ, Allison LA, Maliga P, EMBO J 16:4041-4048 (1997); WO 97/06250);

PclpP promoter (Hajdukiewicz PTJ, Allison LA, Maliga P, EMBO J. 16:4041-4048 (1997); WO 99/46394);

PatpB, Patpl, PpsbB promoters (Hajdukiewicz PTJ, Allison LA,

Maliga P, EMBO J. 16:4041-4048 (1997));

PrpoB promoter (Liere K, Maliga P, EMBO J. 18:249-257 (1999));

PatpB/E promoter ( apoor S, Suzuki JY, Sugiura M, Plant J. 11:327- 337 (1997)).

In addition, prokaryotic promoters (such as those from, e.g., E. coli or

Synechocystis) or synthetic promoters can also be used.

Promoters vary in their strength, i.e., ability to promote transcription. Depending upon the host cell system utilized, any one of a number of suitable promoters known in the art may be used. For example, for constitutive expression, the CaMV 35S promoter, the rice actin promoter, or the ubiquitin promoter may be used. For example, for regulatable expression, the chemically inducible PR-1 promoter from tobacco or Arabidopsis may be used (see, e.g., U.S. Pat. No. 5,689,044 to Ryals, et al).

A suitable category of promoters is that which is wound inducible. Numerous promoters have been described which are expressed at wound sites. Preferred promoters of this kind include those described by Stanford et al. Mol Gen. Genet. 215: 200-208 (1989), Xu et al. Plant Molec. Biol. 22: 573-588 (1993), Logemann et al. Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Moke. Biol. 22: 129-142 (1993), and Warner et al. Plant J. 3: 191-201 (1993).

Suitable tissue specific expression patterns include green tissue specific, root specific, stem specific, and flower specific. Promoters suitable for expression in green tissue include many which regulate genes involved in photosynthesis, and many of these have been cloned from both

monocotyledons and dicotyledons. A suitable promoter is the maize PEPC promoter from the phosphoenol carboxylase gene (Hudspeth & Grula, Plant Molec. Biol. 12: 579-589 (1989)). A suitable promoter for root specific expression is that described by de Framond FEBS 290: 103-106 (1991); EP 0 452 269 to de Framond and a root-specific promoter is that from the T-l gene. A suitable stem specific promoter is that described in U.S. Pat. No. 5,625,136 and which drives expression of the maize trpA gene.

The promoter can be a relatively weak plant expressible promoter. Thus, the promoter can in some embodiments initiate and control

transcription of the operably linked nucleic acids about 10 to about 100 times less efficient that an optimal CaMV35S promoter. Relatively weak plant expressible promoters include the promoters or promoter regions from the opine synthase genes of Agrobacterium spp. such as the promoter or promoter region of the nopaline synthase, the promoter or promoter region of the octopine synthase, the promoter or promoter region of the mannopine synthase, the promoter or promoter region of the agropine synthase and any plant expressible promoter with comparably activity in transcription initation. Other relatively weak plant expressible promoters may be dehiscence zone selective promoters, or promoters expressed predominantly or selectively in dehiscence zone and/or valve margins of fruits, such as the promoters described in W097/13865.

Cis-regulatory elements from the promoter of photoperiod-responsive genes, coordinated motifs integrating hormones and stresses to photoperiod responses, and the promoters of photo-responsive genes such as those described in Mongkolsiriwatana C, Katsetsart J. (Nat. ScL) 43: 164-177 (2009), can also be used. 2. Transcriptional Terminators

A variety of transcriptional terminators are available for use in expression cassettes. These are responsible for the termination of

transcription beyond the transgene and its correct polyadenylation.

Appropriate transcriptional terminators are those that are known to function in plants and include the CaMV 35S terminator, the tml terminator, the nopahne synthase terminator and the pea rbcS E9 terminator. These are used in both monocotyledonous and dicotyledonous plants.

At the extreme 3' end of the transcript, a polyadenylation signal can be engineered. A polyadenylation signal refers to any sequence that can result in polyadenylation of the mRNA in the nucleus prior to export of the mRNA to the cytosol, such as the 3' region of nopahne synthase (Bevan, ML, et al, Nucleic Acids Res. , 11, 369-385 (1983)).

3. Sequences for Expression Enhancement or

Regulation

Numerous sequences have been found to enhance gene expression from within the transcriptional unit and these sequences can be used in conjunction with the genes to increase their expression in transgenic plants. For example, various intron sequences such as introns of the maize Adhl gene have been shown to enhance expression, particularly in

monocotyledonous cells. In addition, a number of non-translated leader sequences derived from viruses are also known to enhance expression, and these are particularly effective in dicotyledonous cells.

4. Coding Sequence Optimization

The coding sequence of the selected gene may be genetically engineered by altering the coding sequence for optimal expression (also referred to herein as "codon optimized") in the crop species of interest. Methods for modifying coding sequences to achieve optimal expression in a particular crop species are well known (see, e.g. Perlak et al., Proc, Natl. Acad. Set USA 88: 3324 (1991); and Koziel et al, Biotechnol. 11 : 194 (1993)). Therefore, in some embodiments, the disclosed nucleic acids sequences, or fragments or variants thereof, are genetically engineered for optimal expression in the crop species of interest. 5. Selectable Markers

Genetic constructs may encode a selectable marker to enable selection of plastid transformation events. There are many methods that have been described for the selection of transformed plants [for review see (Miki et al. , Journal of Biotechnology, 2004, 107, 193-232) and references incorporated within]. Selectable marker genes that have been used extensively in plants include the neomycin phosphotransferase gene nptll (U.S. Patent Nos. 5,034,322, U.S. 5,530,196), hygromycin resistance gene (U.S. Patent No. 5,668,298), the bar gene encoding resistance to

phosphinothricin (U.S. Patent No. 5,276,268), the expression of

aminoglycoside 3 "-adeny transferase (aadA) to confer spectinomycin resistance (U.S. Patent No. 5,073,675), the use of inhibition resistant 5- enolpyruvyl-3-phosphoshikimate synthetase (U.S. Patent No. 4,535,060) and methods for producing glyphosate tolerant plants (U.S. Patent No. 5,463,175; U.S. Patent No. 7,045,684). Methods of plant selection that do not use antibiotics or herbicides as a selective agent have been previously described and include expression of glucosamine-6-phosphate deaminase to inactive glucosamine in plant selection medium (U.S. Pat. No. 6,444,878) and a positive/negative system that utilizes D-amino acids (Erikson et al, Nat Biotechnol, 2004, 22, 455-8). European Patent Publication No. EP 0 530 129 A 1 describes a positive selection system which enables the transformed plants to outgrow the non-transformed lines by expressing a transgene encoding an enzyme that activates an inactive compound added to the growth media. U.S. Patent No. 5,767,378 describes the use of mannose or xylose for the positive selection of transgenic plants. Methods for positive selection using sorbitol dehydrogenase to convert sorbitol to fructose for plant growth have also been described (WO 2010/102293). Screenable marker genes include the beta- glucuronidase gene (Jefferson et al., 1987, EMBO J. 6: 3901-3907; U.S. Patent No. 5,268,463) and native or modified green fluorescent protein gene (Cubitt et al., 1995, Trends Biochem. Set 20: 448- 455; Pan et al, 1996, Plant Physiol 112: 893-900).

Transformation events can also be selected through visualization of fluorescent proteins such as the fluorescent proteins from the nonbioluminescent Anthozoa species which include DsRed, a red fluorescent protein from the Discosoma genus of coral (Mate et al. (1999), Nat

Biotechnol 17: 969-73). An improved version of the DsRed protein has been developed (Bevis and Glick (2002), Nat Biotech 20: 83-87) for reducing aggregation of the protein. Visual selection can also be performed with the yellow fluorescent proteins (YFP) including the variant with accelerated maturation of the signal (Nagai, T. et al. (2002), Nat Biotech 20: 87-90), the blue fluorescent protein, the cyan fluorescent protein, and the green fluorescent protein (Sheen et al. (1995), Plant J 8: 777-84; Davis and Vierstra (1998), Plant Molecular Biology 36: 521-528). A summary of fluorescent proteins can be found in Tzfira et al. (Tzfira et al. (2005), Plant Molecular Biology 57: 503-516) and Verkhusha and Lukyanov (Verkhusha, V. V. and . A. Lukyanov (2004),Nat Biotech 22: 289-296) whose references are incorporated in entirety. Improved versions of many of the fluorescent proteins have been made for various applications. Use of the improved versions of these proteins or the use of combinations of these proteins for selection of transformants will be obvious to those skilled in the art. It is also practical to simply analyze progeny from transformation events for the presence of the PHB thereby avoiding the use of any selectable marker.

For plastid transformation constructs, a preferred selectable marker is the spectinomycin-resistant allele of the plastid 16S ribosomal RNA gene (Staub JM, Maliga P, Plant Cell 4: 39-45 (1992); Svab Z, Hajdukiewicz P, Maliga P, Proc. Natl. Acad. Set USA 87: 8526-8530 (1990)). Selectable markers that have.. since been. successfully used in plastid transformation include the bacterial aadA gene that encodes aminoglycoside 3'- adenyltransferase (AadA) conferring spectinomycin and streptomycin resistance (Svab et al, Proc. Natl Acad. Set USA, 1993, 90, 913-917), nptll that encodes aminoglycoside phosphotransferase for selection on kanamycin (Carrer H, Hockenberry TN, Svab Z, Maliga P., Mol. Gen. Genet. 241 : 49-56 (1993); Lutz KA, et al, Plant J. 37: 906-913 (2004); Lutz KA, et al, Plant Physiol. 145: 1201-1210 (2007)), aphA6, another aminoglycoside phosphotransferase (Huang F-C, et al, Mol. Genet. Genomics 268: 19-27 (2002)), and chloramphenicol acetyltransferase (Li, W., et al. (2010), Plant Mol Biol, DOI 10.1007/s 11103-010-9678-4). Another selection scheme has been reported that uses a chimeric betaine aldehyde dehydrogenase gene (BADH) capable of converting toxic betaine aldehyde to nontoxic glycine betaine (Daniell H, et al., Curr. Genet. 39: 109-116 (2001)).

5. Targeting Sequences

The disclosed vectors and constructs may further include, within the region that encodes the protein to be expressed, one or more nucleotide sequences encoding a targeting sequence. A "targeting" sequence is a nucleotide sequence that encodes an amino acid sequence or motif that directs the encoded protein to a particular cellular compartment, resulting in localization or compartmentalization of the protein. Presence of a targeting amino acid sequence in a protein typically results in translocation of all or part of the targeted protein across an organelle membrane and into the organelle interior. Alternatively, the targeting peptide may direct the targeted protein to remain embedded in the organelle membrane. The

"targeting" sequence or region of a targeted protein may contain a string of contiguous amino acids or a group of noncontiguous amino acids. The targeting sequence can be selected to direct the targeted protein to a plant organelle such as a nucleus, a microbody (e.g., a peroxisome, or a specialized version thereof, such as a glyoxysome) an endoplasmic reticulum, an endosome, a vacuole, a plasma membrane, a cell wall, a mitochondria, a chloroplast or a plastid. A chloroplast targeting sequence is any peptide sequence that can target a protein to the chloroplasts or plastids, such as the transit peptide of the small subunit of the alfalfa ribulose-biphosphate carboxylase (Khoudi, et al, Gene, 197:343-351 (1997)). A peroxisomal targeting sequence refers to any peptide sequence, either N-terminal, internal, or C-terminal, that can target a protein to the peroxisomes, such as the plant C-terminal targeting tripeptide SKL (Banjoko, A. & Trelease, R. N. Plant Physiol, 107:1201-1208 (1995); T. P. Wallace et al, "Plant

Organellular Targeting Sequences," in Plant Molecular Biology, Ed. R. Croy, BIOS Scientific Publishers Limited (1993) pp. 287-288, and peroxisomal targeting in plant is shown in M. Volokita, The Plant J., 361- 366 (1991)). Plastid targeting sequences are known in the art and include the chloroplast small subunit of ribulose-l,5-bisphosphate carboxylase (Rubisco) (de Castro Silva Filho et al. Plant Mol. Biol. 30:769-780 (1996); Schnell et al. J. Biol. Chem. 266(5):3335~3342 (1991)); 5-(enolpyruvyl)shikimate-3- phosphate synthase (EPSPS) (Archer et al. J. Bioenerg. Biomemb.

22(6):789-810 (1990)); tryptophan synthase (Zhao et al. J. Biol. Chem. 270(l l):6081-6087 (1995)); plastocyanin (Lawrence et al. J. Biol. Chem. 272(33):20357-20363 (1997)); chorismate synthase (Schmidt et al. J. Biol. Chem. 268(36):27447-27457 (1993)); and the light harvesting chlorophyll a/b binding protein (LHBP) (Lamppa et al. J. Biol. Chem. 263: 14996-14999 (1988)). See also Von Heijne et al. Plant Mol. Biol. Rep. 9:104-126 (1991); Clark et al. J. Biol. Chem. 264:17544-17550 (1989); Della-Cioppa et al Plant Physiol 84:965-968 (1987); Romer et al. Biochem. Biophys. Res. Commun. 196:1414-1421 (1993); and.Shah et al. Science 233:478-481 (1986). Alternative plastid targeting signals have also been described in the following: US 2008/0263728; Miras, S. et al. (2002), J Biol Chem 277(49): 47770-8; Miras, S. et al. (2007), J Biol Chem 282: 29482-29492.

6. Plants and Tissues for Transfection Both dicotyledons ("dicots") and monocotyledons ("monocots") can be used in the disclosed positive selection system. Monocot seedlings typically have one cotyledon (seed-leaf), in contrast to the two cotyledons typical of dicots. Eudicots are dicots whose pollen has three apertures (i.e. triaperturate pollen), through one of which the pollen tube emerges during pollination. Eudicots contrast with the so-called 'primitive' dicots, such as the magnolia family, which have uniaperturate pollen (i.e. with a single aperture).

Monocots include one of the large divisions of Angiosperm plants (flowering plants with seeds protected within a vessel). They are herbaceous plants with parallel veined leaves and have an embryo with a single cotyledon, as opposed to dicot plants (dicotyledonous), which have an embryo with two cotyledons. Most of the important staple crops of the world, the so-called cereals, such as wheat, barley, rice, maize, sorghum, oats, rye and millet, are monocots. Thus, the plant can be a grass, such as wheat, barley, rice, maize, sorghum, oats, rye and millet.

The plant can therefore be a cereal crop such as wheat, oat, barley, or rice; a forage such as bahiagrass, dallisgrass, kleingrass, guineagrass, reed canary grass, orchardgrass, ricegrass, foxtail, or vetch; a legume such as soybean, lentil, or chickpea; an oilseed such as canola; a vegetable such as onion or carrot; or a specialty crop such as caraway, hemp, or sesame.

In some embodiments, the plant is a sorghum. For example, the plant can be of the species Sorghum almum, Sorghum amplum, Sorghum angustum, Sorghum arundinaceum, Sorghum bicolor, Sorghum

brachypodum, Sorghum bulbosum, Sorghum burmahicum, Sorghum controversum, Sorghum drummondii, Sorghum ecarinatum, Sorghum exstans, Sorghum grande, Sorghum halepense, Sorghum interjectum, Sorghum intrans, Sorghum laxiflorum, Sorghum leiocladum, Sorghum macrospermum, Sorghum matarankense, Sorghum miliaceum, Sorghum nigrum, Sorghum nitidum, Sorghum plumosum, Sorghum propinquum, Sorghum purpureosericeum, Sorghum stipoideum, Sorghum timorense, Sorghum trichocladum, Sorghum versicolor, Sorghum virgatum, or Sorghum vulgare

In some embodiments, the plant is a miscanthus. Thus, the plant can be of the species Miscanthus floridulus, Miscanthus x. giganteus, Miscanthus sacchariflorus (Amur silver-grass), Miscanthus sinensis, Miscanthus tinctorius, or Miscanthus transmorrisonensis.

Additional representative plants useful in the compositions and methods disclosed herein include the Brass ica family including sp. napus, rapa, oleracea, nigra, carinata and juncea industrial oilseeds such as Camelina sativa, Crambe, Jatropha, castor; Arabidopsis thaliana; soybean; cottonseed; sunflower; palm; coconut; rice; safflower; peanut; mustards including Sinapis alba; sugarcane and flax.

Crops harvested as biomass, such as silage corn, alfalfa, switchgrass, or tobacco, also are useful with the methods disclosed herein. Representative tissues for transformation using these vectors include protoplasts, cells, callus tissue, leaf discs, pollen, and meristems. IV. Methods of Making Transgenic Plants

A. Plant Transformation Techniques

The transformation of suitable agronomic plant hosts using vectors expressing transgenes can be accomplished with a variety of methods and plant tissues. Representative transformation procedures include

Agrobacterium-mediated transformation, biolistics, microinjection, electroporation, polyethylene glycol-mediated protoplast transformation, liposome-mediated transformation, and silicon fiber-mediated transformation (U.S. Patent No. 5,464,765 to Coffee, et al; "Gene Transfer to Plants" (Potrykus, et al, eds.) Springer-Verlag Berlin Heidelberg New York (1995); "Transgenic Plants: A Production System for Industrial and Pharmaceutical Proteins" (Owen, et al, eds.) John Wiley & Sons Ltd. England (1996); and "Methods in Plant Molecular Biology: A Laboratory Course Manual" (Maliga etal. eds.) Cold Spring Laboratory Press, New York (1995)).

Plants can be transformed by a number of reported procedures (U.S.

Patent Nos. 5,015,580 to Christou, et al; 5,015,944 to Bubash; 5,024,944 to Collins, et al; 5,322,783 to Tomes et al; 5,416,011 to Hinchee et al. ;

5,169,770 to Chee et al). A number of transformation procedures have been reported for the production of transgenic maize plants including pollen transformation (U.S. Patent No. 5,629,183 to Saunders et al.), silicon fiber- mediated transformation (U.S. Patent No. 5,464,765 to Coffee et al), electroporation of protoplasts (U.S. Patent Nos. 5,231,019 Paszkowski et al; 5,472,869 to Kxzyzek et al; 5,384,253 to Krzyzek et al), gene gun (U.S. Patent Nos. 5,538,877 to Lundquist et al and 5,538,880 to Lundquist et al), and Agrobacter /wm-mediated transformation (EP 0 604 662 Al and WO 94/00977 both to Hiei Yukou et al). The Agrobacterium-mediated procedure is particularly preferred as single integration events of the transgene constructs are more readily obtained using this procedure which greatly facilitates subsequent plant breeding. Cotton can be transformed by particle bombardment (U.S. Patent Nos. 5,004,863 to Umbeck and 5,159,135 to Umbeck). Sunflower can be transformed using a combination of particle bombardment and Agrobacterium infection (EP 0486 233 A2 to Bidney, Dennis; U.S. Patent No. 5,030,572 to Power et al). Flax can be transformed by either particle bombardment or Agrobacterium-mediated transformation. Switchgrass can be transformed using either biolistic or Agrobacterium mediated methods (Richards et al. Plant Cell Rep. 20: 48-54 (2001);

Somleva et al Crop Science 42: 2080-2087 (2002)). Methods for sugarcane transformation have also been described (Franks & Birch Aust. J. Plant Physiol. 18, 471-480 (1991); WO 2002/037951 to Elliott, Adrian, Ross et al).

Recombinase technologies which are useful in practicing the current invention include the cre-lox, FLP/FRT and Gin systems. Methods by which these technologies can be used for the purpose described herein are described for example in (U.S. Patent No. 5,527,695 to Hodges et al.; Dale and Ow, Proc. Natl Acad. Set USA, 88:10558-10562 (1991); Medberry et al, Nucleic Acids Res., 23: 485-490 (1995)).

Engineered minichromosomes can also be used to express one or more genes in plant cells. Cloned telomeric repeats introduced into cells may truncate the distal portion of a chromosome by the formation of a new telomere at the integration site. Using this method, a vector for gene transfer can be prepared by trimming off the arms of a natural plant chromosome and adding an insertion site for large inserts (Yu et al, Proc Natl AcadSci USA, 103:17331-6 (2006); Yu et al, Proc Natl AcadSci USA, 104:8924-9 (2007)). The utility of engineered minichromosome platforms has been shown using Cre//ox and FRT/FLP site-specific recombination systems on a maize minichromosome where the ability to undergo recombination was demonstrated (Yu et al, Proc Natl Acad Sci U SA, 103:17331-6 (2006); Yu et al, Proc Natl Acad Sci USA, l 04:8924-9 (2007)). Such technologies could be applied to minichromosomes, for example, to add genes to an engineered plant. Site specific recombination systems have also been demonstrated to be valuable tools for marker gene removal Kerbach, S. et al. heor. Appl. Genet. 111 :1608-1616 (2005)), gene targeting (Chawla, R et al, Plant Biotechnol .J 4:209-218 (2006); Choi, S. el al, Nucleic Acids Res., 28, El 9 (2000); Srivastava V & Ow DW, Plant Mol Biol. 46:561-566 (2001); Lyznik LA et al, Nucleic Acids Res., 21 : 969-975 (1993)) and gene conversion (Djukanovic V et al, Plant Biotechnol ., 4:345-357 (2006). An alternative approach to chromosome engineering in plants involves in vivo assembly of autonomous plant mmichromosomes (Carlson et al, PLoS Genet., 3:1965-74 (2007). Plant cells can be transformed with centromeric sequences and screened for plants that have assembled autonomous chromosomes de novo. Useful constructs combine a selectable marker gene with genomic DNA fragments containing centromeric satellite and retroelement sequences and/or other repeats.

Another approach useful to the described invention is Engineered Trait Loci ("ETL") technology (US Patent 6,077,697; US Patent Application 2006/0143732). This system targets DNA to a heterochromatic region of plant chromosomes, such as the pericentric heterochromatin, in the short arm of acrocentric chromosomes. Targeting sequences may include ribosomal DNA (rDNA) or lambda phage DNA. The pericentric rDNA region supports stable insertion, low recombination, and high levels of gene expression. This technology is also useful for stacking of multiple traits in a plant (US Patent.Application 2006/0246586).

Zinc-finger nucleases (ZFNs) are also useful for practicing the invention in that they allow double strand DNA cleavage at specific sites in plant chromosomes such that targeted gene insertion or deletion can be performed (Shukla etaL, Nature, (2009); Townsend et al, Nature, (2009).

Following transformation by any one of the methods described above, the following procedures can, for example, be used to obtain a transformed plant expressing the transgenes: select the plant cells that have been transformed on a selective medium, regenerate the plant cells that have been transformed to produce differentiated plants, select transformed plants expressing the transgene producing the desired level of desired

polypeptide(s) in the desired tissue and cellular location.

Transformation techniques for dicotyledons are well known in the art and include Agrobacterium-bascd techniques and techniques that do not require Agrobacterium. on-Agrobacterium techniques involve the uptake of heterologous genetic material directly by protoplasts or cells. This is accomplished by PEG or electroporation mediated uptake, particle bombardment-mediated delivery, or microinjection. In each case the transformed cells may be regenerated to whole plants using standard techniques known in the art.

Transformation of most monocotyledon species has now become somewhat routine. Preferred techniques include direct gene transfer into protoplasts using PEG or electroporation techniques, particle bombardment into callus tissue or organized structures, as well as Agrobacterium-mediated transformation.

Plants from transformation events are grown, propagated and bred to yield progeny with the desired trait, and seeds are obtained with the desired trait, using processes well known in the art.

B. Plastid Transformation

In another embodiment the transgene is directly transformed into the plastid genome. Plastid transformation technology is extensively described in U.S. Patent Nos. 5,451,513 to Maliga et al, 5,545,817 to McBride et al, and 5,545,818 to McBride et al. , in PCT application no. WO 95/16783 to

McBride et al, and in McBride et al. Proc. Natl Acad. Sci. USA 91,7301- 7305 (1994). The basic technique for chloroplast transformation involves introducing regions of cloned plastid DNA flanking a selectable marker together with the gene of interest into a suitable target tissue, e.g., using bioKstics or protoplast transformation (e.g., calcium chloride or PEG mediated transformation). The 1 to 1.5 kb flanking regions, termed targeting sequences, facilitate homologous recombination with the plastid genome and thus allow the replacement or modification of specific regions of the plastome. Suitable plastids that can be transfected include, but are not limited to, chloroplasts, etioplasts, chromoplasts, leucoplasts, amyloplasts, proplastids, statoliths, elaioplasts, proteinoplasts and combinations thereof.

C. Methods for Reproducing Transgenic Plants

Following transformation by any one of the methods described above, the following procedures can be used to obtain a transformed plant expressing the transgenes: select the plant cells that have been transformed on a selective medium; regenerate the plant cells that have been transformed to produce differentiated plants; select transformed plants expressing the transgene producing the desired level of desired polypeptide(s) in the desired tissue and cellular location.

In plastid transformation procedures, further rounds of regeneration of plants from explants of a transformed plant or tissue can be performed to increase the number of transgenic plastids such that the transformed plant reaches a state of homoplasmy (all plastids contain uniform plastomes containing transgene insert).

The cells that have been transformed may be grown into plants in accordance with conventional techniques. See, for example, McCormick et al Plant Cell Reports 5:81-84(1986). These plants may then be grown, and either pollinated with the same transformed variety or different varieties, and the resulting hybrid having constitutive expression of the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that constitutive expression of the desired phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure constitutive expression of the desired phenotypic characteristic has been achieved.

In some scenarios, it may be advantageous to insert a multi-gene pathway into the plant by crossing of lines containing portions of the pathway to produce hybrid plants in which the entire pathway has been reconstructed. This is especially the case when high levels of product in a seed compromises the ability of the seed to germinate or the resulting seedling to survive under normal soil growth conditions. Hybrid lines can be created by crossing a line containing one or more PHB genes with a line containing the other gene(s) needed to complete the PHB biosynthetic pathway. Use of lines that possess cytoplasmic male sterility (Esser, K. et al., 2006, Progress in Botany, Springer Berlin Heidelberg. 67, 31-52) with the appropriate maintainer and restorer lines allows these hybrid lines to be produced efficiently. Cytoplasmic male sterility systems are already available for some Brassicaceae species (Esser, K. et al., 2006, Progress in Botany, Springer Berlin Heidelberg. 67, 31-52). These Brassicaceae species can be used as gene sources to produce cytoplasmic male sterility systems for other oilseeds of interest such as Camelina. V. Screening Methods

Methods are also provided for identifying treatments, such as chemical treatments, that can modify photoperiod sensitivity in a plant.

In some embodiments, the method involves administering a candidate agent to a transgenic plant disclosed herein and comparing the effect of the administration on photoperiod sensitivity in the plant to a control. For example, the purpose of the method can be to identify an agent that causes the transgenic plant to delay or prevent flowering.

In some embodiments, the method involves contacting cells expressing an Mai gene disclosed herein with a candidate agent, monitoring the effect of the candidate agent on Mai gene expression, and comparing the effect of the candidate agent on Mai gene expression to a control. For example, the purpose of the method can be to identify an agent that promotes Mai gene expression. In these embodiments, an increase in Mai gene expression would identify an agent that could be used to increase

photoperiod sensitivity. Likewise, the purpose of the method can be to identify an agent that inhibits Mai gene expression. In these embodiments, a decrease in Mai gene expression would identify an agent that could be used to reduce photoperiod sensitivity.

Mai gene expression can be detected using routine methods, such as immunodetection methods. The methods can be cell-based or cell-free assays. The steps of various useful immunodetection methods have been described in the scientific literature, such as, e.g., Maggio et al., Enzyme- Immunoassay, (1987) and Nakamura, et al., Enzyme Immunoassays:

Heterogeneous and Homogeneous Systems, Handbook of Experimental

Immunology, Vol. 1 : Immunochemistry, 27.1-27.20 (1986), each of which is incorporated herein by reference in its entirety and specifically for its teaching regarding immunodetection methods, immunoassays, in their most simple and direct sense, are binding assays involving binding between antibodies and antigen. Many types and formats of immunoassays are known and all are suitable for detecting the disclosed biomarkers. Examples of immunoassays are enzyme linked immunosorbent assays (ELISAs), radioimmunoassays (RIA), radioimmune precipitation assays (RIP A), immunobead capture assays, Western blotting, dot blotting, gel-shift assays, Flow cytometry, protein arrays, multiplexed bead arrays, magnetic capture, in vivo imaging, fluorescence resonance energy transfer (FRET), and fluorescence recovery /localization after photobleaching (FRAP/ FLAP).

In some embodiments, a reporter construct, such as a fiuorochrome or enzyme, is operably linked to an Mai expression control sequence. In these embodiments, the purpose of the method can be to identify an agent that modulates activation of the Mai expression control sequence by detecting the affect of a candidate agent on reporter expression.

In general, candidate agents can be identified from large libraries of natural products or synthetic (or semi-synthetic) extracts or chemical libraries according to methods known in the art. Those skilled in the field of drug discovery and development will understand that the precise source of test extracts or compounds is not critical to the disclosed screening procedure. Accordingly, virtually any number of chemical extracts or compounds can be screened using the exemplary methods described herein. Examples of such extracts or compounds include, but are not limited to, plant-, fungal-, prokaryotic- or animal-based extracts, fermentation broths, and synthetic compounds, as well as modification of existing compound ¾. Numerous methods are also available for generating random or directed synthesis (e.g., semi-synthesis or total synthesis) of any number of chemical compounds.

Synthetic compound libraries are commercially available, e.g., from Brandon Associates (Merrimack, NH) and Aldrich Chemical (Milwaukee, WI). Alternatively, libraries of natural compounds in the form of bacterial, fungal, plant, and animal extracts are commercially available from a number of sources, including Biotics (Sussex, UK), Xenova (Slough, UK), Harbor Branch Oceangraphics Institute (Ft. Pierce, Fla.), and PharmaMar, U.S.A. (Cambridge, Mass.). In addition, natural and synthetically produced libraries are produced, if desired, according to methods known in the art, e.g., by standard extraction and fractionation methods. Furthermore, if desired, any library or compound is readily modified using standard chemical, physical, or biochemical methods. When a crude extract is found to have a desired activity, further fractionation of the positive lead can be used to isolate chemical constituents responsible for the observed effect. Thus, the goal of the extraction, fractionation, and purification process is the careful characterization and identification of a chemical entity within the crude extract having the activity. The same assays described herein for the detection of activities in mixtures of compounds can be used to purify the active component and to test derivatives thereof. Methods of fractionation and purification of such heterogenous extracts are known in the art. If desired, compounds shown to be useful agents for treatment are chemically modified according to methods known in the art. Compounds identified as being of therapeutic value may be subsequently analyzed using animal models for diseases or conditions, such as those disclosed herein.

.. Candidate agents encompass numerous chemical classes, but are most often organic molecules, e.g., small organic compounds having a molecular weight of more than 100 and less than about 2,500 daltons. Candidate agents comprise functional groups necessary for structural interaction with proteins, particularly hydrogen bonding, and typically include at least an amine, carbonyl, hydroxyl orearboxyl group, for example, at least two of the functional chemical groups. The candidate agents often comprise cyclical carbon or heterocyclic structures and/or aromatic or polyaromatic structures substituted with one or more of the above functional groups. Candidate agents are also found among biomolecules including peptides, saccharides, fatty acids, steroids, purines, pyrimidines, derivatives, structural analogs or combinations thereof. In a further embodiment, candidate agents are peptides.

VI. Methods of Identifying Photoperiod Sensitivity Genes in Related Plants

Methods are also provided for identifying genes that control photoperiod sensitivity in other plants. Therefore, methods for identifying maturity gene orthologues in plants are provided. The methods generally involve using the gene sequences for Mai in S. bicolor or S. propinquum disclosed herein. in preferred embodiments, the plant is closely related to Sorghum bicolor. Thus, in some embodiments, the plant is a Sorghum, Miscanthus, or Saccharum. In some embodiments, the method involves scanning the genetic sequences of a plant for genes that are orthologous to Mai .

In some embodiments, the method involves conducting a BLAST search of plant genomes for genes having the highest nucleic acid sequence identity to that of Mai in S. bicolor or S. propinquum. For example, the orthologous gene can have 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, or a nucleic acid encoding the amino acid sequence of SEQ ID NO:8 or 34, or a fragment or variant thereof.

VII. Methods of Genotyping Photoperiod Sensitive Flowering

A. Haplotypes

The sequences disclosed herein can be used to screen for photoperiod sensitive flowering in plants. For example, the genotype of one or more insertions, deletions, and polymorphisms in or around S. bicolor Mai relative to S. propinquum Mai , and can be used to phenotype a plant as photoperiod sensitive (i.e., having the S. propinquum genotype) or photoperiod insensitive (i.e., having the S. bicolor). For example, deletions, insertions, and polymorphisms can be determined by comparing SEQ ID NO: 1, 3, or 5-oiS. propinquum Mai to SEQ ID NO: 9 or 12 of S. bicolor using global sequence alignment tools, and include, but are not limited to the insertions, deletions, and polymorphisms specifically disclosed above and in Figure 3 A below.

For example, the exons of short-day S. propinquum and day neutral S. bicolor differ by five synonymous mutations: C -> T at position 47; C -> T at position 126; A -> G at position 159; T -> G at position 351; and A -> C at position 543 of SEQ ID NO:7 (S. propinquum) relative to SEQ ID NO:l 1 (S. bicolor). These single nucleotide polymorphisms (SNPs) within the Mai gene locus can serve as a haplotype for photoperiod sensitivity. As used herein, the term "haplotype" refers to the allelic pattern of a group of

(usually contiguous) DNA markers or other polymorphic loci along an individual chromosome or double helical DNA segment.

Having three, four or five of the S. propinquum SNPs can be diagnostic of a photoperiod sensitive plant (i.e., short day flowering), while having three, four or five of the S. bicolor SNPs can be diagnostic of a photoperiod insensitive plant (i.e., day-neutral flowering). A plant is photoperiod sensitive plant (i.e., short day flowering) when it has all five S. propinquum SNPs. A plant is photoperiod insensitive plant (i.e., day-neutral flowering), when it has all five S. bicolor SNPs. For example, C:C:A:T:C relative to positions 47:126: 159:351 :543 of SEQ ID NO:7 is indicative of a photoperiod sensitive (short day flowering) plant, while T:T:G:G:C relative to positions 47:126:159:351 :543 of SEQ ID O:l l is indicative of a photoperiod insensitive (day-neutral flowering) plant.

In some embodiments, there is a correlation between the number of S. propinquum SNPs and level of photoperiod sensitivity. For example, an increasing number of S. propinquum SNPs relative to S. bicolor SNPs is correlated with increasing photoperiod sensitivity.

As described in more detail below, it is understood that genomic DNA will typically be used for determining the SNP genotype of a plant of interest. Methods of aligning sequences are known in the art, and described herein. One of skill in the art can readily identify the positions of the above- disclosed SNPs within genomic sequences, including but not limited to those disclosed herein, such as SEQ ID NO: 1, 2, 3, 4, 5, 6, 9, 10, 12, 13, or a nucleic acid encoding the amino acid sequence of SEQ ID NO: 8 or 34, or variants, fragments, homologs, or orthologs thereof, by aligning the sequence of SEQ ID NO: 7 or 11 to the genomic sequence.

Increased height naturally confers a competitive advantage in light interception. As discussed in the Examples below, favorable alleles at different genes that conferred both optimal height and flowering time to the same progeny by virtue of the suppressed recombination in this genomic region, might have become fixed more quickly than independently- segregating alleles. Accordingly, the S. propinquum haplotype of C:C:A:T:C at positions 47:126:159:351 :543 of SEQ ID NO:7 is diagnostic of increased height relative to the S. bicolor haplotype of T:T:G:G:C at positions 47:126:159:351 :543 of SEQ ID NO: 11.

B. Methods for detecting SNPs and haplotypes

The process of determining which specific nucleotide (i.e., allele) is present at each of one or more SNP positions, such as a disclosed SNP position in the Mai gene locus, is referred to as SNP genotyping. Methods for SNP genotyping are generally known in the art (Chen et al.,

Pharmacogenomics J. , 3(2):77-96 (2003); Kwok, et al., Curr. Issues Mol. Biol. , 5(2):43-60 (2003); Shi, Am. J. Pharmacogenomics, 2(3): 197-205 (2002); and Kwok, Annu. Rev. Genomics Hum. Genet., 2:235-58 (2001)).

SNP genotyping can include the steps of collecting a biological sample from a plant, isolating genomic D A from the cells of the sample, contacting the nucleic acids with one or more primers which specifically hybridize to a region of the isolated nucleic acid containing a target SNP under conditions such that hybridization and amplification of the target nucleic acid region occurs, and determining the nucleotide present at the SNP position of interest, or, in some assays, detecting the presence or absence of an amplification product (assays can be designed so that hybridization and/or amplification will only occur if a particular SNP allele is present or absent). In some assays, the size of the amplification product is detected and compared to the length of a control sample; for example, deletions and insertions can be detected by a change in size of the amplified product compared to a normal genotype.

The neighboring sequence can be used to design SNP detection reagents such as oligonucleotide probes and primers. In some embodiment probe or primers are designed based on the cDNA of S. propinq wn (SEQ ID NO:7), or S. bicolor (SEQ ID NO: 11), In some embodiments, it may desirable for the probe or primer to bind non-coding regions of the Mai gene. Accordingly, one of skill in the art can map the above disclosed haplotype to the genomic sequence of Mai, such as SEQ ID NO:l, 2, 3, 4, 5, or 6 of S. propinquum, or SEQ ID NO: 9, 10, 12, or 13 of S. bicolor for the purpose of designing the SNP probes or primers. UGA 1540 PCX

Common SNP genotyping methods include, but are not limited to, TaqMan assays, molecular beacon assays, nucleic acid arrays, allele- specific primer extension, allele-specific PCR, arrayed primer extension,

homogeneous primer extension assays, primer extension with detection by mass spectrometry, pyrosequencing, multiplex primer extension sorted on genetic arrays, ligation with rolling circle amplification, homogeneous ligation, multiplex ligation reaction sorted on genetic arrays, restriction- fragment length polymorphism, single base extension-tag assays, and the Invader assay. Such methods may be used in combination with detection mechanisms such as, for example, luminescence or chemiluminescence . detection, fluorescence detection, time-resolved fluorescence detection, fluorescence resonance energy transfer, fluorescence polarization, mass spectrometry, and electrical detection.

SNPs can be scored by direct DNA sequencing. A variety of automated sequencing procedures can be utilized, including sequencing by mass spectrometry. Methods for amplifying DNA fragments and sequencing them are well known in the art.

Other .suitable methods for detecting polymorphisms include methods in which protection from cleavage agents is used to detect mismatched bases in NA/RNA or RNA/DNA duplexes (Myers et al., Science, 230: 1242 (1985); Cotton, et al, PNAS, 85:4397 (1988); and Saleeba, et al., Meth. Enzymol, 217:286-295 (1992)), comparison of the electrophoretic mobility of variant and wild type nucleic acid molecules (Orita et al., PNAS, 86:2766 (1989); Cotton, et al, Mutat. Res., 285:125-144 (1993); and Hayashi, et al., Genet. Anal. Tech. Appl, 9:73-79 (1992)), and assaying the movement of polymorphic or wild-type fragments in polyacrylamide gels containing a gradient of denaturant using denaturing gradient gel electrophoresis (DGGE) (Myers et al._s Nature, 313:495 (1985)). Sequence variations at specific locations can also be assessed by nuclease protection assays such as RNase and SI protection or chemical cleavage methods.

In one embodiment, SNP genotyping is performed using the

TaqMan^® assay, which is also known as the 5' nuclease assay. The

TaqMan^® assay detects the accumulation of a specific amplified product during PCR. The TaqMan assay utilizes an oligonucleotide probe labeled with a fluorescent reporter dye and a quencher dye. The reporter dye is excited by irradiation at an appropriate wavelength, it transfers energy to the quencher dye in the same probe via a process called fluorescence resonance energy transfer (FRET). When attached to the probe, the excited reporter dye does not emit a signal. The proximity of the quencher dye to the reporter dye in the intact probe maintains a reduced fluorescence for the reporter. The reporter dye and quencher dye may be at the S'-most and the 3'-most ends, respectively, or vice versa. Alternatively, the reporter dye may be at the 5'- or 3'-most end while the quencher dye is attached to an internal nucleotide, or vice versa. In yet another embodiment, both the reporter and the quencher may be attached to internal nucleotides at a distance from each other such that fluorescence of the reporter is reduced.

During PCR, the 5' nuclease activity of D A polymerase cleaves the probe, thereby separating the reporter dye and the quencher dye and resulting in increased fluorescence of the reporter. Accumulation of PCR product is detected directly by monitoring the increase in fluorescence of the reporter dye. The DNA polymerase cleaves the probe between the reporter dye and the quencher dye only if the probe hybridizes to the target SNP-containing template which is amplified during PCR, and the probe is designed to hybridize to the target SNP site only if a particular SNP allele is present.

Another method for genotyping SNPs is the use of two

oligonucleotide probes in an OLA (U.S. Pat. No. 4,988,617). In this method, one probe hybridizes to a segment of a target nucleic acid with its 3'-most end aligned with the SNP site. A second probe hybridizes to an adjacent segment of the target nucleic acid molecule directly 3' to the first probe. The two juxtaposed probes hybridize to the target nucleic acid molecule, and are ligated in the presence of a linking agent such as a ligase if there is perfect complementarity between the 3¹ most nucleotide of the first probe with the SNP site. If there is a mismatch, ligation would not occur. After the reaction, the ligated probes are separated from the target nucleic acid molecule, and detected as indicators of the presence of a SNP. Another method for SNP genotyping is based on mass spectrometry. Mass spectrometry takes advantage of the unique mass of each of the four nucleotides of DNA. SNPs can be unambiguously genotyped by mass spectrometry by measuring the differences in the mass of nucleic acids having alternative SNP alleles. MALDI-TOF {Matrix Assisted Laser Desorption Ionization-Time of Flight) mass spectrometry technology is useful for extremely precise determinations of molecular mass, such as SNPs. Numerous approaches to SNP analysis have been developed based on mass spectrometry. Exemplary mass spectrometry-based methods of SNP genotyping include primer extension assays, which can also be utilized in combination with other approaches, such as traditional gel-based formats and microarrays.

Typically, the primer extension assay involves designing and annealing a primer to a template PCR amplicon upstream (5^r) from a target SNP position. A mix of dideoxynucleotide triphosphates (ddNTPs) and/or deoxynucleotide triphosphates (dNTPs) are added to a reaction mixture containing template (e.g., a SNP-containing nucleic acid molecule which has typically been amplified, such as by PCR), primer, and DNA polymerase. Extension of the primer terminates at the first position in the template where a nucleotide complementary to one of the ddNTPs in the mix occurs. The primer can be either immediately adjacent (i.e., the nucleotide at the 3' end of the primer hybridizes to the nucleotide next to the target SNP site) or two or more nucleotides removed from the SNP position. If the primer is several nucleotides removed from the target SNP position, the only limitation is that the template sequence between the 3* end of the primer and the SNP position cannot contain a nucleotide of the same type as the one to be detected, or this will cause premature termination of the extension primer. Alternatively, if all four ddNTPs alone, with no dNTPs, are added to the reaction mixture, the primer will always be extended by only one nucleotide, corresponding to the target SNP position. In this instance, primers are designed to bind one nucleotide upstream from the SNP position (i.e., the nucleotide at the 3' end of the primer hybridizes to the nucleotide that is immediately adjacent to the target SNP site on the 5' side of the target SNP site). Extension by only one nucleotide is preferable, as it minimizes the overall mass of the extended primer, thereby increasing the resolution of mass differences between alternative SNP nucleotides. Furthermore, mass-tagged ddNTPs can be employed in the primer extension reactions in place of unmodified ddNTPs. This increases the mass difference between primers extended with these ddNTPs, thereby providing increased sensitivity and accuracy, and is particularly useful for typing heterozygous base positions. Mass-tagging also alleviates the need for intensive sample-preparation procedures and decreases the necessary resolving power of the mass spectrometer. The extended primers can then be purified and analyzed by MALDI-TOF mass spectrometry to determine the identity of the nucleotide present at the target SNP position.

Other methods that can be used to genotype the SNPs include single- strand conformational polymorphism (SSCP), and denaturing gradient gel electrophoresis (DGGE). SSCP identifies base differences by alteration in electrophoretic migration of single stranded PCR products. Single-stranded PCR products can be generated by heating or otherwise denaturing double stranded PCR products. Single-stranded nucleic acids may refold or form secondary structures that are partially dependent on the base sequence. The different electrophoretic mobilities of single-stranded amplification products are related to base-sequence differences at SNP positions. DGGE differentiates SNP alleles based on the different sequence-dependent stabilities and melting properties inherent in polymorphic DNA and the corresponding differences in electrophoretic migration patterns in a denaturing gradient gel.

Sequence-specific ribozymes (U.S. Pat. No. 5,498,531) can also be used to score SNPs based on the development or loss of a ribozyme cleavage site. Perfectly matched sequences can be distinguished from mismatched sequences by nuclease cleavage digestion assays or by differences in melting temperature. If the SNP affects a restriction enzyme cleavage site, the SNP can be identified by alterations in restriction enzyme digestion patterns, and the corresponding changes in nucleic acid fragment lengths determined by gel electrophoresis. C. SNP detection kits

Detection reagents can be developed and used to assay the disclosed SNPs individually or in combination, and such detection reagents can be readily incorporated into a kit or system format. The terms "kits" and "systems", as used herein in the context of SNP detection reagents, are intended to refer to such things as combinations of multiple SNP detection reagents, or one or more SNP detection reagents in combination with one or more other types of elements or components (e.g., other types of biochemical reagents, containers, packages such as packaging intended for commercial sale, substrates to which SNP detection reagents are attached, electronic hardware components, etc.). SNP detection kits and systems, including but not limited to, packaged probe and primer sets (e.g., TaqMan probe/primer sets), arrays/microarrays of nucleic acid molecules, and beads that contain one or more probes, primers, or other detection reagents for detecting one or more of the disclosed SNPs are provided. The kits/systems can optionally include various electronic hardware components; for example, arrays ("DNA chips") and microfluidic systems ("lab-on-a-chip" systems) provided by various manufacturers typically comprise hardware components. Other kits/systems (e.g., probe/primer sets) may not include electronic hardware components, but may be comprised of, for example, one or more SNP detection reagents (along with, optionally, other biochemical reagents) packaged in one or more containers.

In some embodiments, a SNP detection kit typically contains one or more detection reagents and other components (e.g., a buffer, enzymes such as DNA polymerases or ligases, chain extension nucleotides such as deoxynucleotide triphosphates, and in the case of Sanger-type DNA sequencing reactions, chain terminating nucleotides, positive control sequences, negative control sequences, and the like) necessary to carry out an assay or reaction, such as amplification and/or detection of a SNP-containing nucleic acid molecule. A kit may further contain means for determining the amount of a target nucleic acid, and means for comparing the amount with a standard, and can comprise instructions for using the kit to detect the SNP- containing nucleic acid molecule of interest. In one embodiment, kits are provided which contain the necessary reagents to carry out one or more assays to detect one or more of the disclosed SNPs. In an exemplary embodiment, SNP detection kits/systems are in the form of nucleic acid arrays, or compartmentalized kits, including microfluidic/lab-on-a-chip systems.

SNP detection kits may contain, for example, one or more probes, or pairs of probes, that hybridize to a nucleic acid molecule at or near each target SNP position. Multiple pairs of allele-specific probes may be included in the kit/system to simultaneously assay large numbers of SNPs. In some kits, the allele-specific probes are immobilized to a substrate such as an an'ay or bead.

The terms "arrays", "microarrays", and "DNA chips" are used herein interchangeably to refer to an array of distinct polynucleotides affixed to a substrate, such as glass, plastic, paper, nylon or other type of membrane, filter, chip, or any other suitable solid support. The polynucleotides can be synthesized directly on the substrate, or synthesized separate from the substrate and then affixed to the substrate.

Any number of probes, such as allele-specific probes, may be implemented in an array, and each probe or pair of probes can hybridize to a different SNP position. In the case of polynucleotide probes, they can be synthesized at designated areas (or synthesized separately and then affixed to designated areas) on a substrate using a light-directed chemical process. Each DNA chip can contain, for example, thousands to millions of individual synthetic polynucleotide probes arranged in a grid-like pattern and miniaturized. Probes can be attached to a solid support in an ordered, addressable array.

A microarray can be composed of a large number of unique, single- stranded polynucleotides, usually either synthetic antisense polynucleotides or fragments of cDNAs, fixed to a solid support. Typical polynucleotides are about 6-60 nucleotides in length, or about 15-30 nucleotides in length, or about 18-25 nucleotides in length. For certain types of microarrays or other detection kits/systems, it may be preferable to use oligonucleotides that are only about 7-20 nucleotides in length. In other types of arrays, such as arrays used in conjunction with chemiluminescent detection technology, exemplary probe lengths can be, for example, about 15-80 nucleotides in length, or about 50-70 nucleotides in length, or about 55-65 nucleotides in length, or about 60 nucleotides in length. The microarray or detection kit can contain polynucleotides that cover the known 5' or 3' sequence of a gene/transcript or target SNP site, sequential polynucleotides that cover the full-length sequence of a gene/transcript; or unique polynucleotides selected from particular are as along the length of a target gene/transcript sequence. Polynucleotides used in the microarray or detection kit can be specific to a SNP or SNPs of interest (e.g., specific to a particular SNP allele at a target SNP site, or specific to particular SNP alleles at multiple different SNP sites).

Hybridization assays based on polynucleotide arrays rely on the differences in hybridization stability of the probes to perfectly matched and mismatched target sequence variants. For SNP genotyping, it is generally preferable that stringency conditions used in hybridization assays are high enough such that nucleic acid molecules that differ from one another at as little as a single SNP position can be differentiated. Such high stringency conditions may be preferable when using, for example, nucleic acid arrays of allele-specific probes for SNP detection. In some embodiments, the arrays are used in conjunction with chemiluminescent detection technology.

A polynucleotide probe can be synthesized on the surface of the substrate by using a chemical coupling procedure and an inkjet application apparatus, as described in PCT Publication No. WO 95/25111 . In another aspect, a "gridded" array analogous to a dot (or slot) blot may be used to arrange and link cDNA fragments or oligonucleotides to the surface of a substrate using a vacuum system, thermal, UV, mechanical or chemical bonding procedures.

Methods for using such arrays or other kits/systems, to identify SNPs and haplotypes disclosed herein in a test sample are provided. Such methods typically involve incubating a test sample of nucleic acids with an array comprising one or more probes corresponding to at least one SNP position of the present invention, and assaying for binding of a nucleic acid from the test sample with one or more of the probes. Conditions for incubating a SNP detection reagent (or a kit/system that employs one or more such SNP detection reagents) with a test sample vary. Incubation conditions depend on such factors as the format employed in the assay, the detection methods employed, and the type and nature of the detection reagents used in the assay.

A SNP detection kit/system can include components that are used to prepare nucleic acids from a test sample for the subsequent amplification and/or detection of a SNP-containing nucleic acid molecule. Such sample preparation components can be used to produce nucleic acid extracts

(including DNA and/or RNA), proteins or membrane extracts from any bodily fluids (such as blood, serum, plasma, urine, saliva, phlegm, gastric juices, semen, tears, sweat, etc.), skin, hair, cells (especially nucleated cells), biopsies, buccal swabs or tissue specimens.

Another form of kit is a compartmentalized kit A compartmentalized kit includes any kit in which reagents are contained in separate containers. Such containers include, for example, small glass containers, plastic containers, strips of plastic, glass or paper, or arraying material such as silica. Such containers allow one to efficiently transfer reagents from one compartment to another compartment such that the test samples and reagents are not cross-contaminated, or from one container to another vessel not included in the kit, and the agents or solutions of each container can be added in a quantitative fashion from one compartment to another or to another vessel. Such containers may include, for example, one or more containers which will accept the test sample, one or more containers which contain at least one probe or other SNP detection reagent for detecting one or more of the disclosed SNPs, one or more containers which contain wash reagents (such as phosphate buffered saline, Tris-buffers, etc.), and one or more containers which contain the reagents used to reveal the presence of the bound probe or other SNP detection reagents. The kit can optionally further include compartments and/or reagents for, for example, nucleic acid amplification or other enzymatic reactions such as primer extension reactions, hybridization, ligation, electrophoresis (e.g., capillary electrophoresis), mass spectrometry, and/or laser-induced fluorescent detection. The kit may also include instructions for using the kit.

Microfluidic devices may also be used for analyzing SNPs. Such systems miniaturize and compartmentalize processes such as probe/target hybridization, nucleic acid amplification, and capillary electrophoresis reactions in a single functional device. Such microfluidic devices typically utilize detection reagents in at least one aspect of the system, and such detection reagents may be used to detect one or more of the disclosed SNPs. For genotyping SNPs, an exemplary microfluidic system may integrate, for example, nucleic acid amplification, primer extension, capillary

electrophoresis, and a detection method such as laser induced fluorescence detection.

EXAMPLES

Example 1: Genetic mapping of Mai

Materials and Methods

The methods for genetic mapping are published in Lin, et al, Genetics, 141:391-411 (1995).

Results

S. propinquum containing the Mai locus flowers later than cultivars of S. bicolor used in the U.S.A. Segregation for S, bicolor BTx623 versus S. propinquum alleles at the Mai locus imparts dichotomous phenotype when grown in a temperate environment (Lin, et al, Genetics, 141:391-411 (1995)). Interval mapping (Lander, et al, Genetics, 121:185-199 (1989)) was used to analyze an F₂ population of S. bicolor BTx623, a temperate cultivated sorghum, crossed with S. propinquum, a wild tropical sorghum. As shown in Figure 1, the F₂ population of S. bicolor x S. propinquum demonstrated bimodal distribution of flowering time frequency when grown in a temperate environment. Specifically, S. propinquum (189 ±1.9 days) and most F₂s flowered later than S. bicolor (115.4±7.8 days) when photoperiod was less than 12.5 hours. The Mai locus alone accounts for 85.7% of phenotypic variation in flowering time (Lin, et al., Genetics, 141 :391 -411 (1995)) and mapped to chromosome 6, as later corroborated by independent work in different germplasm (Klein, et al, The Plant Genome, 1 :S12-S26 (2008)).

By testing F3 progeny of recombinants in the region, the locus was mapped between DNA markers separated genetically by 1.1 cM (Figure 2A). The 1.1 cM region containing Mai is, physically, among the largest in the genome, with 60-fold less recombination than the genome- wide average of 0.7 mbp/cM. Spanning 34 million base-pairs (mbp), this region alone contains about 5% of sorghum genomic DNA and 1.3% (-400) of genes. QTLs for many additional traits (beyond flowering) are also closely associated with Mai , including a major dwarfing gene (Lin, et at, Genetics, 141 :391-411 (1995)). Classical literature has defined these loci as Mai and Dw2.

Exotic-converted sorghum pairs were compared in the Mai region to access recombinational information resulting from the independent conversion(s) of about 90 sorghum genotypes. "Conversion" takes 12 generations and 4 years (Stephens, et al. Crop Set, 7:396 (1967)), with one backcross followed by two generations of selfing (lacking DNA markers, this was necessary to phenotypically distinguish heterozygotes from

homozygotes for the recessive photoperiod-insensitive allele). Across the sorghum gene pool, Mai has a singularly large role in the genetic

determination of flowering. Among nine diverse exotic-converted sorghum pairs, all nine are 'converted' (introgressed with chromatin from the photoperiod-insensitive donor line) in the Mai region (Lin, et al Genetics, 141 :391-411 (1995)).

In the Mai region and any other regions that remain heterozygous, an exotic-converted pair offers about 3-4x the recombinational information than could be obtained from a single F2 or recombinant inbred genotype

(estimated using standard formulas: (AHard, Hilgardia, 24:235-278 (1956)). A set of 90 exotic-converted pairs that broadly sample sorghum diversity and BTx406, the donor of day-neutral flowering, were genotyped with 9 SSR loci distributed through the region containing Mai, with a peak introgression frequency of 84%. Haplotypes were determined and are illustrated in Figure 2C, with the dark line indicating the span of converted regions. In the region of greatest conversion, additional genes and DNA markers were

characterized, with a peak conversion frequency of 87% for the 400 bp indel that occurs upstream (5') of the Sb06g012260 gene (Figure 2B;

Sb06g012260 itself was not characterized in this study). Frequencies of conversion at the DNA marker loci are plotted along the sorghum genome sequence, with approximate locations of genes in the sequence shown as cross-hatches along the axis. While the terminal regions that these data exclude from consideration are physically small, they contain the majority of genes.

PRR37, a candidate gene with expression patterns correlated with short-day flowering (Murphy, et al, Proceedings of the National Academy of Science of the United States of America, 108:16469-16474 (2011)), maps outside of this region, with less than 20% conversion (Figure 2B), indicating that it does not account for short-day flowering in most if any exotic sorghums.

Genes in the genomic region experiencing high frequencies of 'conversion' (introgression of day-neutral flowering) were re-sequenced in a diversity panel of 384 accessions (87% landraces, 6% wild types, 6% breeding materials and 1% advanced cultivars) phenotyped for flowering under both short-day and long-day conditions, permitting calculation of a "Photoperiod Index" (PRI) reflecting the flowering behavior of each accession (see Methods for Association Genetics). Prior data on 41 SSR markers permitted investigation of population structure and genetic diversity of the panel, providing the relatedness information needed for formal testing of associations between specific alleles and PRI (Remington, et al,

Proceedings of the National Academy of Science of the United States of America, 98:11479-11484 (2001); Thornsberry, et al, Nature Genetics, 28:286-289 (2001); Yu, et al, Nature Genetics, 38:203-208 (2005)).

Sb06g012260 was a gene discovered to be near the peak frequency of conversion. Sb06g012260 is a gene containing an 'FT' functional domain associated with regulation of flowering in Arabidopsis (Kardailsky, et al, Science, 286:1962-1965 (1999) and Oryza (Kojima, et al, Plant and Cell Physiology, 43 : 1096- 1105 (2002)). Candidate alleles of Sb06g012260 were resequenced in a diversity panel of 384 individuals for which flowering time was known (see Example 3).

Analysis of this resequencing data identified two major haplotypes (each with two rare variants), one closely resembling the allele found in the short-day flowering accession of S. propinquwn (Figure 3 A), and the other showing greatest abundance in sorghums from South Africa, the most temperate part of the pre-Columbian range (Figure 4). Statistically- significant association of these haplotypes with PRI were found in

subpopulations in which the two haplotypes each occur at similar frequencies (Figure 4 and Figure 5 A, 5B, and 5C). Figure 5 A, 5B, 5C are based on SNPs from the coding sequence of the Mai gene. The Figures show independent analysis of each subpopulation. TASSEL association analysis including all the subpopulations and the covariance by the population structure is discussed in more detail below and shown in Tables 1 and 2.

Figures 5 A, 5B, and 5C showing flowering (days) for individuals having a short-day haplotype or a day neutral haplotype for the gene

Sb06g012260 in West Africa (Figure 5 A, 2008, p-0.005; R²=0.13) and South Africa (Figure 5B (2008), p=3.84 E-08; R =0.33; and Figure 5C (2007), p=0.0346; R²=0.08). These data also show a statistically-significant association of the haplotypes with flowering in subpopulations in which the two haplotypes each occur at similar frequencies. The most informative subpopulation, sorghums originating in the South Africa region, is the subpopulation in which the day-neutral allele (haplotype) occurs at highest frequency.

The day-neutral haplotype included four deletions: (1) a 423 base pair deletion in the 5' UTR of the Sb06g012260 (2) a -4.2 kb deletion in the 5' UTR of the Sb06g012260, (3) a three base pair deletion starting about 221 base pairs upstream of the Sb06g012260 transcription-start site, and (4) a 27 base pair deletion in the second intron; and five synonymous single nucleotide polymorphism mutations (SNPs) in the coding sequence (Figure 3B). Among the four deletions of the day-neutral haplotype, the 3-bp deletion is particularly damaging, removing from the Sb06g012260 promoter a CAAT box, an invariant DNA sequence in many eukaryotic promoters required for sufficient transcription (Berg, et al., Biochemistry, 5 Ed.

(2002)).

Other elements of the haplotype appear likely to be associated with the phenotype by linkage drag. For example, the 423 bp insertion appears to be a CACTA transposon. CACTA elements have been implicated as a mechanism of movement of genes and gene fragments in sorghum (Paterson, et al, Nature, 457:551-556 (2009)). The element present in the short-day haplotype has a close match in the day-neutral S. bicolor BTx623 genome sequence, presumably its 'parent' element, since that hit is to an autonomous element, while the insertion into S. propinquum has lost ability to transpose. Sequence divergence between the putative 'parent' element and the insertion is 94% - using published approaches to 'date' transposon insertions

(SanMiguel, et al, Nature Genetics, 20:43-45 (1998)) suggests an 'age' of about 2 million years for the element. This suggests that the insertion may have only occurred in the S. bicolor/S. propinquum lineage, since this is much more recent than its divergence from Saccharum and other near relatives.

The approximately 4.2 kb element present in the short-day haplotype contains an inferred open reading frame found on a different chromosome of day-neutral S. bicolor BTx623 (chr. 7, Sb07g008600). Further, this element does not correspond discernibly to any gene of known function, and shows only limited similarity to two other sorghum genes, both also "putative uncharacterized proteins" (Sb03g005850_; Sb08g011060). While a role in short-day flowering cannot yet be ruled out, its presence in day-neutral sorghum argues against a direct role in short-day flowering, and its mobility since the S. bicolor/S. propinquum divergence implies (as for the CACTA element) that it is likely to be an as-yet unrecognized transposon.

The remaining deletion is in the second intron. Example 3: Association Analysis Among Mai Region Markers

Materials and Methods

A public sorghum reference germplasm set that substantially represents the spectrum of diversity in S. bicolor has been characterized with a genome-wide panel of SSRs, and phenotyped for flowering time across a number of diverse environments including some in photoperiods long enough to delay flowering of daylength-sensitive types. These data are freely available, and provide the information needed for formal testing of associations between specific alleles and phenotypes. Because it is predominantly self-pollinating with linkage disequilibrium extending over -15 kb, sorghum is an attractive system in which to employ association genetics to link DNA sequences to their phenotypic consequences.

The diversity panel was evaluated during two different planting seasons representing different day length conditions. The first planting (2007) represented short-day conditions (11.8-12.15 hrs light) and high humidity conditions, conditions under which short-day sorghums (i.e.

photoperiod sensitive) are expected to initiate flowering promptly or similar to neutral day (i.e. photoperiod insensitive). The second (2008) planting was characterized by a transition from long to short-day (13.1 -11.0 hrs) photoperiod and dry conditions, and short-day sorghums would be expected to delay flowering under these conditions.

Flowering time was recorded as the number of days required for 50% of the plants in a single row to flower (DFL50%). Photoperiod Index (PRI) of each accession was defined as the mean difference in DFL50% between the two planting seasons (i.e. PRI = DFL50%2008 - DFL50%2007).

Photoperiod sensitive accessions showed positive PRI values, while negative values identified photoperiod insensitive materials.

Results

TASSEL (Bradbury, et al, Biomformatics, 23:2633-2635 (2007)) was used to perform both linkage disequilibrium analysis and tests of association, the latter employing population structure covariates and a kinship matrix determined for the germplasm panel based on the 80 SSRs. 10 genes distributed across the target region were resequenced, in

most members of the diversity panel (excepting those for which reactions

failed, etc). TASSEL has been used to perform both linkage disequilibrium

analysis and tests of association, the latter employing population structure

covariates and a kinship matrix determined for the germplasm panel based on the existing SSRs.

The results of the resequencing is presented in Tables 1-2, and Figure

6. In partial summary, these data delimit the target region to the interval

between genes Sb06g011767 and Sb06g012520, which is 1.3Mb with 20

annotated genes. The strongest evidence is found at the -4.2 kb indel in the

Sb06g012260 gene.

Table 1 Association analysis among Mai region markers and the photoperiod by single marker analysis

Data Gene Marker df F F df df Error MS Error Rsq Model Rsq Marker

FLOW_2008_2007 SSR7 2 6.0672 0.0026 2 347 472.206 0.0338 0.0338

2.42E-

FLOW_2008_2007 SSRS 2 8.5317 04 2 345 449.7492 0.0471 0.0471

FLOWJ2008J2007 Sb06g010870 2 4.52 0.0116 2 320 483.4132 0.0275 0.0275

FLOW_2008_„2007 Sb06gOH767 1 8.0108 0.0049 1 322 450.9787 0.0243 0.0243

2.94E-

FLOW_2008_2007 400bpINDEL 2 10.8095 05 2 296 454.8433 0.0681 0.0681

1.37E-

FLOW_2008J>007 4kbINDEL 2 16.5587 07 2 340 429.1795 0.0888 0.0888

Sb06g012260 I.S3E-

FLOW_200S_2007 (FT) 2 16.2049 07 2 358 437.37 0.083 0.083

1.88E-

FLOWJ2008J2007 Sb06g012520 2 13.7554 06 2 313 439.8079 0.0808 0.0808

FLOW_2008_2007 Sb06g013230 2 1.3111 0.271 2 315 473.4048 0.0083 0.0083

FLOW 2008 2007 Sb06g0138I0 2 1.4601 0.2337 2 338 474.4558 0.0086 0.0086

Table 2 Association analysis among Mai region markers and the photoperiod with the

correction of population structure (Q)

Data Gene Marker df F PF df df Error MS Error Rsq Mode) Rsq Marker

FLOW_2008_2007 SSR7 2 0.0216 0.9786 6 343 398.859 0.1933 1.02E-04

5.65E-

FLOW_2008_2007 SSR8 2 12.522 06 6 341 358.8457 0.2485 0.0552

FLOW_2008_2007 Sb06g010870 2 1.529 0.2183 6 316 405.8768 0.1937 0.0078

FLOW_2008_2007 Sb06g011767 1 4.0098 0.0461 5 318 386.0947 0.175 0.0104

FLOW_2008_2007 400bpINDEL 2 2.4506 0.088 6 292 377.6165 0.2368 0.0128

6.52E-

FLOW_2008_2007 4kbINDEL 2 7.4975 04 6 336 362.9691 0.2384 0.034

Sb06g012260

FLOW_2008_2007 (FT) 2 6.7615 0.0013 6 354 375.5924 0.2213 0.0297

FLOW_2008_2007 Sb06g012520 2 3.6981 0.0259 6 309 376.269 0.2236 0.0186

FLOW_2008_2007 Sb06g013230 2 1.9067 0.1503 6 311 375.0981 0.2242 0.0095

FLOW_2008_2007 Sb06g013810 2 6.5932 0.0016 6 334 376.9455 0.2216 0.0307 Example 3: P R37 is not Mai

As noted above, PRR37, a candidate gene with expression patterns correlated with short-day flowering (Murphy, et ah, Proceedings of the National Academy of Science of the United States of America, 108:16469- 1 474 (2011)), maps outside of this region, with less than 20% conversion (Figure 3B), indicating that it does not account for short-day flowering in most if any exotic sorghums.

Several additional lines of evidence also show that PR 37 cannot be Mai. The sorghum genotype 100M, used to discern expression patterns correlating the PR 37 candidate allele to short-day flowering (Murphy et ah, Proceedings of the National Academy of Science of the United States of America, 108:16469-16474 (2011)), also contains the short-day haplotype for Sb06g012260, which was confirmed by comparison to the short-day genotype PI209217.

Accordingly, differences in expression patterns between 100M and its near-isogenic line SM100 could be attributable either to P R37,

Sb06g012260, or other intervening genes on the introgressed segment Indeed, in short-day S. propinquwn, PR 37 contains a frameshift mutation that renders the PRR domain and much of the protein nonsensical and also causes premature termination (Figure 3C). While PRR37 cannot account for short-day flowering in most sorghums, prior work by members of the PR 37 team showed it to be in the approximate location of Ma6 (Brady, Texas A&M University, (2006)), a gene with a much smaller effect on flowering.

Homologs of the Mai candidate gene Sb06g0l2260 in sorghum (Paterson, et ah, Nature, 457:551 -56 (2009)), rice (Matsumoto, et ah,

Nature, 436:793-800 (2005)), and Arabidopsis (The Arabidopsis Genome Initiative. Nature, 408:796-815 (2000)) genomes, maize and sugarcane ESTs were identified by BLAST. The sugarcane ESTs were then translated to protein sequences. In total, 6 homologs were found in Arabidopsis (including the FT gene (Kardailsky, et ah, Science, 286(5446): 1962- 1965 (1999)), 19 in rice (including Hd3a (Kojima, et ah, Plant and Cell Physiology,

43(10): 1096-1105 (2002)) and sorghum, 26 in maize and 8 in sugarcane (Figure 7). The candidate gene Sb06g012260 appears to have evolved as a single-gene duplication. Based on a synonymous substitution rate (Ks) of 0.43 from Sb04g008320, currently-used cereal molecular clocks suggest that this duplication occurred ~40Mya (Gaut, et ah, Proc Nat Acad Sci USA 93(19):10274-10279 (1996)). This date is more recent than the estimated divergence of rice and the sorghum/sugarcane/maize lineage, consistent with the finding that a positional ortholog was not discerned in rice. Sb04g008320 does have a rice ortholog (Os02gl3830.1) of unknown function. Other members of the sorghum gene family do have rice orthologs, and several of the sorghum family members are much more similar to rice Hd3a

(Os06g06320.1) than is the Mai candidate gene (Sb06g012260).

For Sb06g012260, a single maize ortholog, GRMZM2G019993, was identified on maize chromosome 2. Since maize has experienced a genome duplication since the divergence of the sorghum and maize lineages, the apparent presence of only one ortholog in the maize genome implies that a second duplicated copy was lost in maize. The missing homeolog would, if still present, be located on maize chrl O, at approximately 105Mb.

Independent research has suggested the possibility of a major flowering time quantitative trait locus on maize chromosome 10 (Ducrocq, et ah, Genetics, 183:1555-1563 (2009); Coles, et ah, Genetics, 184:799-812 (2010)) and the presence of numerous candidate genes including an FT homolog (ZCN19; (Chardon, et ah, Genetics, 168(4):2169-85 (2004); (Danielevskaya, et ah, Plant Physiology, 146:250-64 (2008)). In the present maize genome sequence (Schnable, et al, Science, 326(5956):! 112-15 (2009)), there are 4 maize FT genes on chromosome 10, but none at 105 Mb

(GRMZM2G338454 chrl0:5Mb; AC214791.2_FG002 chrl0:45Mb;

AC217051.3JFG006 chrl0:l 14Mb; GRMZM2G062052 chrl0:127Mb). The one of these closest to the target position

(AC217051.3_FG006 chrl 0:114Mb) is highly divergent in sequence from Sb06g012260, suggesting that it is not likely to be the ortholog.

Example 4: S. halepense has a Mutation in the Sb06g012260 Promoter

The invasive plant Sorghum halepense, or 'Johnson Grass', has adapted to day-neutral photoperiod independently of, and perhaps even more rapidly than, breeder-improved sorghum. Sorghum halepense is a tetraploid

derived from a naturally-occurring cross between wild forms of S. bicolor

and S. propinquum (Celarier, Bull Torrey Bot Club, 85:49-62 (1958);

Paterson, et at, Proceedings of the National Academy of Sciences of the

United States of America, 92:6127-6131 (1995)). Being largely inbreeding,

its wild progenitors would have each been expected to be homozygous for

the short-day flowering Mai allele, with tetraploid S. halepense (also

inbreeding) receiving 4 copies of the allele. Among the limited sampling

available in the US National Plant Germplasm collection, two Old World

accessions ΡΪ209217 from South Africa and PI271616 from India were

confirmed to be short-day flowering - these were also both homozygous for

the short-day haplotype. However, many or all U.S. populations of S.

halepense are believed to include many members that flower in the long days of the temperate summer.

In S. halepense naturalized in the U.S., the central portion of the

short-day flowering haplotype has been largely replaced with a segment that

includes a different mutation in the Sb06g012260 promoter. The results of a

sampling of 480 plants is summarized in Table 4.

Table 4: Presence or Absence of 4 mutations in S. halepense

(% among unambiguous genotypes)

400bp 4.2kb 3bp intron

Non-ambiguous genotypes % among non-ambiguous genotypes

B: Day-neutral S. bicolor genotype; 0.47% 5.71% 0.00% 0.22%

P: Short-day S. propinquum genotype 81.63% 1.14% 10.37% 88.16%

H: S. halepense genotype 0.00% 0.00% 1.67% 0.00%

BP 17.91% 93.15% 3.68% 11.62%

BH (at least one B and one H allele) 0.00% 0.00% 0.67% 0.00%

PH 0.00% 0.00% 72.24% 0.00%

BPH (at least one allele each of B, P, and H) 0.00% 0.00% 10.70% 0.00%

Ambiguous genotypes % among total sample

PH-like (closely resembles PH) 0.00% 0.00% 29.43% 0.00%

Other 11.63% 9.59% 24.03% 5.26% Among 480 plants sampled equally from each of five 5^*. halepense populations from GA, TX (2), NE, and NJ, USA (Morrell, et al, Molecular Ecology, 14:2143-2154 (2005)), 81.6% and 88.2% of plants scorable (i.e. excluding amplification failures or ambiguous migration patterns) were homozygous for the short-day haplotype at both terminal loci (423 bp, intron indels), but only 1.1 and 10.4% at the two internal loci (4,186 and 3 nt indels) (Table 4). Only 39 bp upstream from the site of the CAAT box deletion in day-neutral S. bicolor,. 85.3% of the tetraploid S. halepense plants have at least one copy (with 1.7% being homozygous for all four copies, but noting that 1 , 2, or 3 copies cannot be distinguished in this tetraploid) of a 4 nt insertion (i.e. not found in either progenitor) that disrupts a TC-rich repeat, a cis-acting element involved in defense and stress response

(bioinformatics.psb.ugent.be/webtools/plantcare/html ). TC-rich repeats are enriched in the promoters of photoperiod-responsive genes, and photoperiod- responsiveness is thought to integrate multiple light-, hormone-, and stress- responsive elements (Mongkolsiriwatana, et al, Nat. Set, 43:164-177 (2009)). Further, 98.9% also have at least one copy of the day-neutral (deletion) allele at the 4, 186 nt indel, 5.7% being homozygous for the deletion. Finally, 15.7% of plants also carry one or more copies of the 3 nt deletion.

The adaptation of S. halepense to the temperate climate of the continental U.S.A. may predate the scientific breeding of day-neutral sorghums. Selection of day-neutral Mai alleles occurred during the first 40 years of the 20^th century (Quinby, Texas A&M University Press (1974); Smith, et at, John Wiley and Sons, (2000)) while S. halepense was well- established in the U.S.A. by 1847 and of sufficient importance in 1 00 to be the subject of the first federal appropriation for weed control (McWhorter, Weed Science, 19:496 (1971)).

Sb06g012260 appears to have evolved as a single-gene duplication (Figure 7), shortly after the oryzoid (rice)— panicoid

(sorghum/sugarcane/maize) divergence. Based on a Ks of 0.43 from its nearest homolog, Sb04g008320, this duplication is an estimated 40 million years old (Gaut, et al, Proceedings of the National Academy of Sciences of the United States of America, 93:10274-10279 (1996)), consistent with the lack of a rice ortholog. Sb04g008320 does have a rice ortholog

(Os02gl3830.1), although of unknown function.

Sb06g012260 is extensively diverged from other known floral regulators-indeed, no members of its clade have empirically-demonstrated functions (Figure 7). Other sorghum family members do have rice orthoiogs, and some resemble a rice flowering time QTL Hd3

(Os06g06320.1)(Kojima, et al, Plant and Cell Physiology, 43:1096-1105 (2002)). However, Hd3a is well over 100 million years distant from

Sb06g012260, even more than are the nearest Arabidopsis genes. One family member, Sb02g029725, locates near the likelihood peak of a second sorghum flowering QTL with a small phenotypic effect (FlrAvgBl: Lin et al 1995). Sb06g012260 has a single maize ortholog, GRMZM2G019993, on chromosome 2. Since the maize genome duplicated after its divergence with the sorghum lineage, the presence of only one maize ortholog implies that a second one was lost, from chromosome 10 at ~105Mb. Maize chromosome 10 contains a major flowering time QTL (Ducrocq, et al, Genetics,

183:1555-1563 ( 2009); Coles, et al, Genetics, 184 (2010)) and four FT homologs (Schnable, et al, Science, 326: 1112-1115 (2009)), but the nearest to 105 Mb (AC217051.3_FG006 chrl 0: 114Mb) is so divergent in sequence from Sb06g012260 that it is not considered orthologous (Figure 7).

The importance of Mai to fecundity, via flowering, may have contributed to the evolution of a 'coadapted gene complex' (Lande, Genetical Research, 26:221-235 (1975)) with cis-linkage of alleles at different loci that collectively confer an adaptive phenotype, perhaps facilitated by the recalcitrance of the region to recombination. The Mai region also holds dw2, the gene of largest effect on sorghum stature (height) (Lin, et al, Genetics, 141 :391-411 (1995)), but which can be separated from Mai by infrequent recombination (Quinby, Texas A&M University Press (1974); Lin, Texas A&M University (1998);. Increased height naturally confers a competitive advantage in light interception. Favorable alleles at different genes that conferred both optimal height and flowering time to the same progeny by virtue of the suppressed recombination in this genomic region, might have become fixed more quickly than independently- segregating alleles. Flowering time and plant height were correlated in the diversity panel (r=0.53 in 2007, 0.73 in 2008, each significant at 0.001). While the strongest statistical association we found with plant height was at Sb06g012260 itself (p=0.007), there was also an association at Sb06g007330 (p=0.023), a putative cation efflux family protein. A putatively intervening gene, Sb06g010870, showed no association but could have recently formed alleles or be at an incorrect location, noting that this recombinationally- recalcitrant region is among the most repetitive in the sorghum genome and therefore one of the most difficult in which to assemble whole-genome shotgun sequence (Paterson AH et al. Nature, 457(7229):551-56 (2009)) .

Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of skill in the art to which the disclosed invention belongs. Publications cited herein and the materials for which they are cited are specifically incorporated by reference.

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

Claims

We claim:

1. An isolated nucleic acid, comprising a nucleic acid sequence at least 90% identical to SEQ ID NO:l, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

2. An isolated nucleic acid, comprising a nucleic acid sequence that hybridizes under stringent conditions to a polynucleotide consisting of the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28,

29, 30, 31 , 32, 33, 34, or a complement thereof.

3. An isolated nucleic acid, comprising a photoperiod sensitive control sequence 90% identical to SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 or a complement thereof.

4. An isolated nucleic acid, comprising a photoperiod insensitive control sequence at least 90% identical to SEQ ID NO:27 or a complement thereof.

5. An isolated nucleic acid, comprising a nucleic acid sequence that hybridizes under stringent conditions to the isolated nucleic acid of claims 3 or 4.

6. A recombinant expression vector, comprising a nucleic acid sequence at least 90% identical to SEQ ID NO: 1, 2, 3, , 5, 6, 9, 10, 12, 13, 28, 29,

30, 1, 32, 33, 34 or a complement thereof.

7. A recombinant expression vector, comprising a nucleic acid sequence at least 90% identical to SEQ ID NO: 7, 11, 29, 31, 33 or a complement thereof.

8. The recombinant expression vector of claim 7, further comprising a heterologous expression control sequence.

9. The recombinant expression vector of claim 8, wherein the heterologous expression control sequence comprises a constitutive promoter.

10. The recombinant expression vector of claim 8, wherein the heterologous expression control sequence comprises a tissue specific promoter.

11. A recombinant expression vector, comprising the isolated nucleic acid of claim 3, or the complement thereof, operably linked to a heterologous plant gene, wherein the nucleic acid sequence of claim 3 imposes

photoperiod sensitivity on the heterologous plant gene.

12. A recombinant expression vector, comprising the isolated nucleic acid of claim 4, or the complement thereof, operably linked to a heterologous plant gene, wherein the nucleic acid sequence of claim 3 imposes

photoperiod insensitivity on the heterologous plant gene.

13. A transgenic plant or transgenic plant cell, comprising an expression control sequence operably linked to a nucleic acid sequence that silences expression of a polynucleotide having a nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

14. The transgenic plant or plant cell of claim 13, wherein the transgenic plant has lower photoperiod sensitivity compared to non-transgenic plant of the same species.

15. The transgenic plant or plant cell of claim 13 wherein the transgenic plant or plant cell is selected from the group consisting of Brassica family, industrial oilseeds, Arabidopsis thaliaria, algae, soybean, cottonseed, sunflower, palm, coconut, rice, safflower, peanut, mustards, silage corn, alfalfa, switchgrass, miscanthus, sorghum, tobacco, sugarcane and flax.

16. The transgenic plant or plant cell of claim 15 wherein the transgenic plant or plant cell is a dicotyledon.

17. The transgenic plant or plant cell of claim 15 wherein the transgenic plant or plant cell is a monocotyledon.

18. A seed from the plant of any one of claims 13 to 17.

19. A method of delaying flowering in a plant, comprising introducing to the plant a nucleic acid sequence that silences expression of a polynucleotide having the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

20. The method of claim 19, wherein the plant is a dicotyledon.

21. The method of claim 19, wherein the plant is a monocotyledon.

22. The method of claim 19, wherein the plant has lower photoperiod sensitivity compared to a control plant of the same species.

23. A method of identifying an agent that modulates plant photoperiod sensitivity, comprising

contacting a cell containing an Mai gene with a candidate agent under conditions suitable for Mai gene expression; and

detecting the effect of the candidate agent on Mai gene expression, wherein an detectable increase or decrease in Mai gene expression is an indication that the candidate agent modulates plant photoperiod sensitivity.

24. The method of claim 23, wherein the Mai gene comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 1 1, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or a complement thereof.

25. A method of identifying an agent that modulates plant photoperiod sensitivity, comprising

contacting a cell containing a reporter construct operably linked to an Mai expression control sequence with a candidate agent under conditions suitable for reporter expression; and

detecting the effect of the candidate agent on reporter expression, wherein an detectable increase or decrease in reporter expression is an indication that the candidate agent modulates plant photoperiod sensitivity.

26. The method of claim 25, wherein the Mai expression control sequence comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 or a complement thereof.

27. A method of imposing photoperiod sensitivity on a plant process comprising producing a recombinant nucleic acid molecule comprising a plant gene responsible for the plant process operably linked to a photoperiod sensitive Mai expression control sequence.

28. The method of claim 27, wherein the Mai expression control sequence comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 or a complement thereof.

29. The method of claims 27-28 wherein the plant process is not naturally photoperiod sensitive.

30. A method of imposing photoperiod insensitivity on a plant process comprising producing a recombinant nucleic acid molecule comprising a plant gene responsible for the plant process operably linked to a photoperiod insensitive Mai expression control sequence.

31. The method of claim 30, wherein the Mai expression control sequence comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 27 or a complement thereof.

32. The method of claims 30-31 wherein the plant process is not naturally photoperiod insensitive.

33. A transgenic plant or transgenic plant cell, comprising a plant gene controlling a plant process operably linked to an Mai expression control sequence.

34. The transgenic plant or transgenic plant cell, wherein the Mai expression control sequence is a photoperiod sensitive expression control sequence.

35. The transgenic plant of claim 34, wherein the Mai expression control sequence comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 or a complement thereof.

36. The transgenic plant of claims 34-35 wherein the plant process is not naturally photoperiod sensitive.

37. The transgenic plant or transgenic plant cell, wherein the Mai expression control sequence is a photoperiod insensitive expression control sequence.

38. The transgenic plant of claim 37, wherein the Mai expression control sequence comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 27 or a complement thereof.

39. The transgenic plant of claims 37-38 wherein the plant process is not naturally photoperiod insensitive.

40. A method of delaying flowering in plant comprising altering the sequence of SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 or variants thereof in the plant.

41. The method of claim 40, wherein the altering comprises introducing one or more nucleic acid substitutions, additions, deletions or a combination thereof in SEQ ID NO: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 or variants thereof.

42. A method of increasing or accelerating flowering in a plant, comprising introducing to the plant a nucleic acid sequence comprising a nucleic acid sequence at least 90% identical to SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

43. A method of increasing or accelerating flowering in a plant, comprising introducing to the plant a nucleic acid sequence that increases expression of a polynucleotide having the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

44. The method of claim 43 wherein the nucleic acid sequence that increases expression is a constructively active plant promoter operably linked to a polynucleotide having at least 90% sequence identity to the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 9, 10, 1 1, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

45. The method of claim 43 wherein the nucleic acid sequence that increases expression is a heterologous photoperiod sensitive plant promoter operably linked to a polynucleotide having at least 90% sequence identity to the nucleic acid sequence SEQ ID NO: 1, 2, 3, 4, 5, , 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

46. A transgenic plant comprising a heterologous expression control sequence operably linked to a polynucleotide comprising a nucleic acid sequence at least 90% identical to the nucleotide sequence of SEQ ID NO: 1, 2, 4, 5, 6, 7, 9, 10, 11, 12, 13, 28, 29, 30, 31, 32, 33, 34 or a complement thereof.

47. The transgenic plant of claim 46 wherein the expression control sequence is a photoperiod sensitive plant promoter that increases photoperiod sensitive expression of the polynucleotide.

48. A transgenic plant with increased photoperiod sensitive flowering comprising a promoter with one or more CAAT boxes operatively linked to Mai , wherein the transgenic plant has increased photoperiod sensitivity relative to a non-transgenic plant of the same species.

49. The transgenic plant of claim 48 wherein Mai comprises the nucleic acid sequence of SEQ ID NO: 1, 2, 4, 5, 6, 7, 9, 10, 11, 12, or 13.

50. The transgenic plant of claim 48 wherein the one or more boxes comprises the nucleic acid sequence of SEQ ID NO:24, 25, 26, or combinations thereof.

51. The transgenic plant of claim 48 wherein the promoter and Mai are expressed from an extrachromosomal vector.

52. The transgenic plant of claim 48 wherein the promoter and Mai are integrated into the plant's chromosome.